Unnamed: 0
stringlengths 3
8
| Date
stringlengths 23
23
| Article_title
stringlengths 1
250
| Stock_symbol
stringlengths 1
5
| Url
stringlengths 44
135
| Publisher
stringclasses 1
value | Author
stringclasses 1
value | Article
stringlengths 1
343k
| Lsa_summary
stringlengths 3
53.9k
| Luhn_summary
stringlengths 1
53.9k
| Textrank_summary
stringlengths 1
53.9k
| Lexrank_summary
stringlengths 1
53.9k
| uuid
stringlengths 36
36
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
712400.0
|
2023-12-12 00:00:00 UTC
|
Seacoast Banking (SBCF) Moves 5.1% Higher: Will This Strength Last?
|
DCOMP
|
https://www.nasdaq.com/articles/seacoast-banking-sbcf-moves-5.1-higher%3A-will-this-strength-last
|
nan
|
nan
|
Seacoast Banking SBCF shares soared 5.1% in the last trading session to close at $29.28. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.6% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the SBCF stock higher in last day’s trading session.
This holding company for Seacoast National Bank is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of +17.7%. Revenues are expected to be $135.28 million, down 1.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Seacoast Banking, the consensus EPS estimate for the quarter has been revised 1.3% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on SBCF going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Seacoast Banking is a member of the Zacks Banks - Southeast industry. One other stock in the same industry, Capstar Financial CSTR, finished the last trading session 3.9% higher at $19.10. CSTR has returned 11.4% over the past month.
Capstar Financial's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.33. Compared to the company's year-ago EPS, this represents a change of -29.8%. Capstar Financial currently boasts a Zacks Rank of #3 (Hold).
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Seacoast Banking Corporation of Florida (SBCF) : Free Stock Analysis Report
Capstar Financial (CSTR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This holding company for Seacoast National Bank is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of +17.7%. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
This holding company for Seacoast National Bank is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of +17.7%. Capstar Financial's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.33. Click to get this free report Seacoast Banking Corporation of Florida (SBCF) : Free Stock Analysis Report Capstar Financial (CSTR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Seacoast Banking is a member of the Zacks Banks - Southeast industry. Click to get this free report Seacoast Banking Corporation of Florida (SBCF) : Free Stock Analysis Report Capstar Financial (CSTR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This holding company for Seacoast National Bank is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of +17.7%. For Seacoast Banking, the consensus EPS estimate for the quarter has been revised 1.3% higher over the last 30 days to the current level. Compared to the company's year-ago EPS, this represents a change of -29.8%.
|
aba730bb-adf2-4d02-9ec2-aff892394a19
|
712401.0
|
2023-12-12 00:00:00 UTC
|
Zions (ZION) Soars 9.2%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/zions-zion-soars-9.2%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Zions ZION shares soared 9.2% in the last trading session to close at $45.67. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.9% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the ZION stock higher in last day’s trading session.
This financial holding company is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of -42.4%. Revenues are expected to be $755.15 million, down 14.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Zions, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ZION going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Zions is a member of the Zacks Banks - West industry. One other stock in the same industry, First Financial Northwest FFNW, finished the last trading session 0.2% higher at $12.78. FFNW has returned 16.7% over the past month.
First Financial's consensus EPS estimate for the upcoming report has changed +5.1% over the past month to $0.14. Compared to the company's year-ago EPS, this represents a change of -60%. First Financial currently boasts a Zacks Rank of #3 (Hold).
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Zions Bancorporation, N.A. (ZION) : Free Stock Analysis Report
First Financial Northwest, Inc. (FFNW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This financial holding company is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of -42.4%. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
This financial holding company is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of -42.4%. First Financial's consensus EPS estimate for the upcoming report has changed +5.1% over the past month to $0.14. (ZION) : Free Stock Analysis Report First Financial Northwest, Inc. (FFNW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Zions is a member of the Zacks Banks - West industry. (ZION) : Free Stock Analysis Report First Financial Northwest, Inc. (FFNW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This financial holding company is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of -42.4%. First Financial's consensus EPS estimate for the upcoming report has changed +5.1% over the past month to $0.14. Compared to the company's year-ago EPS, this represents a change of -60%.
|
14ebd8bd-31db-4522-977a-1c818e66cf5b
|
712402.0
|
2023-12-12 00:00:00 UTC
|
5 Stocks to Boost Your Portfolio as Fed Keeps Rate Unchanged
|
DCOMP
|
https://www.nasdaq.com/articles/5-stocks-to-boost-your-portfolio-as-fed-keeps-rate-unchanged
|
nan
|
nan
|
The Federal Reserve left its benchmark policy rate unchanged in the range of the current 5.25-5.5% on Dec 13 in its final FOMC meeting of the year. Wall Street rallied following the announcement, with all three major indexes — the Dow, the S&P 500 and the Nasdaq — recording a jump of 1.4% each.
The Dow ended at 37,090.24 points, its first record close since January 2022. Understandably, investors’ sentiment is high as they believe that the Fed may end its monetary tightening campaign anytime now as inflation continues to cool.
The Fed’s decision was highly anticipated as inflation cooled further in November. The consumer price index (CPI) increased 3.1% last month on a year-over-year basis, the Labor Department said on Dec 12. Month over month CPI increased just 0.1%.
Following the decision to keep interest rates unchanged for the third straight time this year, Fed officials maintained a dovish stance. Federal Reserve Chairman Jerome Powell said that he believes that the current policy rate is near or at its peak, and the central bank will closely monitor inflation data and try not to keep interest rates high for a longer period.
Also, the Fed projected three interest rate cuts of 25 basis points each next year, which is expected to take the policy rate to 4.6% by the end of 2024, lower than the earlier forecast of 5.1%.
Lower interest rates are certainly going to make borrowing costs cheaper. This has raised investors’ confidence as they now expect a softer landing for the economy.
Given this situation investing in consumer discretionary stocks like Accel Entertainment, Inc. ACEL, DoubleDown Interactive Co., Ltd. DDI, Hooker Furnishings Corporation HOFT,Lululemon Athletica Inc. LULU and Warner Music Group Corp. WMG would be a prudent choice.
Our Choices
We have identified five stocks from the consumer discretionary sector that are likely to benefit from the Fed’s decision to keep interest rates unchanged. Each of these stocks carries a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Accel Entertainment, Inc. is a distributed gaming operator primarily in the United States. ACEL’s business consists of the installation, maintenance and operation of VGTs, redemption devices, which disburse winnings and contain ATM functionality, and other amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops and grocery stores.
Accel Entertainment’sexpected earnings growth rate for the current year is 3.5%. The Zacks Consensus Estimate for current-year earnings has improved 11.1% over the past 60 days. ACEL presently has a Zacks Rank #2.
DoubleDown Interactive Co., Ltd. is a developer and publisher of digital social casino games based in Seattle.
DoubleDown Interactive’s expected earnings growth rate for the current year is 334.8%. The Zacks Consensus Estimate for current-year earnings has improved 9.3% over the past 60 days. DDI currently sports a Zacks Rank #1.
Hooker Furnishings Corporation is a leading manufacturer and importer of residential furniture, primarily targeted at the upper-medium price range. HOFT offers diversified products, consisting primarily of home office, entertainment centers, imported occasional, bedroom, and wall systems, across many style categories within this price range.
Hooker Furnishings’ expected earnings growth rate for the current year is 12.4%. The Zacks Consensus Estimate for current-year earnings has improved 70.6% over the past 60 days. HOFT presently sports a Zacks Rank #1.
Lululemon Athletica Inc. designs, manufactures and distributes athletic apparel and accessories for women, men and female youth. LULU offers a line of apparel assortment, including fitness pants, shorts, tops and jackets designed for healthy lifestyle and athletic pursuits, such as yoga, training, and running as well as other sweaty and general fitness under the lululemon athletica brand name.
Lululemon Athletica’s expected earnings growth rate for the current year is 22.9%. The Zacks Consensus Estimate for the current-year earnings has improved 2.1% over the past 60 days. LULU presently carries a Zacks Rank #2.
Warner Music Group Corp. is a music-based content company. WMG’s operating segment consists of Recorded Music and Music Publishing. The Recorded Music segment is involved in the discovery and development of recording artists. Music Publishing owns and acquires rights. Warner Music Groupoperates principally in the United States, the United Kingdom and internationally.
Warner Music Group’s expected earnings growth rate for the current year is 23.8%. The Zacks Consensus Estimate for current-year earnings has improved 5.7% over the past 60 days. WMG presently has a Zacks Rank #2.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
lululemon athletica inc. (LULU) : Free Stock Analysis Report
Hooker Furnishings Corp. (HOFT) : Free Stock Analysis Report
Accel Entertainment, Inc. (ACEL) : Free Stock Analysis Report
Warner Music Group Corp. (WMG) : Free Stock Analysis Report
DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Understandably, investors’ sentiment is high as they believe that the Fed may end its monetary tightening campaign anytime now as inflation continues to cool. Given this situation investing in consumer discretionary stocks like Accel Entertainment, Inc. ACEL, DoubleDown Interactive Co., Ltd. DDI, Hooker Furnishings Corporation HOFT,Lululemon Athletica Inc. LULU and Warner Music Group Corp. WMG would be a prudent choice. HOFT offers diversified products, consisting primarily of home office, entertainment centers, imported occasional, bedroom, and wall systems, across many style categories within this price range.
|
Given this situation investing in consumer discretionary stocks like Accel Entertainment, Inc. ACEL, DoubleDown Interactive Co., Ltd. DDI, Hooker Furnishings Corporation HOFT,Lululemon Athletica Inc. LULU and Warner Music Group Corp. WMG would be a prudent choice. Warner Music Group’s expected earnings growth rate for the current year is 23.8%. Click to get this free report lululemon athletica inc. (LULU) : Free Stock Analysis Report Hooker Furnishings Corp. (HOFT) : Free Stock Analysis Report Accel Entertainment, Inc. (ACEL) : Free Stock Analysis Report Warner Music Group Corp. (WMG) : Free Stock Analysis Report DoubleDown Interactive Co., Ltd.
|
Given this situation investing in consumer discretionary stocks like Accel Entertainment, Inc. ACEL, DoubleDown Interactive Co., Ltd. DDI, Hooker Furnishings Corporation HOFT,Lululemon Athletica Inc. LULU and Warner Music Group Corp. WMG would be a prudent choice. Warner Music Group’s expected earnings growth rate for the current year is 23.8%. Click to get this free report lululemon athletica inc. (LULU) : Free Stock Analysis Report Hooker Furnishings Corp. (HOFT) : Free Stock Analysis Report Accel Entertainment, Inc. (ACEL) : Free Stock Analysis Report Warner Music Group Corp. (WMG) : Free Stock Analysis Report DoubleDown Interactive Co., Ltd.
|
Also, the Fed projected three interest rate cuts of 25 basis points each next year, which is expected to take the policy rate to 4.6% by the end of 2024, lower than the earlier forecast of 5.1%. Given this situation investing in consumer discretionary stocks like Accel Entertainment, Inc. ACEL, DoubleDown Interactive Co., Ltd. DDI, Hooker Furnishings Corporation HOFT,Lululemon Athletica Inc. LULU and Warner Music Group Corp. WMG would be a prudent choice. Lululemon Athletica’s expected earnings growth rate for the current year is 22.9%.
|
b14c64c1-5d03-4578-a9f1-99c17c4f3d10
|
712403.0
|
2023-12-12 00:00:00 UTC
|
Why Enterprise Products Partners (EPD) Outpaced the Stock Market Today
|
DCOMP
|
https://www.nasdaq.com/articles/why-enterprise-products-partners-epd-outpaced-the-stock-market-today
|
nan
|
nan
|
Enterprise Products Partners (EPD) closed the most recent trading day at $26.49, moving +1.11% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.27%. At the same time, the Dow added 0.43%, and the tech-heavy Nasdaq gained 0.19%.
Heading into today, shares of the provider of midstream energy services had lost 0.15% over the past month, outpacing the Oils-Energy sector's loss of 1.25% and lagging the S&P 500's gain of 6.94% in that time.
The investment community will be closely monitoring the performance of Enterprise Products Partners in its forthcoming earnings report. The company is forecasted to report an EPS of $0.66, showcasing a 1.54% upward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $12.87 billion, indicating a 5.73% decline compared to the corresponding quarter of the prior year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $2.48 per share and a revenue of $47.81 billion, indicating changes of -1.59% and -17.84%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Enterprise Products Partners. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.93% lower within the past month. Enterprise Products Partners is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that Enterprise Products Partners has a Forward P/E ratio of 10.56 right now. For comparison, its industry has an average Forward P/E of 12.83, which means Enterprise Products Partners is trading at a discount to the group.
The Oil and Gas - Production Pipeline - MLB industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 160, which puts it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Enterprise Products Partners L.P. (EPD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Heading into today, shares of the provider of midstream energy services had lost 0.15% over the past month, outpacing the Oils-Energy sector's loss of 1.25% and lagging the S&P 500's gain of 6.94% in that time. In the meantime, our current consensus estimate forecasts the revenue to be $12.87 billion, indicating a 5.73% decline compared to the corresponding quarter of the prior year. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Enterprise Products Partners (EPD) closed the most recent trading day at $26.49, moving +1.11% from the previous trading session. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Enterprise Products Partners. Click to get this free report Enterprise Products Partners L.P. (EPD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This industry currently has a Zacks Industry Rank of 160, which puts it in the bottom 37% of all 250+ industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Click to get this free report Enterprise Products Partners L.P. (EPD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Enterprise Products Partners (EPD) closed the most recent trading day at $26.49, moving +1.11% from the previous trading session. Heading into today, shares of the provider of midstream energy services had lost 0.15% over the past month, outpacing the Oils-Energy sector's loss of 1.25% and lagging the S&P 500's gain of 6.94% in that time. Our research shows that these estimate changes are directly correlated with near-term stock prices.
|
d9eadee4-727c-477a-984d-758d954bc31e
|
712404.0
|
2023-12-12 00:00:00 UTC
|
NextEra Energy (NEE) Outperforms Broader Market: What You Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/nextera-energy-nee-outperforms-broader-market%3A-what-you-need-to-know
|
nan
|
nan
|
The latest trading session saw NextEra Energy (NEE) ending at $62.78, denoting a +0.43% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.27% for the day. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
Shares of the parent company of Florida Power & Light Co. Have appreciated by 9.67% over the course of the past month, underperforming the Utilities sector's gain of 10.86% and outperforming the S&P 500's gain of 6.94%.
The upcoming earnings release of NextEra Energy will be of great interest to investors. The company is expected to report EPS of $0.51, unchanged from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $6.17 billion, showing a 0.14% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of $3.12 per share and a revenue of $27.52 billion, demonstrating changes of +7.59% and +31.32%, respectively, from the preceding year.
Investors should also pay attention to any latest changes in analyst estimates for NextEra Energy. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Currently, NextEra Energy is carrying a Zacks Rank of #3 (Hold).
In terms of valuation, NextEra Energy is presently being traded at a Forward P/E ratio of 20.03. For comparison, its industry has an average Forward P/E of 16.81, which means NextEra Energy is trading at a premium to the group.
Investors should also note that NEE has a PEG ratio of 2.45 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Utility - Electric Power industry currently had an average PEG ratio of 2.93 as of yesterday's close.
The Utility - Electric Power industry is part of the Utilities sector. With its current Zacks Industry Rank of 51, this industry ranks in the top 21% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NextEra Energy, Inc. (NEE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Simultaneously, our latest consensus estimate expects the revenue to be $6.17 billion, showing a 0.14% escalation compared to the year-ago quarter. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The latest trading session saw NextEra Energy (NEE) ending at $62.78, denoting a +0.43% adjustment from its last day's close. For the full year, the Zacks Consensus Estimates project earnings of $3.12 per share and a revenue of $27.52 billion, demonstrating changes of +7.59% and +31.32%, respectively, from the preceding year. Click to get this free report NextEra Energy, Inc. (NEE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With its current Zacks Industry Rank of 51, this industry ranks in the top 21% of all industries, numbering over 250. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Click to get this free report NextEra Energy, Inc. (NEE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The latest trading session saw NextEra Energy (NEE) ending at $62.78, denoting a +0.43% adjustment from its last day's close. Investors should also pay attention to any latest changes in analyst estimates for NextEra Energy. Currently, NextEra Energy is carrying a Zacks Rank of #3 (Hold).
|
9fc37ec1-1dd5-491e-ba8f-f1b351265521
|
712405.0
|
2023-12-12 00:00:00 UTC
|
Here's Why Holding Interpublic Group (IPG) is a Good Decision
|
DCOMP
|
https://www.nasdaq.com/articles/heres-why-holding-interpublic-group-ipg-is-a-good-decision
|
nan
|
nan
|
Interpublic Group’s IPG innovation with IPG Health's inclusive clinical trials, IPG Mediabrands' Retail Media Solution and Real IDä for post-cookie identity resolution are bolstering the company’s growth. IPG's strategic acquisitions focus on high-growth sectors globally, with 11 completed from 2018 to 2022.
Factors That Bode Well
Interpublic Group is capitalizing on innovative product launches. IPG Health is pioneering an initiative to promote diversity in clinical trials through a holistic approach involving medical expertise, data analytics and patient engagement. Simultaneously, IPG Mediabrands is rolling out the Unified Retail Media Solution to tackle challenges in the expanding Retail Media Networks landscape. Furthermore, Interpublic Group has introduced Real IDä in the Cloud, an identity resolution application by Acxiom, which prioritizes consumer privacy in a post-cookie era and highlights IPG's commitment to innovation and client success.
The company's steadfast dedication to enhancing shareholder returns positions it as a dependable choice for long-term wealth accumulation. Demonstrating this commitment, it disbursed dividends of $457.3 million in 2022, $427.7 million in 2021 and $398.1 million in 2020. These consistent dividend payouts reflect its commitment to generating value for shareholders and underscore its confidence in the strength of its business.
Interpublic Group adheres to a strategic and disciplined approach to acquisitions, concentrating on high-growth capabilities and diverse geographic markets. The company consistently invests globally, acquiring and investing in companies to broaden its product portfolio and aligning with the evolving landscape of marketing services and media opportunities.
Interpublic Group of Companies, Inc. (The) Revenue (TTM)
Interpublic Group of Companies, Inc. (The) revenue-ttm | Interpublic Group of Companies, Inc. (The) Quote
In recent years, Interpublic Group has pursued acquisitions spanning the marketing spectrum, encompassing data, technology, e-commerce and healthcare communication firms, as well as agencies with comprehensive service capabilities. The company concluded one acquisition in 2022, four in 2020, one in 2019 and five in 2018.
Risks
IPG’s cash position is affected by seasonality in business. This is because of clients’ fluctuating annual media spending budgets and changing media spending patterns, which vary throughout the year with different localities. Seasonality is observed in the first nine months of a year, with the biggest impact in the first quarter.
Interpublic Group’s current ratio at the end of third-quarter 2023 was pegged at 1.04, lower than the current ratio of 1.05 reported at the end of the prior-year quarter. A decline in the current ratio does not bode well for the company.
IPG currently carries a Zacks Rank #3 (Hold).
Stocks to Consider
Here are a few better-ranked stocks from the Business Services sector:
Gartner IT: The Zacks Consensus Estimate for Gartner’s 2023 revenues indicates 7.9% growth from the year-ago figure while earnings are expected to decline 1.9%. The company beat the consensus estimate in all the trailing four quarters, with an average surprise of 34.4%.
IT currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FTI Consulting FCN: The Zacks Consensus Estimate for FCN’s 2023 revenues indicates 12.1% growth from the year-ago figure while earnings are expected to grow 3.4%. The company beat the consensus estimate in three of the trailing four quarters and missed on one instance, the average surprise being 8.5%.
FCN carries a Zacks Rank #2 (Buy) at present.
Broadridge Financial Solutions BR: The Zacks Consensus Estimate for Broadridge’s 2023 revenues indicates 7.7% growth from the year-ago figure while earnings are expected to grow 10.1%. The company beat the consensus estimate in three of the past four quarters and matched on one instance, the average surprise being 5.4%.
BR currently has a Zacks Rank of 2.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report
Interpublic Group of Companies, Inc. (The) (IPG) : Free Stock Analysis Report
FTI Consulting, Inc. (FCN) : Free Stock Analysis Report
Gartner, Inc. (IT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
IPG Health is pioneering an initiative to promote diversity in clinical trials through a holistic approach involving medical expertise, data analytics and patient engagement. Furthermore, Interpublic Group has introduced Real IDä in the Cloud, an identity resolution application by Acxiom, which prioritizes consumer privacy in a post-cookie era and highlights IPG's commitment to innovation and client success. Interpublic Group adheres to a strategic and disciplined approach to acquisitions, concentrating on high-growth capabilities and diverse geographic markets.
|
Interpublic Group’s IPG innovation with IPG Health's inclusive clinical trials, IPG Mediabrands' Retail Media Solution and Real IDä for post-cookie identity resolution are bolstering the company’s growth. Broadridge Financial Solutions BR: The Zacks Consensus Estimate for Broadridge’s 2023 revenues indicates 7.7% growth from the year-ago figure while earnings are expected to grow 10.1%. Click to get this free report Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report Interpublic Group of Companies, Inc. (The) (IPG) : Free Stock Analysis Report FTI Consulting, Inc. (FCN) : Free Stock Analysis Report Gartner, Inc. (IT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Interpublic Group’s IPG innovation with IPG Health's inclusive clinical trials, IPG Mediabrands' Retail Media Solution and Real IDä for post-cookie identity resolution are bolstering the company’s growth. Interpublic Group of Companies, Inc. (The) Revenue (TTM) Interpublic Group of Companies, Inc. (The) revenue-ttm | Interpublic Group of Companies, Inc. (The) Quote In recent years, Interpublic Group has pursued acquisitions spanning the marketing spectrum, encompassing data, technology, e-commerce and healthcare communication firms, as well as agencies with comprehensive service capabilities. Click to get this free report Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report Interpublic Group of Companies, Inc. (The) (IPG) : Free Stock Analysis Report FTI Consulting, Inc. (FCN) : Free Stock Analysis Report Gartner, Inc. (IT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Interpublic Group’s IPG innovation with IPG Health's inclusive clinical trials, IPG Mediabrands' Retail Media Solution and Real IDä for post-cookie identity resolution are bolstering the company’s growth. Interpublic Group of Companies, Inc. (The) Revenue (TTM) Interpublic Group of Companies, Inc. (The) revenue-ttm | Interpublic Group of Companies, Inc. (The) Quote In recent years, Interpublic Group has pursued acquisitions spanning the marketing spectrum, encompassing data, technology, e-commerce and healthcare communication firms, as well as agencies with comprehensive service capabilities. You can see the complete list of today’s Zacks #1 Rank stocks here.
|
dd2c17ff-db65-4b17-89a9-dd517db41994
|
712406.0
|
2023-12-12 00:00:00 UTC
|
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
|
DCOMP
|
https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights-biogen-prothena-ac-immunes-and-vaxxinity
|
nan
|
nan
|
For Immediate Release
Chicago, IL – December 12, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Biogen BIIB, Prothena PRTA, AC Immune's ACIU and Vaxxinity, Inc. VAXX.
Here are highlights from Monday’s Analyst Blog:
Alzheimer's Disease Space Evolves in 2023: Stocks in Focus
The Alzheimer's disease (AD) space continued to be in the spotlight in 2023 with the approval of Biogen and Eisai's drug Leqembi, which was initially granted accelerated approval in January.
In July, the drug was granted traditional approval based on data from Eisai's late-stage global Clarity AD clinical study, wherein Leqembi met its primary endpoint and all key secondary endpoints with statistically significant results.
The study confirmed the clinical benefit of Leqembi. The approval made Leqembi the first and only approved anti-amyloid Alzheimer's disease treatment shown to reduce the rate of disease progression and slow down cognitive impairment in the early and mild dementia stages of the disease.
Alzheimer's is a progressive, fatal disease of the brain characterized by a decline in memory, language and other thinking skills, as well as changes in mood and behavior.
We remind readers that this is the second drug from Biogen and Eisai that has won FDA approval. The regulatory body had earlier approved their controversial AD drug, Aduhelm. However, the euphoria surrounding Aduhelm faded soon as the drug witnessed a slow launch due to reimbursement issues as its efficacy was scrutinized.
Nevertheless, investors are now optimistic about the pipeline candidates of other companies developing treatments for AD.
Companies like Eli Lilly and Prothena continue to be in focus in this regard. The space is evolving as there is a renewed interest in AD vaccines now.
The interest comes on the heels of data showing an increase of amyloid-related imaging abnormalities (ARIA) observed in the case of the approved therapies, reflected as vasogenic edema or sulcal effusion (ARIA-E) or as hemosiderin deposits such as microhemorrhages and superficial siderosis (ARIA-H). The ease of administration and less frequent dosing (Leqembi requires twice-monthly infusions) associated with vaccines are also added benefits, which have propelled a few companies to evaluate AD vaccines.
Earlier in the year, the FDA granted Fast Track designation to AC Immune's anti-amyloid beta active immunotherapy (vaccine)-candidate, ACI-24.060, for the treatment of AD.
Per AC Immune, by inducing a polyclonal response, including antibodies against both oligomeric amyloid beta and pyroglutamate- amyloid beta, ACI-24.060 targets the same toxic species as disease-modifying anti-amyloid beta monoclonal antibodies that slowed AD progression in phase III studies.
The company plans to release more data in the first half of 2024 showing the effect of ACI-24.060 on amyloid plaque reduction, a surrogate marker for disease modification.
AC Immune is also developing a potential first-in-class anti-phosphorylated-Tau vaccine candidate for AD with Janssen Pharmaceuticals.
Vaxxinity, Inc. also obtained Fast Track Designation for its AD vaccine UB-311 in the United States. UB-311 targets toxic forms of aggregated amyloid beta in the brain to fight AD.
In August 2023, Vaxxinity announced publication data from a phase IIa study that showed that UB-311 "was safe and well-tolerated," with early clinical data demonstrating a trend for slowing cognitive decline in mild AD.
The phase IIa data showed the safety, tolerability, immunogenicity, and early clinical efficacy of UB-311 when evaluated with quarterly or biannual booster doses. UB-311 demonstrated robust, rapid and titrated antibody response to amyloid beta. It was generally well-tolerated, with no cases of ARIA-E and limited cases of asymptomatic ARIA-H.
Prothena has a portfolio of programs for the potential treatment of AD, including PRX012, which targets amyloid beta and PRX123, a novel dual amyloid beta-tau (Aβ-Tau) vaccine.
Prothena's PRX012, too, is a next-generation subcutaneous antibody being developed for the treatment of AD. It targets a key epitope at the N-terminus of Aβ with high binding potency. Two preclinical studies had earlier shown superior binding characteristics of PRX012, demonstrating a 20-fold higher affinity to Aβ soluble protofibrils when compared with Leqembi and cleared pyroglutamate-modified Aβ at lower concentrations when compared with Eli Lilly's investigational candidate donanemab.
Prothena is also developing a dual Aβ-Tau vaccine, PRX123, — a potential prevention and treatment for AD — to target key epitopes within Aβ and tau proteins to promote amyloid clearance and block pathogenic tau interaction. An investigational new drug application filing for the vaccine is anticipated by the end of 2023.
Reportedly, attempts were made earlier on as well to develop AD vaccines but were shelved after enrolled participants developed a brain inflammation known as meningoencephalitis.
Nevertheless, the approval of Leqembi has now shown how AD treatments work. Hence, AD vaccine makers are now better equipped to develop shots that will not only generate response but also keep inflammation in control.
These experimental vaccines still have a long and challenging path ahead. Breakthroughs in this space will be instrumental in driving growth.
The abovementioned stocks carry a Zacks Rank #3 (Hold) each. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Biogen Inc. (BIIB) : Free Stock Analysis Report
Prothena Corporation plc (PRTA) : Free Stock Analysis Report
AC Immune (ACIU) : Free Stock Analysis Report
Vaxxinity, Inc. (VAXX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The interest comes on the heels of data showing an increase of amyloid-related imaging abnormalities (ARIA) observed in the case of the approved therapies, reflected as vasogenic edema or sulcal effusion (ARIA-E) or as hemosiderin deposits such as microhemorrhages and superficial siderosis (ARIA-H). Earlier in the year, the FDA granted Fast Track designation to AC Immune's anti-amyloid beta active immunotherapy (vaccine)-candidate, ACI-24.060, for the treatment of AD. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.
|
Stocks recently featured in the blog include: Biogen BIIB, Prothena PRTA, AC Immune's ACIU and Vaxxinity, Inc. VAXX. Here are highlights from Monday’s Analyst Blog: Alzheimer's Disease Space Evolves in 2023: Stocks in Focus The Alzheimer's disease (AD) space continued to be in the spotlight in 2023 with the approval of Biogen and Eisai's drug Leqembi, which was initially granted accelerated approval in January. Click to get this free report Biogen Inc. (BIIB) : Free Stock Analysis Report Prothena Corporation plc (PRTA) : Free Stock Analysis Report AC Immune (ACIU) : Free Stock Analysis Report Vaxxinity, Inc. (VAXX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Monday’s Analyst Blog: Alzheimer's Disease Space Evolves in 2023: Stocks in Focus The Alzheimer's disease (AD) space continued to be in the spotlight in 2023 with the approval of Biogen and Eisai's drug Leqembi, which was initially granted accelerated approval in January. Per AC Immune, by inducing a polyclonal response, including antibodies against both oligomeric amyloid beta and pyroglutamate- amyloid beta, ACI-24.060 targets the same toxic species as disease-modifying anti-amyloid beta monoclonal antibodies that slowed AD progression in phase III studies. Click to get this free report Biogen Inc. (BIIB) : Free Stock Analysis Report Prothena Corporation plc (PRTA) : Free Stock Analysis Report AC Immune (ACIU) : Free Stock Analysis Report Vaxxinity, Inc. (VAXX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Monday’s Analyst Blog: Alzheimer's Disease Space Evolves in 2023: Stocks in Focus The Alzheimer's disease (AD) space continued to be in the spotlight in 2023 with the approval of Biogen and Eisai's drug Leqembi, which was initially granted accelerated approval in January. Nevertheless, the approval of Leqembi has now shown how AD treatments work. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.
|
f07fa70c-b93b-4390-8319-b13480073f33
|
712407.0
|
2023-12-12 00:00:00 UTC
|
Buy now, pay later company Affirm pushes further into retail gift cards
|
DCOMP
|
https://www.nasdaq.com/articles/buy-now-pay-later-company-affirm-pushes-further-into-retail-gift-cards
|
nan
|
nan
|
By Arriana McLymore and Lisa Baertlein
NEW YORK, Dec 12 (Reuters) - Buy now, pay later company Affirm said it is teaming up with a major provider of retail-branded gift cards to let shoppers purchase digital gift cards for the holiday season and pay for them with installment payments spread over as many as 12 months.
Affirm's partnership with privately held Blackhawk Network, one of the largest distributors of retailers' pre-paid gift cards, comes as Affirm and other buy now, pay later (BNPL) firms are soaring in popularity.
U.S. shoppers spent $15.9 billion from October to December using BNPL, a 17.5% increase from last year, according to Adobe Analytics. Top categories for BNPL purchases are electronics, apparel, grocery and home furniture.
BNPL loans allow customers to receive items within days of ordering them online. Shoppers can typically pay in four-installments that range from monthly to biweekly increments or pay within a 30-day period.
San Francisco-based Affirm announced on Tuesday that shoppers can now buy gift cards - among the most popular purchases during the holiday season - from Nordstrom, REI and Bath & Body Works with Affirm. Shoppers buy the cards through Affirm.com or its app. They can use the gift cards online and in physical stores.
Affirm shoppers can purchase gift cards for between $50 and $500, despite some of the retailers listing minimums of $25. Shoppers can choose four-installment payment plans for zero interest or they can opt for monthly payments that include interest rates between 0% and 36% based on credit and eligibility checks.
Affirm said it has been testing its service for gift card purchases for a month. "We did have a goal of getting it tested and wrapped in time for holiday because the most popular days for gift card (purchases) are right before Christmas," Wayne Pommen, Affirm's Chief Revenue Officer, told Reuters.
The gift cards essentially give Affirm a way to expand its BNPL service, which is typically marketed online, into physical retail stores. Affirm CEO Max Levchin in November told analysts that the company is expanding into other segments after being in an "e-commerce cage for a very long time."
Affirm said shoppers' total charges are provided upfront and there are no late or hidden fees. Neither Affirm nor Blackhawk would say what fees they collect from retailers participating in the program.
The company isn't the first BNPL brand to allow gift card purchases. Stockholm-based Klarna also lets shoppers purchase digital gift cards through its app.
Blackhawk earns revenue when shoppers activate their gift cards and collects management, transaction and technology fees from its enterprise clients who want to be on its digital gift-card mall, according to filings with the U.S. Securities and Exchange Commission.
(Reporting by Arriana McLymore in New York City Editing by Mark Potter)
((arriana.mclymore@thomsonreuters.com; 917-667-8733; Reuters Messaging: Twitter: @Arriana))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
"We did have a goal of getting it tested and wrapped in time for holiday because the most popular days for gift card (purchases) are right before Christmas," Wayne Pommen, Affirm's Chief Revenue Officer, told Reuters. The gift cards essentially give Affirm a way to expand its BNPL service, which is typically marketed online, into physical retail stores. Blackhawk earns revenue when shoppers activate their gift cards and collects management, transaction and technology fees from its enterprise clients who want to be on its digital gift-card mall, according to filings with the U.S. Securities and Exchange Commission.
|
By Arriana McLymore and Lisa Baertlein NEW YORK, Dec 12 (Reuters) - Buy now, pay later company Affirm said it is teaming up with a major provider of retail-branded gift cards to let shoppers purchase digital gift cards for the holiday season and pay for them with installment payments spread over as many as 12 months. The gift cards essentially give Affirm a way to expand its BNPL service, which is typically marketed online, into physical retail stores. Stockholm-based Klarna also lets shoppers purchase digital gift cards through its app.
|
By Arriana McLymore and Lisa Baertlein NEW YORK, Dec 12 (Reuters) - Buy now, pay later company Affirm said it is teaming up with a major provider of retail-branded gift cards to let shoppers purchase digital gift cards for the holiday season and pay for them with installment payments spread over as many as 12 months. Affirm's partnership with privately held Blackhawk Network, one of the largest distributors of retailers' pre-paid gift cards, comes as Affirm and other buy now, pay later (BNPL) firms are soaring in popularity. San Francisco-based Affirm announced on Tuesday that shoppers can now buy gift cards - among the most popular purchases during the holiday season - from Nordstrom, REI and Bath & Body Works with Affirm.
|
By Arriana McLymore and Lisa Baertlein NEW YORK, Dec 12 (Reuters) - Buy now, pay later company Affirm said it is teaming up with a major provider of retail-branded gift cards to let shoppers purchase digital gift cards for the holiday season and pay for them with installment payments spread over as many as 12 months. Affirm's partnership with privately held Blackhawk Network, one of the largest distributors of retailers' pre-paid gift cards, comes as Affirm and other buy now, pay later (BNPL) firms are soaring in popularity. Neither Affirm nor Blackhawk would say what fees they collect from retailers participating in the program.
|
32437678-6aff-44af-aca6-e76c7c2ef546
|
712408.0
|
2023-12-12 00:00:00 UTC
|
5 Hospital Stocks to Watch Amid Promising Industry Trends
|
DCOMP
|
https://www.nasdaq.com/articles/5-hospital-stocks-to-watch-amid-promising-industry-trends
|
nan
|
nan
|
Technological innovation and digital transformation are poised to confer a competitive edge, boosting efficiency for the Zacks Medical-Hospital industry players. Growing competition in this market remains a common theme. As the COVID-19 impact wanes, M&A and consolidation activities are expected to pick up in the fragmented market. Medical inflation and workforce challenges are keeping the industry players under pressure. With utilization, expenses are expected to improve for the hospital companies. Companies like HCA Healthcare Inc. HCA, Universal Health Services Inc. UHS, Tenet Healthcare Corporation THC, Acadia Healthcare Company, Inc. ACHC and Community Health Systems, Inc. CYH are expected to benefit from these developments.
Industry Overview
The Zacks Medical-Hospital industry comprises for-profit hospital companies that provide healthcare through different types of hospitals, such as acute care, rehabilitation and psychiatric. These hospital entities are engaged in internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, telehealth services, mental health care and diagnostic and emergency services. Revenues of these companies depend on inpatient occupancy levels, medical and ancillary services ordered by physicians and provided to patients, and the volume of outpatient procedures. These hospital companies receive payments for patient services from the government under the Medicare program, Medicaid or similar programs, managed care plans (including plans offered through the American Health Benefit Exchanges), private insurers and directly from patients.
4 Key Trends Defining the Hospital Industry's Future
Embracing the Digital Frontier: Hospitals are leveraging ongoing technological advancements to enhance services and drive growth. This shift optimizes operations, reduces costs, enhances convenience and elevates the overall patient experience. The adoption of telehealth and telemedicine, accelerated by the COVID-19 pandemic, is expected to persist in its growth trajectory. Companies are incorporating artificial intelligence (AI) and automation, coupled with real-time analytics, to deliver quality care. AI aids in refining clinical workflow management and medical diagnoses, reducing patient wait times and treatment costs.
Patient Volume Growth: The resurgence of deferred elective procedures in recent quarters, post-pandemic constraints, has propelled patient volumes. Nevertheless, concerns linger for patients due to medical inflation, escalating coverage costs and financial constraints, prompting delays in addressing non-emergency medical needs. The upswing in out-of-pocket costs poses a potential deterrent to patient volume growth. However, mitigating factors such as the Affordable Care Act (ACA) and comparable safety nets may offer some relief in this challenging scenario. The U.S. Census Bureau's revised report indicates that rapid growth in the 65+ age group, driven by scientific and healthcare advancements, is amplifying demand for hospital services.
Escalating Costs: The upsurge in patient volumes, along with increased prices for hospital supplies and inflationary pressures, is projected to amplify hospitals' operating costs. While workforce challenges show signs of improvement, they persist as a concern. Companies are strategically prioritizing labor productivity enhancements and the integration of new technologies to optimize expenditure. Additionally, leveraging contract renegotiations with suppliers and vendors is identified as a potential catalyst for cost management and operational efficiency.
Resurgence in M&A: Merger-and-acquisition (M&A) activity in hospitals and health systems, having sharply declined during the COVID-19 pandemic, is now witnessing a robust rebound. The fragmented industry is expected to see several deals in the upcoming days. Business consolidation, new tech partnerships and evolving business models can majorly improve hospital companies' profitability. Per a Deloitte report, 86% of surveyed health system executives foresee M&A substantially impacting their 2024 strategic plans.
Zacks Industry Rank Indicates Rosy Outlook
The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all member stocks, indicates bright near-term prospects. The Zacks Medical-Hospital industry, which is housed within the broader Zacks Medical sector, currently carries a Zacks Industry Rank #90, which places it in the top 36% of nearly 250 Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
The industry’s positioning in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are optimistic about this group’s earnings growth potential.
Before we present the stocks that you may want to monitor, let’s take a look at the industry’s recent stock market performance and valuation picture.
Industry Outperforms Sector But Lags S&P 500
The Zacks Medical-Hospital industry has fared better than its broader sector over the past year but lagged the Zacks S&P 500 composite. During this period, the stocks in this industry have gained 5.7% against the Zacks Medical sector’s 9.4% decline. The S&P 500 index jumped 16.1% during this time.
One-Year Price Performance
Industry's Current Valuation
On the basis of the trailing 12-month EV/EBITDA (Enterprise Value/ Earnings Before Interest Tax Depreciation and Amortization) ratio, which is commonly used for valuing hospital stocks, the industry trades at 8.56X compared with the S&P 500’s 13.33X and the sector’s 10.54X.
Over the past five years, the industry has traded as high as 9.55X and as low as 5.57X, with a median of 7.81X, as the charts below show.
EV/EBITDA Ratio (Past 5 Years)
5 Stocks Worth Your Attention
Below, we have presented five stocks with a Zacks Rank #3 (Hold) from the Medical-Hospital industry. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
HCA Healthcare: The company offers services through surgery centers, free-standing emergency rooms, physician clinics and urgent care centers. The expansion of its telemedicine business is anticipated to contribute to revenue growth. It is well-positioned for growth, driven by increasing patient volumes and admissions. The Managed Medicare and Medicaid operations are expected to further support top-line growth. HCA's strategic inorganic growth initiatives contribute to scaling its business and it prioritizes enhancing shareholder value through dividend increases and share repurchases.
The Zacks Consensus Estimate for one of the biggest for-profit publicly traded hospitals’ 2023 EPS indicates 7.6% year-over-year growth. The consensus mark for 2023 revenues signals a 6.6% increase from a year ago. HCA Healthcare beat earnings estimates twice in the past four quarters and missed on the other occasions, the average surprise being 4.8%. Shares of the company have jumped 13.9% over the past month.
Price & Consensus: HCA
Universal Health Services: The company operates acute care facilities and outpatient and behavioral health care units, with a focus on behavioral indications such as autism, eating disorders, substance use disorder and military disorderliness through its Patriot Support Program. The company experiences momentum from increased patient days and an extensive care network. The expansion of licensed beds in acute care hospitals and strategic joint ventures in the behavioral health portfolio is anticipated to contribute to its growth.
The Zacks Consensus Estimate for Universal Health’s 2023 bottom line indicates 4.7% year-over-year growth. The consensus mark for its 2023 revenues signals a 6.2% increase from a year ago. UHS beat earnings estimates in all the past four quarters, the average surprise being 5.5%. Shares of the company have gained 10.8% in the past month.
Price & Consensus: UHS
Tenet Healthcare Corporation: The company offers diversified healthcare services, primarily through general hospitals and related healthcare units. Notably, it experiences growth in the Ambulatory Care and Hospital segments, driven by increasing adjusted patient volumes and emergency room visits. The Ambulatory Care unit is significantly bolstered by robust performance in its USPI division. Prudent buyouts and tuck-in acquisitions contribute to the company's overall success and contractual rate increases in the Conifer unit further enhance its financial performance.
The Zacks Consensus Estimate for THC’s 2023 bottom line is pegged at $5.84 per share, which improved 1.9% over the past 60 days. The consensus mark for 2023 revenues signals a 6.4% increase from the prior year. Tenet Healthcare beat earnings estimates in all the past four quarters, the average surprise being 27.8%. Shares of the company have gained 31% over the past month.
Price & Consensus: THC
Acadia Healthcare: The company delivers behavioral healthcare services in the United States and Puerto Rico. The company's performance is strengthened by improving patient volumes, admissions and the expansion of service lines into new states. ACHC is progressing toward its goal of adding 300 beds by the year-end and aims to open six CTCs in 2023. Active pursuit of joint ventures with reputable healthcare systems underscores the company's commitment to expanding capabilities.
The Zacks Consensus Estimate for ACHC’s 2023 bottom line indicates 13.3% year-over-year growth. The consensus mark for 2023 revenues signals an 11.7% increase from a year ago. ACHC beat on earnings thrice in the last four quarters and missed on one occasion, the average surprise being 3.6%. Shares of the company have gained 2.9% in the past month.
Price & Consensus: ACHC
Community Health Systems: It is a prominent operator of general acute care hospitals and outpatient facilities throughout the United States. Its positive results are fueled by increasing patient volumes, admissions and improved occupancy rates. With a strategic focus on telehealth, CYH positions itself for long-term growth. The company pursues acquisitions in hospitals where management can enhance value by expanding specialty medical services and achieving economies of scale. Also, it actively engages in divesting non-core assets to bolster profitability, same-store metrics and cash flow.
The Zacks Consensus Estimate for CYH’s 2023 bottom line indicates a 34.8% improvement from a year ago. The consensus mark for its 2023 revenues signals 2% growth from the prior year. The earnings estimates remained stable over the past week. Shares of the company have gained 3.7% in the past month.
Price & Consensus: CYH
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
Community Health Systems, Inc. (CYH) : Free Stock Analysis Report
Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The U.S. Census Bureau's revised report indicates that rapid growth in the 65+ age group, driven by scientific and healthcare advancements, is amplifying demand for hospital services. HCA's strategic inorganic growth initiatives contribute to scaling its business and it prioritizes enhancing shareholder value through dividend increases and share repurchases. Price & Consensus: ACHC Community Health Systems: It is a prominent operator of general acute care hospitals and outpatient facilities throughout the United States.
|
Companies like HCA Healthcare Inc. HCA, Universal Health Services Inc. UHS, Tenet Healthcare Corporation THC, Acadia Healthcare Company, Inc. ACHC and Community Health Systems, Inc. CYH are expected to benefit from these developments. Price & Consensus: HCA Universal Health Services: The company operates acute care facilities and outpatient and behavioral health care units, with a focus on behavioral indications such as autism, eating disorders, substance use disorder and military disorderliness through its Patriot Support Program. Click to get this free report HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report Universal Health Services, Inc. (UHS) : Free Stock Analysis Report Tenet Healthcare Corporation (THC) : Free Stock Analysis Report Community Health Systems, Inc. (CYH) : Free Stock Analysis Report Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Companies like HCA Healthcare Inc. HCA, Universal Health Services Inc. UHS, Tenet Healthcare Corporation THC, Acadia Healthcare Company, Inc. ACHC and Community Health Systems, Inc. CYH are expected to benefit from these developments. The Zacks Medical-Hospital industry, which is housed within the broader Zacks Medical sector, currently carries a Zacks Industry Rank #90, which places it in the top 36% of nearly 250 Zacks industries. Click to get this free report HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report Universal Health Services, Inc. (UHS) : Free Stock Analysis Report Tenet Healthcare Corporation (THC) : Free Stock Analysis Report Community Health Systems, Inc. (CYH) : Free Stock Analysis Report Acadia Healthcare Company, Inc. (ACHC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
During this period, the stocks in this industry have gained 5.7% against the Zacks Medical sector’s 9.4% decline. The Zacks Consensus Estimate for THC’s 2023 bottom line is pegged at $5.84 per share, which improved 1.9% over the past 60 days. The Zacks Consensus Estimate for CYH’s 2023 bottom line indicates a 34.8% improvement from a year ago.
|
baefc399-d01d-4013-a9a4-8665e074061d
|
712409.0
|
2023-12-12 00:00:00 UTC
|
Growth Stocks Could Propel China ETFs in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/growth-stocks-could-propel-china-etfs-in-2024
|
nan
|
nan
|
This year, Chinese growth stocks have been hampered by declines by the broader market in the world’s second-largest economy. But some market observers believe it will be high-octane consumer internet and technology equities that ignite a new China bull market in 2024.
Should that prediction prove accurate, it’d likely benefit exchange traded funds such as the KraneShares CSI China Internet ETF (KWEB). While this has been a trying year for broader China benchmarks and ETFs, KWEB deserves a bit of credit. The fund is outpacing the widely followed MSCI China Index by about 250 basis points, as of December 8.
Recently, some KWEB holdings have shown signs of life, indicating the ETF could merit near-term consideration for investors looking to position for the possibility of a more earnest rebound by Chinese stocks in 2024.
Call on KWEB for China Rebound
In a recent report to clients, JPMorgan analysts highlighted several Chinese growth stocks that could be leaders should that country’s equity markets rebound next year. The bank called the names, several of which reside in the KWEB portfolio, “timely buys” noting that “fundamentals and market capitalization [are] emerging from troughs.”
Alibaba (NYSE: BABA), KWEB’s second-largest holding, at a weight of almost 9%, wasn’t among the bank’s most preferred Chinese growth stock ideas. But the stock gained some praise from analysts as an avenue for investors looking to tap into China’s burgeoning artificial intelligence (AI) market.
Among the KWEB holdings that fit JPMorgan’s bill as “timely buys” are the ETF’s largest component, Tencent (700-HK). Tencent, which is China’s largest internet company, accounts for 9.81% of the KWEB portfolio and jibes with JPMorgan’s view that growth over value will carry the day for Chinese stocks in 2024.
NetEase (NTES) and Kuaishou Technology (1024-HK) are also among JPMorgan’s top ideas among Chinese stocks for 2024. Both are top 10 holdings in KWEB, and combine for nearly 10% of the ETF’s roster.
Another issue to consider, particularly when it comes to KWEB and Chinese growth stocks, is how monetary policy shapes up in the country next year. Some clues to that effect could arrive over the near term.
“That policy meeting has been widely expected this fall. But there’s been no formal announcement while winter approaches. Also filling up the calendar is the annual central economic work conference for setting year-ahead policy, typically held in the middle of December,” reported Evelyn Cheng for CNBC.
For more news, information, and analysis, visit the China Insights Channel.
Read more on ETFTrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Recently, some KWEB holdings have shown signs of life, indicating the ETF could merit near-term consideration for investors looking to position for the possibility of a more earnest rebound by Chinese stocks in 2024. Tencent, which is China’s largest internet company, accounts for 9.81% of the KWEB portfolio and jibes with JPMorgan’s view that growth over value will carry the day for Chinese stocks in 2024. Also filling up the calendar is the annual central economic work conference for setting year-ahead policy, typically held in the middle of December,” reported Evelyn Cheng for CNBC.
|
This year, Chinese growth stocks have been hampered by declines by the broader market in the world’s second-largest economy. Should that prediction prove accurate, it’d likely benefit exchange traded funds such as the KraneShares CSI China Internet ETF (KWEB). Call on KWEB for China Rebound In a recent report to clients, JPMorgan analysts highlighted several Chinese growth stocks that could be leaders should that country’s equity markets rebound next year.
|
Call on KWEB for China Rebound In a recent report to clients, JPMorgan analysts highlighted several Chinese growth stocks that could be leaders should that country’s equity markets rebound next year. The bank called the names, several of which reside in the KWEB portfolio, “timely buys” noting that “fundamentals and market capitalization [are] emerging from troughs.” Alibaba (NYSE: BABA), KWEB’s second-largest holding, at a weight of almost 9%, wasn’t among the bank’s most preferred Chinese growth stock ideas. Tencent, which is China’s largest internet company, accounts for 9.81% of the KWEB portfolio and jibes with JPMorgan’s view that growth over value will carry the day for Chinese stocks in 2024.
|
This year, Chinese growth stocks have been hampered by declines by the broader market in the world’s second-largest economy. Call on KWEB for China Rebound In a recent report to clients, JPMorgan analysts highlighted several Chinese growth stocks that could be leaders should that country’s equity markets rebound next year. Tencent, which is China’s largest internet company, accounts for 9.81% of the KWEB portfolio and jibes with JPMorgan’s view that growth over value will carry the day for Chinese stocks in 2024.
|
ac10196e-4438-4127-bdcd-87cb14559fe5
|
712410.0
|
2023-12-12 00:00:00 UTC
|
The Zacks Analyst Blog Highlights Merck, Equinor, Illinois Tool Works, Arthur J. Gallagher and Atlassian
|
DCOMP
|
https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights-merck-equinor-illinois-tool-works-arthur-j.-gallagher
|
nan
|
nan
|
For Immediate Release
Chicago, IL – December 12, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck & Co., Inc. MRK, Equinor ASA EQNR, Illinois Tool Works Inc. ITW, Arthur J. Gallagher & Co. AJG and Atlassian Corp. TEAM.
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Merck, Equinor and Illinois Tool Works
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc., Equinor ASA and Illinois Tool Works Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Merck have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-2.2% vs. +7.3%). The company is witnessing generic competition for several drugs and rising competitive pressure, mainly on the diabetes franchise, will continue to be overhangs on the top line. There are concerns about Merck's ability to grow its non-oncology business ahead of Keytruda's loss of exclusivity later in the decade.
Nevertheless, Merck's products like Keytruda and Gardasil have been driving sales. With continued label expansion into new indications, particularly earlier-stage launches, Keytruda is expected to remain a key top-line driver.
Animal health and vaccine products are core growth drivers. Merck boasts a strong cancer pipeline, including Keytruda, which should drive long-term growth. Merck is investing in M&A activity to strengthen its pipeline.
(You can read the full research report on Merck here >>>)
Shares of Equinor have gained +11.5% over the past six months against the Zacks Oil and Gas - Refining and Marketing industry's gain of +16.7%. This integrated energy company has a global footprint spanning across more than 30 countries. In Europe, it ranks as the second-largest supplier of natural gas. It is proactively directing investments into renewable energy projects to tackle the issues posed by climate change.
Equinor anticipates a significant expansion of its renewable production capabilities, targeting a range of 4-6 GW by 2026, with further ambitions to elevate this capacity to 12-16 GW by 2035.
However, its balance sheet has a notable level of debt exposure compared with industry peers, which could potentially affect its financial flexibility. The company also reported weak third-quarter earnings due to reduced production volumes and lower prices of liquids and gas in Norway. Its ambitious capital budget poses a challenge. As such, the stock warrants a cautious stance.
(You can read the full research report on Equinor here >>>)
Shares of Illinois Tool Works have outperformed the Zacks Manufacturing - General Industrial industry over the past year (+13.9% vs. +13.7%). The company is benefiting from improving supply chains and underlying demand. Strength in the Automotive OEM segment, driven by favorable customer mix and product line simplification activities is aiding the company's performance.
Decreasing cost of sales and enterprise initiatives are supporting Illinois Tool's margin performance. The company's efforts to add shareholder value are encouraging. However, persistent weakness in the Test & Measurement and Electronics segment due to softness in semiconductor-related business in the North American region is concerning.
The decline in the specialty films, consumer packaging, specialty films and strength films businesses within the Specialty Products segment is an added woe. Given Illinois Tool's international presence, foreign currency headwinds are weighing on its top line.
(You can read the full research report on Illinois Tool Works here >>>)
Other noteworthy reports we are featuring today include Arthur J. Gallagher & Co and Atlassian Corp.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
Arthur J. Gallagher & Co. (AJG) : Free Stock Analysis Report
Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report
Equinor ASA (EQNR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Stocks recently featured in the blog include Merck & Co., Inc. MRK, Equinor ASA EQNR, Illinois Tool Works Inc. ITW, Arthur J. Gallagher & Co. AJG and Atlassian Corp. Strength in the Automotive OEM segment, driven by favorable customer mix and product line simplification activities is aiding the company's performance. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.
|
Stocks recently featured in the blog include Merck & Co., Inc. MRK, Equinor ASA EQNR, Illinois Tool Works Inc. ITW, Arthur J. Gallagher & Co. AJG and Atlassian Corp. Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc., Equinor ASA and Illinois Tool Works Inc.. Click to get this free report Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report Merck & Co., Inc. (MRK) : Free Stock Analysis Report Arthur J. Gallagher & Co. (AJG) : Free Stock Analysis Report Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report Equinor ASA (EQNR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Monday’s Analyst Blog: Top Research Reports for Merck, Equinor and Illinois Tool Works The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc., Equinor ASA and Illinois Tool Works Inc.. Click to get this free report Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report Merck & Co., Inc. (MRK) : Free Stock Analysis Report Arthur J. Gallagher & Co. (AJG) : Free Stock Analysis Report Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report Equinor ASA (EQNR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Monday’s Analyst Blog: Top Research Reports for Merck, Equinor and Illinois Tool Works The Zacks Research Daily presents the best research output of our analyst team. Shares of Equinor have gained +11.5% over the past six months against the Zacks Oil and Gas - Refining and Marketing industry's gain of +16.7%. Want the latest recommendations from Zacks Investment Research?
|
e8f9232d-7bba-49cd-86c8-d42b49b15967
|
712411.0
|
2023-12-12 00:00:00 UTC
|
US STOCKS-Wall St set for dull start after tame inflation data
|
DCOMP
|
https://www.nasdaq.com/articles/us-stocks-wall-st-set-for-dull-start-after-tame-inflation-data
|
nan
|
nan
|
By Shristi Achar A and Johann M Cherian
Dec 12 (Reuters) - Wall Street's main indexes were set for a dull start on Tuesday as the latest inflation reading turned investors cautious ahead of the Federal Reserve's policy meeting, even as it raised expectations that interest rates have peaked.
Consumer Price Index (CPI) rose 3.1% on an annual basis in line with estimates from economists polled by Reuters. Core prices, excluding volatile items like food and energy costs, also matched expectations, rising 4% annually.
On a month-on-month basis, consumer prices rose 0.1% last month, compared with estimates of it remaining unchanged.
"This report was pretty close to being in line. It doesn't really change the narrative that the Fed is probably going to share about how progress has been made on taming the monster of inflation. But there's still work to be done," said Brian Jacobsen, chief economist at Annex Wealth Management.
Money markets have almost fully priced in a rate-hike pause at the end of the Fed meeting, with traders seeing a 54% chance of at least a 25-basis-point cut in March 2024, as per CME Group's FedWatch tool.
The two-day Fed's monetary policy meeting will begin later in the day.
Expectations that the U.S. central bank would start easing them from next year have lifted the three main stock indexes to their highest close for the year on Monday.
The European Central Bank and the Bank of England are also scheduled to deliver their policy verdicts later this week.
Google-parent Alphabet GOOGL.O underperformed its megacap peers, down 1% in premarket trading, after "Fortnite" maker Epic Games prevailed in its high-profile antitrust trial over the company.
At 9:02 a.m. ET, Dow e-minis 1YMcv1 were up 27 points, or 0.07%, S&P 500 e-minis EScv1 were down 2.75 points, or 0.06%, and Nasdaq 100 e-minis NQcv1 were up 9 points, or 0.06%.
Among other movers, OracleORCL.N fell 9.4% as the cloud services provider forecast third-quarter revenue below estimates on slowing demand for its cloud service.
LucidLCID.O was down 3% after the electric-vehicle maker's CFO Sherry House stepped down.
Airbnb ABNB.O fell 2.3% after Barclays downgraded the rental firm to "underweight" from "equal weight".
(Reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Shounak Dasgupta and Arun Koyyur)
((Shristi.AcharA@thomsonreuters.com; https://twitter.com/ShristiAchar))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Shristi Achar A and Johann M Cherian Dec 12 (Reuters) - Wall Street's main indexes were set for a dull start on Tuesday as the latest inflation reading turned investors cautious ahead of the Federal Reserve's policy meeting, even as it raised expectations that interest rates have peaked. Money markets have almost fully priced in a rate-hike pause at the end of the Fed meeting, with traders seeing a 54% chance of at least a 25-basis-point cut in March 2024, as per CME Group's FedWatch tool. Google-parent Alphabet GOOGL.O underperformed its megacap peers, down 1% in premarket trading, after "Fortnite" maker Epic Games prevailed in its high-profile antitrust trial over the company.
|
By Shristi Achar A and Johann M Cherian Dec 12 (Reuters) - Wall Street's main indexes were set for a dull start on Tuesday as the latest inflation reading turned investors cautious ahead of the Federal Reserve's policy meeting, even as it raised expectations that interest rates have peaked. Consumer Price Index (CPI) rose 3.1% on an annual basis in line with estimates from economists polled by Reuters. On a month-on-month basis, consumer prices rose 0.1% last month, compared with estimates of it remaining unchanged.
|
By Shristi Achar A and Johann M Cherian Dec 12 (Reuters) - Wall Street's main indexes were set for a dull start on Tuesday as the latest inflation reading turned investors cautious ahead of the Federal Reserve's policy meeting, even as it raised expectations that interest rates have peaked. Consumer Price Index (CPI) rose 3.1% on an annual basis in line with estimates from economists polled by Reuters. Expectations that the U.S. central bank would start easing them from next year have lifted the three main stock indexes to their highest close for the year on Monday.
|
By Shristi Achar A and Johann M Cherian Dec 12 (Reuters) - Wall Street's main indexes were set for a dull start on Tuesday as the latest inflation reading turned investors cautious ahead of the Federal Reserve's policy meeting, even as it raised expectations that interest rates have peaked. Consumer Price Index (CPI) rose 3.1% on an annual basis in line with estimates from economists polled by Reuters. Expectations that the U.S. central bank would start easing them from next year have lifted the three main stock indexes to their highest close for the year on Monday.
|
fbb7c535-c6a7-4b44-a981-f4f8c308de39
|
712412.0
|
2023-12-12 00:00:00 UTC
|
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
|
DCOMP
|
https://www.nasdaq.com/articles/3-top-ranked-dividend-stocks%3A-a-smarter-way-to-boost-your-retirement-income-114
|
nan
|
nan
|
Believe it or not, seniors fear running out of cash more than they fear dying.
And older Americans have legitimate reasons for this worry, even if they have dutifully saved for their golden years. That's because the traditional ways people manage retirement may no longer provide enough income to meet expenses - and with people generally living longer, the principal retirement savings is exhausted far too early in the retirement period.
Retirement investing approaches of the past don't work today.
For example, 10-year Treasury bonds in the late 1990s offered a yield of around 6.50%, which translated to an income source you could count on. However, today's yield is much lower and probably not a viable return option to fund typical retirements.
The effect of this drop in rates is substantial: over 20 years, the change in yield for a $1 million investment in 10-year Treasuries is over $1 million.
Today's retirees are getting hit hard by reduced bond yields - and the Social Security picture isn't too rosy either. Right now and for the near future, Social Security benefits are still being paid, but it has been estimated that the Social Security funds will be depleted as soon as 2035.
So what's a retiree to do? You could cut your expenses to the bone, and take the risk that your Social Security checks don't shrink. Or you could find an alternative investment that provides a steady, higher-rate income stream to replace dwindling bond yields.
Invest in Dividend Stocks
We feel that these dividend-paying equities - as long as they are from high-quality, low-risk issuers - can give retirement investors a smart option to replace low-yielding Treasury bonds (or other bonds).
Look for stocks that have paid steady, increasing dividends for years (or decades), and have not cut their dividends even during recessions.
One approach to recognizing appropriate stocks is to look for companies with an average dividend yield of 3% and positive average annual dividend growth. Numerous stocks hike dividends over time, counterbalancing inflation risks.
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio.
AES (AES) is currently shelling out a dividend of $0.17 per share, with a dividend yield of 3.68%. This compares to the Utility - Electric Power industry's yield of 3.51% and the S&P 500's yield of 1.67%. The company's annualized dividend growth in the past year was 5%. Check AES (AES) dividend history here>>>
Heartland BancCorp. (HLAN) is paying out a dividend of $0.76 per share at the moment, with a dividend yield of 3.59% compared to the Banks - Midwest industry's yield of 3.38% and the S&P 500's yield. The annualized dividend growth of the company was 10% over the past year. Check Heartland BancCorp. (HLAN) dividend history here>>>
Currently paying a dividend of $0.28 per share, Invitation Home (INVH) has a dividend yield of 3.13%. This is compared to the REIT and Equity Trust - Residential industry's yield of 4.43% and the S&P 500's current yield. Annualized dividend growth for the company in the past year was 18.18%. Check Invitation Home (INVH) dividend history here>>>
But aren't stocks generally more risky than bonds?
The fact is that stocks, as an asset class, carry more risk than bonds. To counterbalance this, invest in superior quality dividend stocks that not only can grow over time but more significantly, can also decrease your overall portfolio volatility with respect to the broader stock market.
An upside to adding dividend stocks to your retirement portfolio: they can help lessen the effects of inflation, since many dividend-paying companies (especially blue chip stocks) generally increase their dividends over time.
Thinking about dividend-focused mutual funds or ETFs? Watch out for fees.
If you're interested in investing in dividends, but are thinking about mutual funds or ETFs rather than stocks, beware of fees. Mutual funds and specialized ETFs may carry high fees, which could lower the overall gains you earn from dividends, undercutting your dividend income strategy. Be sure to look for funds with low fees if you decide on this approach.
Bottom Line
Regardless of whether you select high-quality, low-fee funds or stocks, looking for a steady stream of income from dividend-paying equities can potentially lead you to a solid and more peaceful retirement.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The AES Corporation (AES) : Free Stock Analysis Report
Invitation Home (INVH) : Free Stock Analysis Report
Heartland BancCorp. (HLAN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Today's retirees are getting hit hard by reduced bond yields - and the Social Security picture isn't too rosy either. Bottom Line Regardless of whether you select high-quality, low-fee funds or stocks, looking for a steady stream of income from dividend-paying equities can potentially lead you to a solid and more peaceful retirement. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
|
(HLAN) dividend history here>>> Currently paying a dividend of $0.28 per share, Invitation Home (INVH) has a dividend yield of 3.13%. Mutual funds and specialized ETFs may carry high fees, which could lower the overall gains you earn from dividends, undercutting your dividend income strategy. Click to get this free report The AES Corporation (AES) : Free Stock Analysis Report Invitation Home (INVH) : Free Stock Analysis Report Heartland BancCorp.
|
One approach to recognizing appropriate stocks is to look for companies with an average dividend yield of 3% and positive average annual dividend growth. (HLAN) is paying out a dividend of $0.76 per share at the moment, with a dividend yield of 3.59% compared to the Banks - Midwest industry's yield of 3.38% and the S&P 500's yield. An upside to adding dividend stocks to your retirement portfolio: they can help lessen the effects of inflation, since many dividend-paying companies (especially blue chip stocks) generally increase their dividends over time.
|
Retirement investing approaches of the past don't work today. Invest in Dividend Stocks We feel that these dividend-paying equities - as long as they are from high-quality, low-risk issuers - can give retirement investors a smart option to replace low-yielding Treasury bonds (or other bonds). An upside to adding dividend stocks to your retirement portfolio: they can help lessen the effects of inflation, since many dividend-paying companies (especially blue chip stocks) generally increase their dividends over time.
|
8e236241-77f6-4a12-9065-de4c3c682f7e
|
712413.0
|
2023-12-12 00:00:00 UTC
|
GSK's Jemperli Gets EU Nod for Endometrial Cancer Expanded Use
|
DCOMP
|
https://www.nasdaq.com/articles/gsks-jemperli-gets-eu-nod-for-endometrial-cancer-expanded-use
|
nan
|
nan
|
GSK plc GSK announced that the European Commission (EC) has granted marketing authorization to its cancer drug, Jemperli (dostarlimab), for expanded use in primary advanced or recurrent endometrial cancer.
The EC has now approved Jemperli in combination with carboplatin and paclitaxel as a frontline treatment for mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced/recurrent endometrial cancer in adult patients who are candidates for systemic therapy.
Until now, Jemperli was approved on a conditional basis in the EU as a monotherapy to treat adult patients with dMMR/MSI-H recurrent or advanced endometrial cancer that has progressed on or following a prior platinum-containing regimen. With the latest approval, Jemperli becomes eligible for an expanded patient population in Europe, including in earlier line-setting.
The latest EC nod for Jemperli in the frontline setting also converts this conditional approval to a full approval.
Shares of GSK have rallied 3.5% year to date against the industry’s decline of 20.4%.
Image Source: Zacks Investment Research
The EC’s nod for Jemperli in frontline use was based on pivotal data from Part 1 of the RUBY phase III study. Data from the study showed that treatment with Jemperli in combination with carboplatin plus paclitaxel resulted in a 72% reduction in the risk of disease progression or death versus chemotherapy alone.
The FDA approved Jemperli in combination with carboplatin plus paclitaxel as a frontline treatment for dMMR/MSI-H primary advanced/recurrent endometrial cancer in July 2023.
Jemperli is also approved for second-line endometrial cancer and dMMR recurrent or advanced solid tumors in the United States.
Jemperli is one of the recently approved drugs in GSK’s portfolio that has been seeing strong uptake owing to an increase in new patient starts in the United States. The drug generated sales worth £81 million in the first nine months of 2023.
Several label expansion studies are currently ongoing on Jemperli in endometrial cancer.
In a separate press release, GSK announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review the regulatory application seeking label expansion of its respiratory syncytial virus (RSV) vaccine, Arexvy, for the prevention of RSV disease in adults aged 50-59 who are at a higher risk.
Arexvy is approved in Japan for the prevention of RSV disease in adults aged 60 years and above.
Zacks Rank & Stocks to Consider
GSK currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the healthcare sector are Journey Medical Corporation DERM, Entrada Therapeutics, Inc. TRDA and Puma Biotechnology, Inc. PBYI, each sporting a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, estimates for Journey Medical’s 2023 loss per share have narrowed from $1.28 to 16 cents. Meanwhile, loss per share estimates for 2024 have narrowed from 41 cents to 35 cents. Year to date, shares of DERM have surged 214.6%.
Earnings of Journey Medical beat estimates in one of the last four quarters while missing the same on the remaining three occasions. DERM delivered a four-quarter earnings surprise of 118.25%, on average.
In the past 60 days, estimates for Entrada Therapeutics’ 2023 loss per share have narrowed from $2.07 to 9 cents. Meanwhile, loss per share estimates for 2024 have narrowed from $2.35 to $2.04. Year to date, shares of TRDA have decreased 4%.
Earnings of Entrada Therapeutics beat estimates in three of the last four quarters while missing the same on the remaining occasion. TRDA delivered a four-quarter average earnings surprise of 70.68%.
In the past 60 days, estimates for Puma Biotechnology’s 2023 earnings per share have improved from 67 cents to 72 cents. During the same period, earnings per share estimates for 2024 have moved up from 55 cents to 64 cents. Year to date, shares of PBYI have lost 10.2%.
Earnings of Puma Biotechnology beat estimates in three of the last four quarters while missing the same on the remaining occasion. PBYI delivered a four-quarter average earnings surprise of 76.55%.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report
Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report
Journey Medical Corporation (DERM) : Free Stock Analysis Report
Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The EC has now approved Jemperli in combination with carboplatin and paclitaxel as a frontline treatment for mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced/recurrent endometrial cancer in adult patients who are candidates for systemic therapy. Until now, Jemperli was approved on a conditional basis in the EU as a monotherapy to treat adult patients with dMMR/MSI-H recurrent or advanced endometrial cancer that has progressed on or following a prior platinum-containing regimen. Image Source: Zacks Investment Research The EC’s nod for Jemperli in frontline use was based on pivotal data from Part 1 of the RUBY phase III study.
|
GSK plc GSK announced that the European Commission (EC) has granted marketing authorization to its cancer drug, Jemperli (dostarlimab), for expanded use in primary advanced or recurrent endometrial cancer. Some better-ranked stocks in the healthcare sector are Journey Medical Corporation DERM, Entrada Therapeutics, Inc. TRDA and Puma Biotechnology, Inc. PBYI, each sporting a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report Journey Medical Corporation (DERM) : Free Stock Analysis Report Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
GSK plc GSK announced that the European Commission (EC) has granted marketing authorization to its cancer drug, Jemperli (dostarlimab), for expanded use in primary advanced or recurrent endometrial cancer. Some better-ranked stocks in the healthcare sector are Journey Medical Corporation DERM, Entrada Therapeutics, Inc. TRDA and Puma Biotechnology, Inc. PBYI, each sporting a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report Journey Medical Corporation (DERM) : Free Stock Analysis Report Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Several label expansion studies are currently ongoing on Jemperli in endometrial cancer. Zacks Investment Research has just released an urgent special report to help you bank on this trend. Want the latest recommendations from Zacks Investment Research?
|
32e0b739-f183-44b4-8ac4-7cc0af923e41
|
712414.0
|
2023-12-12 00:00:00 UTC
|
Wall Street’s Top 3 Bull Market Picks for High Returns
|
DCOMP
|
https://www.nasdaq.com/articles/wall-streets-top-3-bull-market-picks-for-high-returns
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
We may be about to enter a wonderful era for U.S. stocks. That’s because the market has become much less fearful about inflation and high interest rates, while the economy still appears to be in very good shape. What’s more, the Street (finally!) appears to be ready to buy stocks other than The Magnificent Seven on a grand scale. Providing evidence for the latter point, RBC Capital, a large Canadian bank, has become very bullish on small-cap stocks, according to Barron’s, while CNBC’s Jim Cramer also recently “suggested (that) the market has renewed interest in smaller cap stocks, expanding outside the “Magnificent Seven” tech stocks.”
So with the stock rally poised to continue for some time while broadening well beyond the Magnificent Seven, here are three of Wall Street’s top bull market stock picks to buy. All of these names have excellent medium-term prospects, huge long-term potential, and are beloved by the lion’s share of Street analysts.
ServiceNow (NOW)
Source: Sundry Photography / Shutterstock.com
Released in September, ServiceNow’s (NYSE:NOW) latest platform, named Vancouver, widely utilizes artificial intelligence. The firm claims that, as a result, the employees of its customers can get the data they need faster than ever before.
Vancouver even makes programming much faster and easier by allowing users to create computer programs with “natural language,” rather than code.
While a few of NOW’s competitors have offered similar innovations, I believe that NOW’s AI may be one of the best available. That’s because many large, impressive enterprises have already agreed to utilize the platform. Specifically, “A huge department in the Government of the United States, (and) one of the biggest real estate firms in the world,” along with Deloitte, one of the world’s largest consulting firms, and chip giant Nvidia (NASDAQ:NVDA) have all selected Vancouver, CEO Bill McDermott reported recently.
Of the 37 Wall Street analysts who cover NOW stock, 34 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
Quanta Services (PWR)
Source: Shutterstock
Wall Street is falling in love with Quanta Services (NYSE:PWR), as the Street is starting to agree with my thesis about the company benefiting tremendously from the clean-energy revolution.
For example, investment bank Stifel last month cited the firm as a “pick and shovel” means of benefit from “the renewable energy transition and related growth in power grid investment,” along with government funding of those initiatives, according to Seeking Alpha. The bank kept a “buy” rating on the shares.
Last month, Goldman Sachs raised its rating on PWR to “buy” from “neutral,” given its attractive valuation and its long, successful history. Goldman’s belief that the company will benefit from strong “macro trends.” And Citi on Dec. 4 identified PWR as one of its top “buy ideas.”
Of the 15 Wall Street analysts who cover PWR stock, 12 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
Visa (V)
Source: Tada Images / Shutterstock.com
Visa (NYSE:V) is clearly benefiting from the strength of the American consumer, as it reported strong fiscal fourth-quarter results on Oct. 24.
Specifically, the credit-card network’s revenue climbed 11% last quarter versus the same period a year earlier, while its net income soared 19% year-over-year.
“Throughout the year, we have seen resilient consumer spending, ongoing recovery of cross border travel spend versus 2019 and continued growth across our new flows and value added services businesses,” CEO Ryan McInerney said in a statement.
Of the 38 Wall Street analysts who cover V stock, 31 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
On the date of publication, Larry Ramer’s wife held a long position in NOW. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Larry Ramer has conducted research and written articles on U.S. stocks for 15 years. He has been employed by The Fly and Israel’s largest business newspaper, Globes. Larry began writing columns for InvestorPlace in 2015. Among his highly successful, contrarian picks have been PLUG, XOM and solar stocks. You can reach him on Stocktwits at @larryramer.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Wall Street’s Top 3 Bull Market Picks for High Returns appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Specifically, the credit-card network’s revenue climbed 11% last quarter versus the same period a year earlier, while its net income soared 19% year-over-year. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Wall Street’s Top 3 Bull Market Picks for High Returns appeared first on InvestorPlace.
|
Of the 37 Wall Street analysts who cover NOW stock, 34 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Goldman’s belief that the company will benefit from strong “macro trends.” And Citi on Dec. 4 identified PWR as one of its top “buy ideas.” Of the 15 Wall Street analysts who cover PWR stock, 12 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Of the 38 Wall Street analysts who cover V stock, 31 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
|
Of the 37 Wall Street analysts who cover NOW stock, 34 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Goldman’s belief that the company will benefit from strong “macro trends.” And Citi on Dec. 4 identified PWR as one of its top “buy ideas.” Of the 15 Wall Street analysts who cover PWR stock, 12 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Of the 38 Wall Street analysts who cover V stock, 31 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
|
Of the 37 Wall Street analysts who cover NOW stock, 34 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Goldman’s belief that the company will benefit from strong “macro trends.” And Citi on Dec. 4 identified PWR as one of its top “buy ideas.” Of the 15 Wall Street analysts who cover PWR stock, 12 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks. Of the 38 Wall Street analysts who cover V stock, 31 rate it either a “buy” or a “strong buy,” making it one of Wall Street’s top bull market stock picks.
|
67d3dfa9-7a22-4f43-b286-96a7e8710e17
|
712415.0
|
2023-12-12 00:00:00 UTC
|
Gibraltar Industries, Inc. (ROCK) Hits Fresh High: Is There Still Room to Run?
|
DCOMP
|
https://www.nasdaq.com/articles/gibraltar-industries-inc.-rock-hits-fresh-high%3A-is-there-still-room-to-run-0
|
nan
|
nan
|
Have you been paying attention to shares of Gibraltar Industries (ROCK)? Shares have been on the move with the stock up 14.3% over the past month. The stock hit a new 52-week high of $77.52 in the previous session. Gibraltar Industries has gained 68.9% since the start of the year compared to the 50.6% move for the Zacks Construction sector and the 58.2% return for the Zacks Building Products - Miscellaneous industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on November 2, 2023, Gibraltar Industries reported EPS of $1.38 versus consensus estimate of $1.12.
For the current fiscal year, Gibraltar Industries is expected to post earnings of $4.13 per share on $1.38 billion in revenues. This represents a 21.47% change in EPS on a -0.42% change in revenues. For the next fiscal year, the company is expected to earn $4.63 per share on $1.45 billion in revenues. This represents a year-over-year change of 12.12% and 4.62%, respectively.
Valuation Metrics
Gibraltar Industries may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Gibraltar Industries has a Value Score of A. The stock's Growth and Momentum Scores are A and F, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 18.8X current fiscal year EPS estimates, which is a premium to the peer industry average of 18.6X. On a trailing cash flow basis, the stock currently trades at 17.7X versus its peer group's average of 12.4X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Gibraltar Industries currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Gibraltar Industries fits the bill. Thus, it seems as though Gibraltar Industries shares could still be poised for more gains ahead.
How Does ROCK Stack Up to the Competition?
Shares of ROCK have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is Armstrong World Industries, Inc. (AWI). AWI has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of C, and a Momentum Score of B.
Earnings were strong last quarter. Armstrong World Industries, Inc. beat our consensus estimate by 23.08%, and for the current fiscal year, AWI is expected to post earnings of $5.48 per share on revenue of $1.29 billion.
Shares of Armstrong World Industries, Inc. have gained 19% over the past month, and currently trade at a forward P/E of 19.11X and a P/CF of 14.7X.
The Building Products - Miscellaneous industry is in the top 15% of all the industries we have in our universe, so it looks like there are some nice tailwinds for ROCK and AWI, even beyond their own solid fundamental situation.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Gibraltar Industries, Inc. (ROCK) : Free Stock Analysis Report
Armstrong World Industries, Inc. (AWI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level. Armstrong World Industries, Inc. beat our consensus estimate by 23.08%, and for the current fiscal year, AWI is expected to post earnings of $5.48 per share on revenue of $1.29 billion. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
For the current fiscal year, Gibraltar Industries is expected to post earnings of $4.13 per share on $1.38 billion in revenues. In terms of its value breakdown, the stock currently trades at 18.8X current fiscal year EPS estimates, which is a premium to the peer industry average of 18.6X. Click to get this free report Gibraltar Industries, Inc. (ROCK) : Free Stock Analysis Report Armstrong World Industries, Inc. (AWI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Gibraltar Industries has gained 68.9% since the start of the year compared to the 50.6% move for the Zacks Construction sector and the 58.2% return for the Zacks Building Products - Miscellaneous industry. Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Gibraltar Industries fits the bill. Click to get this free report Gibraltar Industries, Inc. (ROCK) : Free Stock Analysis Report Armstrong World Industries, Inc. (AWI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
For the next fiscal year, the company is expected to earn $4.63 per share on $1.45 billion in revenues. Gibraltar Industries has a Value Score of A. Free: See Our Top Stock and 4 Runners Up >> Want the latest recommendations from Zacks Investment Research?
|
feef72f6-7427-4434-92fe-f440fd6d6737
|
712416.0
|
2023-12-12 00:00:00 UTC
|
Here is What to Know Beyond Why Lamb Weston (LW) is a Trending Stock
|
DCOMP
|
https://www.nasdaq.com/articles/here-is-what-to-know-beyond-why-lamb-weston-lw-is-a-trending-stock-0
|
nan
|
nan
|
Lamb Weston (LW) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this frozen foods supplier have returned +9.1%, compared to the Zacks S&P 500 composite's +5.2% change. During this period, the Zacks Food - Miscellaneous industry, which Lamb Weston falls in, has gained 5.2%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings Estimates
Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Lamb Weston is expected to post earnings of $1.40 per share, indicating a change of +9.4% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
The consensus earnings estimate of $5.84 for the current fiscal year indicates a year-over-year change of +24.8%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $6.21 indicates a change of +6.3% from what Lamb Weston is expected to report a year ago. Over the past month, the estimate has remained unchanged.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Lamb Weston is rated Zacks Rank #2 (Buy).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth Forecast
Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Lamb Weston, the consensus sales estimate for the current quarter of $1.69 billion indicates a year-over-year change of +32.6%. For the current and next fiscal years, $6.86 billion and $7.24 billion estimates indicate +28.3% and +5.5% changes, respectively.
Last Reported Results and Surprise History
Lamb Weston reported revenues of $1.67 billion in the last reported quarter, representing a year-over-year change of +48%. EPS of $1.63 for the same period compares with $0.75 a year ago.
Compared to the Zacks Consensus Estimate of $1.59 billion, the reported revenues represent a surprise of +4.45%. The EPS surprise was +49.54%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
Valuation
No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Lamb Weston is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Conclusion
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lamb Weston. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lamb Weston (LW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Conclusion The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lamb Weston.
|
Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Lamb Weston is rated Zacks Rank #2 (Buy). Last Reported Results and Surprise History Lamb Weston reported revenues of $1.67 billion in the last reported quarter, representing a year-over-year change of +48%. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
|
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Lamb Weston is rated Zacks Rank #2 (Buy). While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
When earnings estimates for a company go up, the fair value for its stock goes up as well. EPS of $1.63 for the same period compares with $0.75 a year ago. The company topped consensus revenue estimates each time over this period.
|
d4332e7c-b31f-4573-b63f-99b927aa3e18
|
712417.0
|
2023-12-12 00:00:00 UTC
|
Fabrinet (FN) Soars to 52-Week High, Time to Cash Out?
|
DCOMP
|
https://www.nasdaq.com/articles/fabrinet-fn-soars-to-52-week-high-time-to-cash-out-0
|
nan
|
nan
|
Shares of Fabrinet (FN) have been strong performers lately, with the stock up 11.1% over the past month. The stock hit a new 52-week high of $187.8 in the previous session. Fabrinet has gained 45.8% since the start of the year compared to the 50% move for the Zacks Computer and Technology sector and the 17.9% return for the Zacks Electronics - Miscellaneous Components industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on November 6, 2023, Fabrinet reported EPS of $2 versus consensus estimate of $1.87.
For the current fiscal year, Fabrinet is expected to post earnings of $8.25 per share on $2.83 billion in revenues. This represents a 7.56% change in EPS on a 7.13% change in revenues. For the next fiscal year, the company is expected to earn $9.25 per share on $3.22 billion in revenues. This represents a year-over-year change of 12.16% and 13.62%, respectively.
Valuation Metrics
Fabrinet may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Fabrinet has a Value Score of B. The stock's Growth and Momentum Scores are A and F, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 22.7X current fiscal year EPS estimates, which is a premium to the peer industry average of 21.6X. On a trailing cash flow basis, the stock currently trades at 22.7X versus its peer group's average of 12.3X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Fabrinet currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Fabrinet meets the list of requirements. Thus, it seems as though Fabrinet shares could still be poised for more gains ahead.
How Does FN Stack Up to the Competition?
Shares of FN have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is OSI Systems, Inc. (OSIS). OSIS has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of B, and a Momentum Score of D.
Earnings were strong last quarter. OSI Systems, Inc. beat our consensus estimate by 7.06%, and for the current fiscal year, OSIS is expected to post earnings of $7.90 per share on revenue of $1.51 billion.
Shares of OSI Systems, Inc. have gained 12.9% over the past month, and currently trade at a forward P/E of 16.5X and a P/CF of 14.99X.
The Electronics - Miscellaneous Components industry may rank in the bottom 52% of all the industries we have in our universe, but there still looks like there are some nice tailwinds for FN and OSIS, even beyond their own solid fundamental situation.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Fabrinet (FN) : Free Stock Analysis Report
OSI Systems, Inc. (OSIS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself. On a trailing cash flow basis, the stock currently trades at 22.7X versus its peer group's average of 12.3X. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
For the current fiscal year, Fabrinet is expected to post earnings of $8.25 per share on $2.83 billion in revenues. In terms of its value breakdown, the stock currently trades at 22.7X current fiscal year EPS estimates, which is a premium to the peer industry average of 21.6X. Click to get this free report Fabrinet (FN) : Free Stock Analysis Report OSI Systems, Inc. (OSIS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Zacks Rank We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. OSIS has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of B, and a Momentum Score of D. Earnings were strong last quarter. Click to get this free report Fabrinet (FN) : Free Stock Analysis Report OSI Systems, Inc. (OSIS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
For the next fiscal year, the company is expected to earn $9.25 per share on $3.22 billion in revenues. Fabrinet has a Value Score of B. OSIS has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of B, and a Momentum Score of D. Earnings were strong last quarter.
|
dd32703c-dcc3-4e86-af0a-d50206dfe04f
|
712418.0
|
2023-12-12 00:00:00 UTC
|
MI Homes Inc. Shares Climb 0.1% Past Previous 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/mi-homes-inc.-shares-climb-0.1-past-previous-52-week-high-market-mover-0
|
nan
|
nan
|
MI Homes Inc. (MHO) shares closed 0.1% higher than its previous 52 week high, giving the company a market cap of $3B. The stock is currently up 167.8% year-to-date, up 165.7% over the past 12 months, and up 449.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 86.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 49.7%
The company's stock price performance over the past 12 months beats the peer average by 55.2%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -22.0% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
MI Homes Inc. (MHO) shares closed 0.1% higher than its previous 52 week high, giving the company a market cap of $3B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 49.7% The company's stock price performance over the past 12 months beats the peer average by 55.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -22.0% lower than the average peer.
|
MI Homes Inc. (MHO) shares closed 0.1% higher than its previous 52 week high, giving the company a market cap of $3B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 49.7% The company's stock price performance over the past 12 months beats the peer average by 55.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -22.0% lower than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 49.7% The company's stock price performance over the past 12 months beats the peer average by 55.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -22.0% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Trading Activity Trading volume this week was 86.8% higher than the 20-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 49.7% The company's stock price performance over the past 12 months beats the peer average by 55.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -22.0% lower than the average peer.
|
ce35200f-efb0-468e-aae3-ee1233a34281
|
712419.0
|
2023-12-12 00:00:00 UTC
|
Invesco (IVZ) Surges 7.6%: Is This an Indication of Further Gains?
|
DCOMP
|
https://www.nasdaq.com/articles/invesco-ivz-surges-7.6%3A-is-this-an-indication-of-further-gains
|
nan
|
nan
|
Invesco (IVZ) shares soared 7.6% in the last trading session to close at $17.58. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 18.9% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on finance stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the Invesco stock moved higher.
This investment management company is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -5.1%. Revenues are expected to be $1.1 billion, down 0.6% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Invesco, the consensus EPS estimate for the quarter has been revised marginally lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on IVZ going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Invesco belongs to the Zacks Financial - Investment Management industry. Another stock from the same industry, Lazard (LAZ), closed the last trading session 4.9% higher at $34.95. Over the past month, LAZ has returned 19.4%.
Lazard's consensus EPS estimate for the upcoming report has changed -2.5% over the past month to $0.38. Compared to the company's year-ago EPS, this represents a change of -44.9%. Lazard currently boasts a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Invesco Ltd. (IVZ) : Free Stock Analysis Report
Lazard Ltd (LAZ) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on finance stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. This investment management company is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -5.1%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Invesco belongs to the Zacks Financial - Investment Management industry. Lazard's consensus EPS estimate for the upcoming report has changed -2.5% over the past month to $0.38. Click to get this free report Invesco Ltd. (IVZ) : Free Stock Analysis Report Lazard Ltd (LAZ) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Invesco belongs to the Zacks Financial - Investment Management industry. Click to get this free report Invesco Ltd. (IVZ) : Free Stock Analysis Report Lazard Ltd (LAZ) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Invesco belongs to the Zacks Financial - Investment Management industry. Another stock from the same industry, Lazard (LAZ), closed the last trading session 4.9% higher at $34.95. Lazard's consensus EPS estimate for the upcoming report has changed -2.5% over the past month to $0.38.
|
b9bdcba5-f630-45d2-9580-a65da7b56336
|
712420.0
|
2023-12-12 00:00:00 UTC
|
Comerica Incorporated (CMA) Soars 7.1%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/comerica-incorporated-cma-soars-7.1%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Comerica Incorporated (CMA) shares soared 7.1% in the last trading session to close at $56.81. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 17.8% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the Comerica Incorporated stock moved higher.
This company is expected to post quarterly earnings of $1.36 per share in its upcoming report, which represents a year-over-year change of -47.3%. Revenues are expected to be $852.74 million, down 16.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Comerica Incorporated, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CMA going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Comerica Incorporated is part of the Zacks Banks - Major Regional industry. The PNC Financial Services Group, Inc (PNC), another stock in the same industry, closed the last trading session 4.8% higher at $153.31. PNC has returned 13.5% in the past month.
For The PNC Financial Services Group, Inc, the consensus EPS estimate for the upcoming report has changed +0.5% over the past month to $3.01. This represents a change of -13.8% from what the company reported a year ago. The PNC Financial Services Group, Inc currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Comerica Incorporated (CMA) : Free Stock Analysis Report
The PNC Financial Services Group, Inc (PNC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. For The PNC Financial Services Group, Inc, the consensus EPS estimate for the upcoming report has changed +0.5% over the past month to $3.01. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The PNC Financial Services Group, Inc (PNC), another stock in the same industry, closed the last trading session 4.8% higher at $153.31. For The PNC Financial Services Group, Inc, the consensus EPS estimate for the upcoming report has changed +0.5% over the past month to $3.01. Click to get this free report Comerica Incorporated (CMA) : Free Stock Analysis Report The PNC Financial Services Group, Inc (PNC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Comerica Incorporated is part of the Zacks Banks - Major Regional industry. Click to get this free report Comerica Incorporated (CMA) : Free Stock Analysis Report The PNC Financial Services Group, Inc (PNC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Hence, the Comerica Incorporated stock moved higher. For The PNC Financial Services Group, Inc, the consensus EPS estimate for the upcoming report has changed +0.5% over the past month to $3.01. The PNC Financial Services Group, Inc currently has a Zacks Rank of #3 (Hold).
|
423b1b5c-da57-426e-842c-decf628ff0d8
|
712421.0
|
2023-12-12 00:00:00 UTC
|
3 Exciting Small Cap Stocks with Dividend Yields Over 5%
|
DCOMP
|
https://www.nasdaq.com/articles/3-exciting-small-cap-stocks-with-dividend-yields-over-5
|
nan
|
nan
|
As broader markets continue to rally on the Fed's decision to leave rates unchanged, many small-cap stocks are joining the party.
Even better, with their stocks spiking today, here are a few small-cap stocks that have sizable dividend yields making them more enticing as broader economic fears continue to subside.
Deluxe DLX
Payment solutions provider Deluxe Corporation looks very appealing with its Zacks Business-Office Products Industry in the top 1% of over 250 Zacks industries.
Trading around $20 with a 6.15% annual dividend yield, Deluxe’s stock makes the case for being undervalued at just 6.3X forward earnings which is a sharp discount to its industry average of 17X and the S&P 500’s 21.9X.
Image Source: Zacks Investment Research
Following a very strong year, Deluxe’s stock has been overlooked with fiscal 2023 earnings now expected to dip -21% to $3.22 per share. However, FY24 EPS is projected to rebound and rise 3% and Deluxe’s stock is starting to check the box in other key financial metrics such as EV/EBITDA and price to cash flow (P/CF) while still having a high return on equity (ROE).
Image Source: Zacks Investment Research
FAT Brands FAT
Trading at $5 a share, FAT Brands stock looks tempting especially with it being noteworthy that its Zacks Retail-Restaurants Industry is in the top 20% of all Zacks industries.
FAT Brands is a multi-brand, restaurant franchising company that primarily operates Fatburger, Buffalo’s Café, Buffalo’s Express, and the Ponderosa & Bonanza Steakhouse concepts. What is most intriguing is that while FAT Brands is not turning an operating profit it has been able to raise its dividend 3 times in the last 5 years with a current yield of 9.59% and the company’s top-line growth alludes to its future earnings potential.
Image Source: Zacks Investment Research
Furthermore, FAT Brands' cash on hand has risen sharply since the company went public in 2017 as total sales are forecasted to jump 16% this year and soar another 35% in FY24 to $640 million.
Image Source: Zacks Investment Research
Janus Henderson Group JHG
At just under $30 a share, Janus Henderson Group’s stock still has a market cap under $10 billion and stands out in terms of value. The investment management company offers investors a 5.44% annual dividend yield with its services consisting of investment advisors for equities, fixed income, property, and private equity sectors.
Notably, fiscal 2023 earnings estimates are up 5% over the last 60 days from $2.24 a share to $2.36 per share. Plus, FY24 EPS estimates are up 3% in the last two months and Janus Henderson’s stock trades at a reasonable 12.1X forward earnings multiple.
Image Source: Zacks Investment Research
Other key financial metrics are also attractive such as price to cash flow, EV/EBITDA, and the company’s 6.41% total debt to capital percentage which is well below the optimum level of 40% and suggests Janus Henderson should be able to sustain its generous dividend.
Image Source: Zacks Investment Research
Takeaway
These small-cap stocks appear to have more room to run and may continue to participate in the recent rally among broader markets. To that point, Deluxe, FAT Brands, and Janus Henderson’s stock all sport a Zacks Rank #2 (Buy) and their lofty dividends make them even more compelling at the moment.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Deluxe Corporation (DLX) : Free Stock Analysis Report
Janus Henderson Group plc (JHG) : Free Stock Analysis Report
FAT Brands Inc. (FAT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
However, FY24 EPS is projected to rebound and rise 3% and Deluxe’s stock is starting to check the box in other key financial metrics such as EV/EBITDA and price to cash flow (P/CF) while still having a high return on equity (ROE). Image Source: Zacks Investment Research Furthermore, FAT Brands' cash on hand has risen sharply since the company went public in 2017 as total sales are forecasted to jump 16% this year and soar another 35% in FY24 to $640 million. Image Source: Zacks Investment Research Other key financial metrics are also attractive such as price to cash flow, EV/EBITDA, and the company’s 6.41% total debt to capital percentage which is well below the optimum level of 40% and suggests Janus Henderson should be able to sustain its generous dividend.
|
Image Source: Zacks Investment Research FAT Brands FAT Trading at $5 a share, FAT Brands stock looks tempting especially with it being noteworthy that its Zacks Retail-Restaurants Industry is in the top 20% of all Zacks industries. Image Source: Zacks Investment Research Janus Henderson Group JHG At just under $30 a share, Janus Henderson Group’s stock still has a market cap under $10 billion and stands out in terms of value. Click to get this free report Deluxe Corporation (DLX) : Free Stock Analysis Report Janus Henderson Group plc (JHG) : Free Stock Analysis Report FAT Brands Inc. (FAT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Image Source: Zacks Investment Research FAT Brands FAT Trading at $5 a share, FAT Brands stock looks tempting especially with it being noteworthy that its Zacks Retail-Restaurants Industry is in the top 20% of all Zacks industries. Image Source: Zacks Investment Research Janus Henderson Group JHG At just under $30 a share, Janus Henderson Group’s stock still has a market cap under $10 billion and stands out in terms of value. Click to get this free report Deluxe Corporation (DLX) : Free Stock Analysis Report Janus Henderson Group plc (JHG) : Free Stock Analysis Report FAT Brands Inc. (FAT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Trading around $20 with a 6.15% annual dividend yield, Deluxe’s stock makes the case for being undervalued at just 6.3X forward earnings which is a sharp discount to its industry average of 17X and the S&P 500’s 21.9X. Image Source: Zacks Investment Research FAT Brands FAT Trading at $5 a share, FAT Brands stock looks tempting especially with it being noteworthy that its Zacks Retail-Restaurants Industry is in the top 20% of all Zacks industries. Image Source: Zacks Investment Research Janus Henderson Group JHG At just under $30 a share, Janus Henderson Group’s stock still has a market cap under $10 billion and stands out in terms of value.
|
a1762b20-9026-44bb-9966-af9769c11f34
|
712422.0
|
2023-12-12 00:00:00 UTC
|
Australia shares hit over 4-mth high on boost from commodities, banks stocks
|
DCOMP
|
https://www.nasdaq.com/articles/australia-shares-hit-over-4-mth-high-on-boost-from-commodities-banks-stocks
|
nan
|
nan
|
Dec 15 (Reuters) - Australian shares climbed a more than four-month high on Friday, buoyed by better-than-expected jobs data and optimism after U.S. Federal Reserve indicated that interest rates might be lowered in 2024.
The S&P/ASX 200 index .AXJO rose 0.8% to 7434.0 by 0023 GMT, its highest level since Aug. 2. The benchmark is set for a third straight weekly gain and its best week since July 14.
On Thursday, the local employment data exceeded expectations for a second straight month, but the jobless rate rose to a 1-1/2-year high as more people went looking for work, adding to signs of loosening in the labour market.
Additionally, the Fed took a dovish stance in its final monetary policy meeting of 2024 on Wednesday, keeping rates on hold for a third straight month, while signalling a possibility of lower borrowing cuts in 2024.
In Sydney, heavyweight mining stocks .AXMM led gains on the benchmark, trading 2.1% higher, eyeing their best week since Sept. 15, with sector majors Rio Tinto RIO.AX and Fortescue FMG.AX up 2.4% and 1.6%, respectively.
Gold stocks .AXGD gained 1.0% tracking bullion prices. GOL/
Shares of Evolution Mining EVN.AX climbed 1.2%.
Rate-sensitive financials stocks .AXFJ rose 0.5%, set for a fourth straight weekly gain, and best week since July 14. The 'Big Four' banks rose between 0.2% and 1.2%.
Energy stocks .AXEJ were up 1.7%, on track for their best week since Oct. 13, and best day since Nov. 14, on gains in oil prices. O/R
Australian Clinical Labs ACL.AXsaid it intended to withdraw its takeover bid for medical centre operator Healius HLS.AX, citing a "significant" deterioration in the performance of Healius since the offer was announced.
Shares of Healius and Australian Care were down 0.7% and 1.4%, respectively.
New Zealand's benchmark S&P/NZX 50 index .NZ50 ticked 0.3% lower to 11,517.69, but was set for its seventh straight weekly gain.
(Reporting by Adwitiya Srivastava in Bengaluru; Editing by Rashmi Aich)
((Adwitiya.Srivastava@thomsonreuters.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Dec 15 (Reuters) - Australian shares climbed a more than four-month high on Friday, buoyed by better-than-expected jobs data and optimism after U.S. Federal Reserve indicated that interest rates might be lowered in 2024. On Thursday, the local employment data exceeded expectations for a second straight month, but the jobless rate rose to a 1-1/2-year high as more people went looking for work, adding to signs of loosening in the labour market. Additionally, the Fed took a dovish stance in its final monetary policy meeting of 2024 on Wednesday, keeping rates on hold for a third straight month, while signalling a possibility of lower borrowing cuts in 2024.
|
The benchmark is set for a third straight weekly gain and its best week since July 14. Rate-sensitive financials stocks .AXFJ rose 0.5%, set for a fourth straight weekly gain, and best week since July 14. New Zealand's benchmark S&P/NZX 50 index .NZ50 ticked 0.3% lower to 11,517.69, but was set for its seventh straight weekly gain.
|
The benchmark is set for a third straight weekly gain and its best week since July 14. Rate-sensitive financials stocks .AXFJ rose 0.5%, set for a fourth straight weekly gain, and best week since July 14. New Zealand's benchmark S&P/NZX 50 index .NZ50 ticked 0.3% lower to 11,517.69, but was set for its seventh straight weekly gain.
|
Dec 15 (Reuters) - Australian shares climbed a more than four-month high on Friday, buoyed by better-than-expected jobs data and optimism after U.S. Federal Reserve indicated that interest rates might be lowered in 2024. The benchmark is set for a third straight weekly gain and its best week since July 14. Shares of Healius and Australian Care were down 0.7% and 1.4%, respectively.
|
8c4fb18f-d196-4627-9672-f08790ee6276
|
712423.0
|
2023-12-12 00:00:00 UTC
|
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
|
DCOMP
|
https://www.nasdaq.com/articles/mind-bending-growth%3A-3-psychedelic-stocks-with-trippy-potential
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Mental health has been one of the hot topics in the medical industry over the past few years. Widespread awareness was brought to the public eye during the COVID-19 pandemic as people in prolonged lockdowns struggled with isolation as well as the threat of a deadly virus. The World Health Organization has issued statements to emphasize how mental health issues are serious, life-altering conditions not to be downplayed. As a response, various US states raised legislation to legalize psilocybin services to address psychiatric issues. This triggered investor interest in psychedelic stocks.
While some may say it’s still too early, a few might argue that this is a great chance to get on the ground floor of something big.
So, let’s look at psychedelic stocks that offer the best potential growth in the coming years.
Cybin (CYBN)
Source: luckakcul / Shutterstock.com
Cybin NYSEAMERICAN:CYBN) is a biopharmaceutical company in Canada that creates psychedelic-based therapeutics to help patients suffering from mental health conditions. It has systematic research on psychedelic molecules under its dDMT and N,N-dimethyltryptamine (DMT) programs. The company is currently working on a proprietary deuterated psilocybin analog (CYB003) that is aimed at treating major depressive disorders (currently in Phase 3). It also has a proprietary deuterated dDMT molecule for generalized anxiety disorder (CYB004), which has advanced to Phase 2. The company holds an IP portfolio with 30 granted patents and 160 patents pending in the psychedelic drug development sector.
As of late, CYBN has received a lot of positive news, with recent highlights showcasing a reduction in major depressive disorder symptoms from its proprietary deuterated psilocybin analog positive Phase 2 interim data for CYB003. The company also announced the Small Pharma Inc. acquisition, which will help push its research efforts in N, N-dimethyltryptamine (DMT), and deuterated DMT programs to a new level. Furthermore, Cybin anticipates new milestones in its studies for the SPL028, CYB004, CYB003, and deuterated (dDMT) programs.
The companies’ proactive approach to regulatory approval and advancements in treating anxiety disorder has put CYBN on the path to higher potential growth. Analysts are also happy with the company’s direction and recommend it as a Strong Buy. It’s also one of our top psychedelic stocks to buy.
Supernus Pharmaceuticals (SUPN)
Source: local_doctor / Shutterstock.com
Supernus Pharmaceuticals (NASDAQ:SUPN) is a biopharmaceutical known for treating central nervous system (CNS) diseases. Its primary focus is on creating and commercializing treatments used in neuroscience. SUPN packs a strong portfolio of treatments that range from migraine to hypomobility in Parkinson’s disease.
It also works on potential treatments for depression, epilepsy, hypomobility in PD, and other CNS disorders. Some of Supernus’ well-known treatment products include Trokendi XR (topiramate) & Oxtellar XR (oxcarbazepine) for epilepsy treatment and APOKYN (apomorphine hydrochloride injection) for advanced Parkinson’s disease patients.
Looking at its financials, the company finished an impressive third quarter, prompting it to raise its full-year adjusted earnings guidance to $95-110 million, a substantial increase from its original $75-100 million range. Total revenue (excluding Trokendi XR net sales) went up 24% YoY. There was a strong uptick in Qelbree ADHD medication sales, up 103% YoY. The company also has several promising products in the pipeline. These include SPN-830, resubmitted and accepted for FDA approval, and several other drug trials for ADHD, depression, and epilepsy drugs. This strong momentum and an impressive pipeline make SUPN one of the promising psychedelic stocks to buy.
Biogen (BIIB)
Source: Shutterstock
Biogen (NASDAQ:BIIB) is a biotechnology company specializing in therapy development for serious and intricate diseases. The company carries a portfolio of treatments for various types of spinal muscular atrophy (SMA), Alzheimer’s disease, and sclerosis. It has also been taking steps in advancing treatments for postpartum depression (PPD), major depressive disorder (MDD), certain forms of lupus, and Alzheimer’s disease. Its well-known products in the market include AVONEX, PLEGRIDY, TYSABRI, FUMADERM, SPINRAZA, ADUHELM, and FAMPYRA.
The company is on its way to becoming a leader in treating Alzheimer’s disease. It recently launched LEQEMBI with FDA approval for the treatment of the disease. ZURZUVAE also got approval for the treatment of post-partum depression. Furthermore, the recent acquisition of Reata Pharmaceuticals opens up additional revenue streams in the near term.
In addition, the company has also implemented its “Fit for Growth” to bolster its financials by aligning its cost structure with revenue and focusing on growth drivers. In fact, Biogen reported a strong quarter, with revenues reaching $2.53 billion and beating analyst estimates by 9.27%. This intense focus on growth and getting its product approved for the market puts BIIB in our top psychedelic companies to buy.
On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The companies’ proactive approach to regulatory approval and advancements in treating anxiety disorder has put CYBN on the path to higher potential growth. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential appeared first on InvestorPlace.
|
As of late, CYBN has received a lot of positive news, with recent highlights showcasing a reduction in major depressive disorder symptoms from its proprietary deuterated psilocybin analog positive Phase 2 interim data for CYB003. Supernus Pharmaceuticals (SUPN) Source: local_doctor / Shutterstock.com Supernus Pharmaceuticals (NASDAQ:SUPN) is a biopharmaceutical known for treating central nervous system (CNS) diseases. Some of Supernus’ well-known treatment products include Trokendi XR (topiramate) & Oxtellar XR (oxcarbazepine) for epilepsy treatment and APOKYN (apomorphine hydrochloride injection) for advanced Parkinson’s disease patients.
|
The company is currently working on a proprietary deuterated psilocybin analog (CYB003) that is aimed at treating major depressive disorders (currently in Phase 3). Some of Supernus’ well-known treatment products include Trokendi XR (topiramate) & Oxtellar XR (oxcarbazepine) for epilepsy treatment and APOKYN (apomorphine hydrochloride injection) for advanced Parkinson’s disease patients. This intense focus on growth and getting its product approved for the market puts BIIB in our top psychedelic companies to buy.
|
So, let’s look at psychedelic stocks that offer the best potential growth in the coming years. These include SPN-830, resubmitted and accepted for FDA approval, and several other drug trials for ADHD, depression, and epilepsy drugs. This intense focus on growth and getting its product approved for the market puts BIIB in our top psychedelic companies to buy.
|
5f4c21d2-3686-4539-aa50-7a6b012fa353
|
712424.0
|
2023-12-12 00:00:00 UTC
|
Matson Inc Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/matson-inc-shares-near-52-week-high-market-mover-0
|
nan
|
nan
|
Matson Inc (MATX) shares closed today at 0.1% below its 52 week high of $101.71, giving the company a market cap of $3B. The stock is currently up 62.9% year-to-date, up 63.8% over the past 12 months, and up 217.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 66.7% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
The Relative Strength Index (RSI) on the stock was between 30 and 70.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 67.6%
The company's stock price performance over the past 12 months beats the peer average by 108.8%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 331.9% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Matson Inc (MATX) shares closed today at 0.1% below its 52 week high of $101.71, giving the company a market cap of $3B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 66.7% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 67.6% The company's stock price performance over the past 12 months beats the peer average by 108.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 331.9% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 67.6% The company's stock price performance over the past 12 months beats the peer average by 108.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 331.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 67.6% The company's stock price performance over the past 12 months beats the peer average by 108.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 331.9% higher than the average peer.
|
f2599a50-87d3-4dee-9900-97de0b2a7824
|
712425.0
|
2023-12-12 00:00:00 UTC
|
Brady Corp. - Class A Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/brady-corp.-class-a-shares-near-52-week-high-market-mover-2
|
nan
|
nan
|
Brady Corp. - Class A (BRC) shares closed today at 1.0% below its 52 week high of $59.06, giving the company a market cap of $2B. The stock is currently up 26.4% year-to-date, up 29.9% over the past 12 months, and up 54.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 40.5% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 35.4%
The company's stock price performance over the past 12 months beats the peer average by 62.6%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -35.8% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Brady Corp. - Class A (BRC) shares closed today at 1.0% below its 52 week high of $59.06, giving the company a market cap of $2B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 35.4% The company's stock price performance over the past 12 months beats the peer average by 62.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -35.8% lower than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 35.4% The company's stock price performance over the past 12 months beats the peer average by 62.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -35.8% lower than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 35.4% The company's stock price performance over the past 12 months beats the peer average by 62.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -35.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 35.4% The company's stock price performance over the past 12 months beats the peer average by 62.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -35.8% lower than the average peer.
|
5c8fc3f3-8f88-4eab-b754-43e0dea04cda
|
712426.0
|
2023-12-12 00:00:00 UTC
|
Hilltop Holdings Inc Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/hilltop-holdings-inc-shares-approach-52-week-high-market-mover
|
nan
|
nan
|
Hilltop Holdings Inc (HTH) shares closed today at 1.6% below its 52 week high of $34.68, giving the company a market cap of $2B. The stock is currently up 17.3% year-to-date, up 23.1% over the past 12 months, and up 112.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 128.0% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by -1502.9%
The company's stock price performance over the past 12 months beats the peer average by -2077.0%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 130.9% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Hilltop Holdings Inc (HTH) shares closed today at 1.6% below its 52 week high of $34.68, giving the company a market cap of $2B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1502.9% The company's stock price performance over the past 12 months beats the peer average by -2077.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 130.9% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 128.0% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1502.9% The company's stock price performance over the past 12 months beats the peer average by -2077.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 130.9% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1502.9% The company's stock price performance over the past 12 months beats the peer average by -2077.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 130.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1502.9% The company's stock price performance over the past 12 months beats the peer average by -2077.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 130.9% higher than the average peer.
|
cd3a3bec-3a70-4a8c-a3b0-3df4aada5ffd
|
712427.0
|
2023-12-12 00:00:00 UTC
|
Boeing Co. Shares Climb 2.8% Past Previous 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/boeing-co.-shares-climb-2.8-past-previous-52-week-high-market-mover
|
nan
|
nan
|
Boeing Co. (BA) shares closed 2.8% higher than its previous 52 week high, giving the company a market cap of $155B. The stock is currently up 34.5% year-to-date, up 36.1% over the past 12 months, and down 17.3% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 32.2% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 103.4%
The company's stock price performance over the past 12 months beats the peer average by 95.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Boeing Co. (BA) shares closed 2.8% higher than its previous 52 week high, giving the company a market cap of $155B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 103.4% The company's stock price performance over the past 12 months beats the peer average by 95.2%
|
Boeing Co. (BA) shares closed 2.8% higher than its previous 52 week high, giving the company a market cap of $155B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 103.4% The company's stock price performance over the past 12 months beats the peer average by 95.2%
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 103.4% The company's stock price performance over the past 12 months beats the peer average by 95.2% This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Trading Activity Trading volume this week was 32.2% higher than the 20-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 103.4% The company's stock price performance over the past 12 months beats the peer average by 95.2%
|
3e039ed6-43d8-4425-bb7c-1eed27d292c3
|
712428.0
|
2023-12-12 00:00:00 UTC
|
Why Redfin Stock Popped Today
|
DCOMP
|
https://www.nasdaq.com/articles/why-redfin-stock-popped-today
|
nan
|
nan
|
Shares of Redfin (NASDAQ: RDFN) rallied 15.9% on Thursday as investors in the online real estate platform celebrated the prospect of lower interest rates in the coming year.
Good news for mortgage rates
Redfin's pop today extended a late rally that began Wednesday afternoon after U.S. Federal Reserve officials opted to leave their benchmark interest rate flat for the third straight month, at a targeted range of between 5.25% and 5.5%. More exciting for investors in Redfin, however, is that policymakers on the Federal Open Market Committee also signaled there will be at least three rate cuts in 2024. This will mark the first rate reductions since the Fed began raising rates in March 2022 in an effort to combat sky-high inflation.
Investors should keep in mind that the Fed doesn't directly set mortgage rates. But its management of the federal funds rate does influence mortgage lenders as they determine how much interest to charge on mortgage loans.
Suffice it to say if mortgage rates come down, it could serve as a significant positive catalyst for Redfin as it works to recover from persistently high mortgage rates and a weak housing market.
What's next for Redfin stock?
In a press release early this morning, Redfin highlighted that daily average mortgage rates have already declined to 6.82% -- the first time daily rates have dipped below 7% since July -- while housing payments have fallen to their lowest level since April.
"Rates dropped after the Fed brought good news to homebuyers at its December 13 meeting, indicating they're on a path toward lowering interest rates more and sooner than expected," Redfin elaborated. "That's another piece of evidence that mortgage rates are likely to drop into the mid-6% range in 2024, consistent with Redfin's housing-market predictions."
Shares of Redfin are still down around 90% from their early 2021 peak. But the stock has also more than doubled so far in 2023. As more investors bet on its inevitable turnaround as rates continue to decline, this pop might well be the start of a much more encouraging long-term trend.
Should you invest $1,000 in Redfin right now?
Before you buy stock in Redfin, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Redfin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Steve Symington has positions in Redfin. The Motley Fool has positions in and recommends Redfin. The Motley Fool recommends the following options: short February 2024 $8 calls on Redfin. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Shares of Redfin (NASDAQ: RDFN) rallied 15.9% on Thursday as investors in the online real estate platform celebrated the prospect of lower interest rates in the coming year. More exciting for investors in Redfin, however, is that policymakers on the Federal Open Market Committee also signaled there will be at least three rate cuts in 2024. As more investors bet on its inevitable turnaround as rates continue to decline, this pop might well be the start of a much more encouraging long-term trend.
|
Good news for mortgage rates Redfin's pop today extended a late rally that began Wednesday afternoon after U.S. Federal Reserve officials opted to leave their benchmark interest rate flat for the third straight month, at a targeted range of between 5.25% and 5.5%. Before you buy stock in Redfin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Redfin wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Steve Symington has positions in Redfin.
|
Good news for mortgage rates Redfin's pop today extended a late rally that began Wednesday afternoon after U.S. Federal Reserve officials opted to leave their benchmark interest rate flat for the third straight month, at a targeted range of between 5.25% and 5.5%. Suffice it to say if mortgage rates come down, it could serve as a significant positive catalyst for Redfin as it works to recover from persistently high mortgage rates and a weak housing market. Before you buy stock in Redfin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Redfin wasn't one of them.
|
Before you buy stock in Redfin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Redfin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Steve Symington has positions in Redfin.
|
e5dfee80-c900-4528-913a-d8dd0c362c4d
|
712429.0
|
2023-12-12 00:00:00 UTC
|
Simpson Manufacturing Co., Inc. Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/simpson-manufacturing-co.-inc.-shares-approach-52-week-high-market-mover-1
|
nan
|
nan
|
Simpson Manufacturing Co., Inc. (SSD) shares closed today at 1.8% below its 52 week high of $195.81, giving the company a market cap of $8B. The stock is currently up 121.8% year-to-date, up 107.4% over the past 12 months, and up 287.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 20.2% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 294.1%
The company's stock price performance over the past 12 months beats the peer average by 322.6%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 47.3% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Simpson Manufacturing Co., Inc. (SSD) shares closed today at 1.8% below its 52 week high of $195.81, giving the company a market cap of $8B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 294.1% The company's stock price performance over the past 12 months beats the peer average by 322.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 47.3% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 20.2% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 294.1% The company's stock price performance over the past 12 months beats the peer average by 322.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 47.3% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 294.1% The company's stock price performance over the past 12 months beats the peer average by 322.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 47.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 294.1% The company's stock price performance over the past 12 months beats the peer average by 322.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 47.3% higher than the average peer.
|
dff2079c-8d6c-46eb-a65e-e95fb48d52c5
|
712430.0
|
2023-12-12 00:00:00 UTC
|
Ally Financial Inc Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/ally-financial-inc-shares-approach-52-week-high-market-mover
|
nan
|
nan
|
Ally Financial Inc (ALLY) shares closed today at 0.1% below its 52 week high of $34.91, giving the company a market cap of $10B. The stock is currently up 48.6% year-to-date, up 42.6% over the past 12 months, and up 75.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 91.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 489.1%
The company's stock price performance over the past 12 months beats the peer average by 420.5%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.5% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 489.1% The company's stock price performance over the past 12 months beats the peer average by 420.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator.
|
Ally Financial Inc (ALLY) shares closed today at 0.1% below its 52 week high of $34.91, giving the company a market cap of $10B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 489.1% The company's stock price performance over the past 12 months beats the peer average by 420.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.5% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 489.1% The company's stock price performance over the past 12 months beats the peer average by 420.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 489.1% The company's stock price performance over the past 12 months beats the peer average by 420.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.5% higher than the average peer.
|
14e5e67d-c669-4d20-911f-1073901fabea
|
712431.0
|
2023-12-12 00:00:00 UTC
|
Urban Edge Properties Shares Close in on 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/urban-edge-properties-shares-close-in-on-52-week-high-market-mover
|
nan
|
nan
|
Urban Edge Properties (UE) shares closed today at 1.0% below its 52 week high of $18.69, giving the company a market cap of $2B. The stock is currently up 38.1% year-to-date, up 27.8% over the past 12 months, and up 22.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 124.4% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 1522.9%
The company's stock price performance over the past 12 months beats the peer average by -1654.7%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 436.0% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Urban Edge Properties (UE) shares closed today at 1.0% below its 52 week high of $18.69, giving the company a market cap of $2B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1522.9% The company's stock price performance over the past 12 months beats the peer average by -1654.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 436.0% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 124.4% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1522.9% The company's stock price performance over the past 12 months beats the peer average by -1654.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 436.0% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1522.9% The company's stock price performance over the past 12 months beats the peer average by -1654.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 436.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1522.9% The company's stock price performance over the past 12 months beats the peer average by -1654.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 436.0% higher than the average peer.
|
77860fce-d2b6-4a07-acea-36feae5f4ebe
|
712432.0
|
2023-12-12 00:00:00 UTC
|
Stewart Information Services Corp. Shares Close in on 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/stewart-information-services-corp.-shares-close-in-on-52-week-high-market-mover-1
|
nan
|
nan
|
Stewart Information Services Corp. (STC) shares closed today at 1.5% below its 52 week high of $57.31, giving the company a market cap of $1B. The stock is currently up 39.1% year-to-date, up 34.5% over the past 12 months, and up 62.5% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 33.7% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 91.3%
The company's stock price performance over the past 12 months beats the peer average by 70.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 261.4% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Stewart Information Services Corp. (STC) shares closed today at 1.5% below its 52 week high of $57.31, giving the company a market cap of $1B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 91.3% The company's stock price performance over the past 12 months beats the peer average by 70.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 261.4% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 33.7% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 91.3% The company's stock price performance over the past 12 months beats the peer average by 70.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 261.4% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 91.3% The company's stock price performance over the past 12 months beats the peer average by 70.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 261.4% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 91.3% The company's stock price performance over the past 12 months beats the peer average by 70.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 261.4% higher than the average peer.
|
f3904fa4-85b9-4527-ad10-90cb8177c6b5
|
712433.0
|
2023-12-12 00:00:00 UTC
|
Sally Beauty Holdings Inc Shares Close the Week 23.0% Higher - Weekly Wrap
|
DCOMP
|
https://www.nasdaq.com/articles/sally-beauty-holdings-inc-shares-close-the-week-23.0-higher-weekly-wrap
|
nan
|
nan
|
Sally Beauty Holdings Inc (SBH) shares closed this week 23.0% higher than it did at the end of last week. The stock is currently up 4.7% year-to-date, up 7.3% over the past 12 months, and down 29.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Shares traded as high as $13.30 and as low as $10.62 this week.
Shares closed 29.8% below its 52-week high and 79.5% above its 52-week low.
Trading volume this week was 16.8% higher than the 10-day average and 37.7% higher than the 30-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
The company share price beats the performance of its peers in the Consumer Discretionary industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date lags the peer average by -82.1%
The company's stock price performance over the past 12 months lags the peer average by -74.9%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.4% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Consumer Discretionary industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -82.1% The company's stock price performance over the past 12 months lags the peer average by -74.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator.
|
Sally Beauty Holdings Inc (SBH) shares closed this week 23.0% higher than it did at the end of last week. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Consumer Discretionary industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -82.1% The company's stock price performance over the past 12 months lags the peer average by -74.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.4% lower than the average peer.
|
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Consumer Discretionary industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -82.1% The company's stock price performance over the past 12 months lags the peer average by -74.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Trading volume this week was 16.8% higher than the 10-day average and 37.7% higher than the 30-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Consumer Discretionary industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -82.1% The company's stock price performance over the past 12 months lags the peer average by -74.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.4% lower than the average peer.
|
db9f4d07-15e9-43dd-b52d-429056bbfef1
|
712434.0
|
2023-12-12 00:00:00 UTC
|
Acuity Brands Inc (AYI) Hit a 52 Week High, Can the Run Continue?
|
DCOMP
|
https://www.nasdaq.com/articles/acuity-brands-inc-ayi-hit-a-52-week-high-can-the-run-continue
|
nan
|
nan
|
Have you been paying attention to shares of Acuity Brands (AYI)? Shares have been on the move with the stock up 12.5% over the past month. The stock hit a new 52-week high of $206.95 in the previous session. Acuity Brands has gained 23.4% since the start of the year compared to the 50.6% move for the Zacks Construction sector and the 17% return for the Zacks Building Products - Lighting industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on October 4, 2023, Acuity Brands reported EPS of $3.97 versus consensus estimate of $3.57 while it missed the consensus revenue estimate by 0.72%.
For the current fiscal year, Acuity Brands is expected to post earnings of $13.39 per share on $3.83 billion in revenues. This represents a -4.7% change in EPS on a -3.01% change in revenues. For the next fiscal year, the company is expected to earn $13.84 per share on $4.01 billion in revenues. This represents a year-over-year change of 3.36% and 4.51%, respectively.
Valuation Metrics
Acuity Brands may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Acuity Brands has a Value Score of A. The stock's Growth and Momentum Scores are B and F, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 15.3X current fiscal year EPS estimates, which is not in-line with the peer industry average of 20.6X. On a trailing cash flow basis, the stock currently trades at 12.4X versus its peer group's average of 11.8X. Additionally, the stock has a PEG ratio of 1.53. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks Rank
We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Acuity Brands currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Acuity Brands fits the bill. Thus, it seems as though Acuity Brands shares could still be poised for more gains ahead.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Acuity Brands Inc (AYI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
For the current fiscal year, Acuity Brands is expected to post earnings of $13.39 per share on $3.83 billion in revenues. A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
In its last earnings report on October 4, 2023, Acuity Brands reported EPS of $3.97 versus consensus estimate of $3.57 while it missed the consensus revenue estimate by 0.72%. For the current fiscal year, Acuity Brands is expected to post earnings of $13.39 per share on $3.83 billion in revenues. In terms of its value breakdown, the stock currently trades at 15.3X current fiscal year EPS estimates, which is not in-line with the peer industry average of 20.6X.
|
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). Zacks Rank We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Acuity Brands fits the bill.
|
For the next fiscal year, the company is expected to earn $13.84 per share on $4.01 billion in revenues. Acuity Brands has a Value Score of A. Free: See Our Top Stock and 4 Runners Up >> Want the latest recommendations from Zacks Investment Research?
|
ee2d4568-3d63-44c5-87b1-a986e705f12c
|
712435.0
|
2023-12-12 00:00:00 UTC
|
Unity Software Inc Shares Close the Week 20.0% Higher - Weekly Wrap
|
DCOMP
|
https://www.nasdaq.com/articles/unity-software-inc-shares-close-the-week-20.0-higher-weekly-wrap
|
nan
|
nan
|
Unity Software Inc (U) shares closed this week 20.0% higher than it did at the end of last week. The stock is currently up 33.9% year-to-date, up 17.7% over the past 12 months, and down 44.0% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Shares traded as high as $38.38 and as low as $31.60 this week.
Shares closed 21.4% below its 52-week high and 77.3% above its 52-week low.
Trading volume this week was 79.0% higher than the 10-day average and 94.7% higher than the 30-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 2.8.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 180.4%
The company's stock price performance over the past 12 months beats the peer average by 109.4%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 2.8. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 180.4% The company's stock price performance over the past 12 months beats the peer average by 109.4% This story was produced by the Kwhen Automated News Generator.
|
Unity Software Inc (U) shares closed this week 20.0% higher than it did at the end of last week. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 180.4% The company's stock price performance over the past 12 months beats the peer average by 109.4%
|
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 180.4% The company's stock price performance over the past 12 months beats the peer average by 109.4% This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Trading volume this week was 79.0% higher than the 10-day average and 94.7% higher than the 30-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 180.4% The company's stock price performance over the past 12 months beats the peer average by 109.4%
|
222e4b9e-4c79-48a6-99ad-4637ee993b6c
|
712436.0
|
2023-12-12 00:00:00 UTC
|
Main Street Capital Corporation Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/main-street-capital-corporation-shares-approach-52-week-high-market-mover-2
|
nan
|
nan
|
Main Street Capital Corporation (MAIN) shares closed today at 1.0% below its 52 week high of $43.24, giving the company a market cap of $3B. The stock is currently up 26.5% year-to-date, up 25.6% over the past 12 months, and up 67.5% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 48.1% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 293.3%
The company's stock price performance over the past 12 months beats the peer average by 282.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.8% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 293.3% The company's stock price performance over the past 12 months beats the peer average by 282.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator.
|
Main Street Capital Corporation (MAIN) shares closed today at 1.0% below its 52 week high of $43.24, giving the company a market cap of $3B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 293.3% The company's stock price performance over the past 12 months beats the peer average by 282.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.8% lower than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 293.3% The company's stock price performance over the past 12 months beats the peer average by 282.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 293.3% The company's stock price performance over the past 12 months beats the peer average by 282.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -61.8% lower than the average peer.
|
7694771c-9565-4296-8b7e-3dd31866b589
|
712437.0
|
2023-12-12 00:00:00 UTC
|
Amphenol Corp. - Class A Shares Climb 0.4% Past Previous 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/amphenol-corp.-class-a-shares-climb-0.4-past-previous-52-week-high-market-mover
|
nan
|
nan
|
Amphenol Corp. - Class A (APH) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $59B. The stock is currently up 30.8% year-to-date, up 22.2% over the past 12 months, and up 149.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 35.9% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by -282.9%
The company's stock price performance over the past 12 months beats the peer average by -217.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 710.3% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Amphenol Corp. - Class A (APH) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $59B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -282.9% The company's stock price performance over the past 12 months beats the peer average by -217.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 710.3% higher than the average peer.
|
Amphenol Corp. - Class A (APH) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $59B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -282.9% The company's stock price performance over the past 12 months beats the peer average by -217.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 710.3% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -282.9% The company's stock price performance over the past 12 months beats the peer average by -217.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 710.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -282.9% The company's stock price performance over the past 12 months beats the peer average by -217.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 710.3% higher than the average peer.
|
095a7e40-b2a7-44eb-9c22-c8aa143627fa
|
712438.0
|
2023-12-12 00:00:00 UTC
|
Phillips 66 Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/phillips-66-shares-near-52-week-high-market-mover
|
nan
|
nan
|
Phillips 66 (PSX) shares closed today at 1.1% below its 52 week high of $131.37, giving the company a market cap of $57B. The stock is currently up 30.0% year-to-date, up 33.6% over the past 12 months, and up 85.6% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 14.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Energy industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 559.6%
The company's stock price performance over the past 12 months beats the peer average by 161.2%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 25.2% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Phillips 66 (PSX) shares closed today at 1.1% below its 52 week high of $131.37, giving the company a market cap of $57B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Energy industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 559.6% The company's stock price performance over the past 12 months beats the peer average by 161.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 25.2% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 14.8% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Energy industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 559.6% The company's stock price performance over the past 12 months beats the peer average by 161.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 25.2% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Energy industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 559.6% The company's stock price performance over the past 12 months beats the peer average by 161.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 25.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Energy industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 559.6% The company's stock price performance over the past 12 months beats the peer average by 161.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 25.2% higher than the average peer.
|
f2de01da-3058-428b-a4cb-6691773ac529
|
712439.0
|
2023-12-12 00:00:00 UTC
|
Amneal Pharmaceuticals Inc - Class A Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/amneal-pharmaceuticals-inc-class-a-shares-near-52-week-high-market-mover
|
nan
|
nan
|
Amneal Pharmaceuticals Inc - Class A (AMRX) shares closed today at 1.1% below its 52 week high of $5.25, giving the company a market cap of $1B. The stock is currently up 151.3% year-to-date, up 114.6% over the past 12 months, and down 69.0% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 27.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.
Technical Indicators
The Relative Strength Index (RSI) on the stock was between 30 and 70.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by -1281.4%
The company's stock price performance over the past 12 months beats the peer average by -975.0%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 10502.6% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Amneal Pharmaceuticals Inc - Class A (AMRX) shares closed today at 1.1% below its 52 week high of $5.25, giving the company a market cap of $1B. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1281.4% The company's stock price performance over the past 12 months beats the peer average by -975.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 10502.6% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 27.8% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1281.4% The company's stock price performance over the past 12 months beats the peer average by -975.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 10502.6% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1281.4% The company's stock price performance over the past 12 months beats the peer average by -975.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 10502.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1281.4% The company's stock price performance over the past 12 months beats the peer average by -975.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 10502.6% higher than the average peer.
|
bcf18098-3694-4dc3-b192-8f743e42ddae
|
712440.0
|
2023-12-12 00:00:00 UTC
|
Spirit Realty Capital Inc Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/spirit-realty-capital-inc-shares-approach-52-week-high-market-mover
|
nan
|
nan
|
Spirit Realty Capital Inc (SRC) shares closed today at 1.6% below its 52 week high of $44.61, giving the company a market cap of $6B. The stock is currently up 17.2% year-to-date, up 14.5% over the past 12 months, and up 55.0% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 3.2% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date lags the peer average by -17.2%
The company's stock price performance over the past 12 months beats the peer average by 37.3%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.3% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Spirit Realty Capital Inc (SRC) shares closed today at 1.6% below its 52 week high of $44.61, giving the company a market cap of $6B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -17.2% The company's stock price performance over the past 12 months beats the peer average by 37.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.3% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 3.2% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -17.2% The company's stock price performance over the past 12 months beats the peer average by 37.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.3% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -17.2% The company's stock price performance over the past 12 months beats the peer average by 37.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -17.2% The company's stock price performance over the past 12 months beats the peer average by 37.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 2.3% higher than the average peer.
|
dd357525-6dd8-4315-bb42-3883e1104609
|
712441.0
|
2023-12-12 00:00:00 UTC
|
Photronics, Inc. Shares Close the Week 39.1% Higher - Weekly Wrap
|
DCOMP
|
https://www.nasdaq.com/articles/photronics-inc.-shares-close-the-week-39.1-higher-weekly-wrap
|
nan
|
nan
|
Photronics, Inc. (PLAB) shares closed this week 39.1% higher than it did at the end of last week. The stock is currently up 72.8% year-to-date, up 69.0% over the past 12 months, and up 188.0% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Shares traded as high as $29.23 and as low as $20.81 this week.
Trading volume this week was 55.6% higher than the 10-day average and 154.6% higher than the 30-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.8.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis
The company share price beats the performance of its peers in the Information Technology industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 104.5%
The company's stock price performance over the past 12 months beats the peer average by 203.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 143.5% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.8. The stock closed below its Bollinger band, indicating it may be oversold. This story was produced by the Kwhen Automated News Generator.
|
Photronics, Inc. (PLAB) shares closed this week 39.1% higher than it did at the end of last week. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Information Technology industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 104.5% The company's stock price performance over the past 12 months beats the peer average by 203.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 143.5% higher than the average peer.
|
Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Information Technology industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 104.5% The company's stock price performance over the past 12 months beats the peer average by 203.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 143.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Photronics, Inc. (PLAB) shares closed this week 39.1% higher than it did at the end of last week. Trading volume this week was 55.6% higher than the 10-day average and 154.6% higher than the 30-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
|
d3c790e3-7389-40c0-b779-1c75d5da7ea6
|
712442.0
|
2023-12-12 00:00:00 UTC
|
Eaton Corporation plc Shares Close in on 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/eaton-corporation-plc-shares-close-in-on-52-week-high-market-mover-2
|
nan
|
nan
|
Eaton Corporation plc (ETN) shares closed today at 1.0% below its 52 week high of $239.89, giving the company a market cap of $94B. The stock is currently up 54.2% year-to-date, up 50.0% over the past 12 months, and up 285.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 41.0% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 125.4%
The company's stock price performance over the past 12 months beats the peer average by 142.7%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 9.6% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Eaton Corporation plc (ETN) shares closed today at 1.0% below its 52 week high of $239.89, giving the company a market cap of $94B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 125.4% The company's stock price performance over the past 12 months beats the peer average by 142.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 9.6% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 41.0% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 125.4% The company's stock price performance over the past 12 months beats the peer average by 142.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 9.6% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 125.4% The company's stock price performance over the past 12 months beats the peer average by 142.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 9.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 125.4% The company's stock price performance over the past 12 months beats the peer average by 142.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 9.6% higher than the average peer.
|
c13bbd61-bcdf-471e-addd-190ee5c2c11d
|
712443.0
|
2023-12-12 00:00:00 UTC
|
Arista Networks Inc Shares Climb 0.5% Past Previous 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/arista-networks-inc-shares-climb-0.5-past-previous-52-week-high-market-mover
|
nan
|
nan
|
Arista Networks Inc (ANET) shares closed 0.5% higher than its previous 52 week high, giving the company a market cap of $71B. The stock is currently up 90.4% year-to-date, up 76.4% over the past 12 months, and up 319.3% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 38.2% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 885.1%
The company's stock price performance over the past 12 months beats the peer average by 1744.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 247.1% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Arista Networks Inc (ANET) shares closed 0.5% higher than its previous 52 week high, giving the company a market cap of $71B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 885.1% The company's stock price performance over the past 12 months beats the peer average by 1744.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 247.1% higher than the average peer.
|
Arista Networks Inc (ANET) shares closed 0.5% higher than its previous 52 week high, giving the company a market cap of $71B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 885.1% The company's stock price performance over the past 12 months beats the peer average by 1744.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 247.1% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 885.1% The company's stock price performance over the past 12 months beats the peer average by 1744.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 247.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 885.1% The company's stock price performance over the past 12 months beats the peer average by 1744.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 247.1% higher than the average peer.
|
6a868959-75de-473d-a031-681fa80a4cb4
|
712444.0
|
2023-12-12 00:00:00 UTC
|
Crypto Is on the Rise and Could Help You Become a Millionaire: 2 Unstoppable Crypto Stocks to Buy in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/crypto-is-on-the-rise-and-could-help-you-become-a-millionaire%3A-2-unstoppable-crypto-stocks
|
nan
|
nan
|
When most people think about becoming a crypto millionaire, they usually think about buying a single crypto like Bitcoin (CRYPTO: BTC) and then holding on to it as it delivers stratospheric returns. Over a long enough period of time, even a relatively small upfront investment could turn into $1 million or more. And, indeed, according to Henley & Partners' Crypto Wealth Report, there are more than 40,000 Bitcoin millionaires in the world right now.
But here's another strategy that you might not have considered: buying crypto stocks that have the potential to outperform Bitcoin. This year, for example, Bitcoin is up more than 160%, but a number of crypto stocks are up 300% or more for the year. Here's a closer look at two crypto stocks that could help put you on the path to millionaire status.
Coinbase Global
Cryptocurrency exchange Coinbase Global (NASDAQ: COIN), up a sizzling 330% in 2023, could be one of the biggest beneficiaries of any extended Bitcoin rally in 2024. When Bitcoin is down, investor interest wanes. But when Bitcoin is up, investors suddenly decide to dip their toes into the crypto waters. So Bitcoin could be the key to bringing in new users and increasing overall trading volume.
Bitcoin now accounts for about a third of all trading volume on the Coinbase platform. Thus, while Coinbase offers 240 possible cryptos to trade, the real focus is on Bitcoin. And right now, Coinbase appears to be looking for ways to tap into the growing investor excitement around Bitcoin. In one recent marketing promotion, all you had to do was make a single crypto trade on the platform, and you'd be entered into a drawing for two Bitcoins (worth more than $86,000 at today's prices).
Image source: Getty Images.
In addition to courting the individual retail investor, Coinbase has been looking for ways to become more attractive to large institutional investors. In August 2022, for example, it partnered with BlackRock, the largest asset manager in the world, to provide crypto trading services to institutional investors. Then, last June, BlackRock tapped Coinbase to be the custodian for its highly anticipated spot Bitcoin exchange-traded fund (ETF) offering.
And there are other long-term initiatives on tap at Coinbase, including one that involves the tokenization of real-world assets. The big idea here is to enable Wall Street firms to trade traditional financial assets on the blockchain. In August, Coinbase launched Base, its own proprietary blockchain, to help make that a reality.
The big caveat, of course, is that Coinbase has delivered such outsize returns this year that some institutional investors are starting to take profits on their positions. Ark Invest, for example, recently sold $100 million in Coinbase shares in a single week. This is most likely just routine portfolio rebalancing at the end of the year, but what if Cathie Wood of Ark Invest thinks the rally was overdone?
MicroStrategy
Another crypto stock that is highly leveraged to the price of Bitcoin is MicroStrategy (NASDAQ: MSTR). On the surface, MicroStrategy might look a lot like an enterprise software stock. But MicroStrategy is really just a giant Bitcoin treasury. Some have even compared the company to a Bitcoin ETF.
Currently, MicroStrategy holds 174,530 Bitcoins on its balance sheet, making the company the largest public holder of Bitcoin in the world. To put that number into context, the current circulating supply of Bitcoin is about 20 million coins. Thus, MicroStrategy controls just under 1% of the total available Bitcoin supply in the world.
As might be imagined, this means that the price of MicroStrategy is highly leveraged to the price of Bitcoin. If Bitcoin goes up, then the price of MicroStrategy goes up. Year to date, Bitcoin is up more than 160% this year, and MicroStrategy is up 310%. As long as the price of Bitcoin continues to go up, the value of MicroStrategy should continue to go up too.
Just keep in mind, though, that most of MicroStrategy's market value is tied up in Bitcoin. The total market cap of MicroStrategy right now is $9.1 billion, while the total value of the Bitcoins on its balance sheet is $7.5 billion. Thus, the market is giving only a small valuation to the underlying software business of MicroStrategy. While the company is now getting into AI-powered software solutions, the core enterprise software business of MicroStrategy is only growing at a 1% clip.
How much Bitcoin is too much Bitcoin?
In 2024, investors will have several ways to buy Bitcoin. They can buy Bitcoin directly in the crypto market. They will be able to buy Bitcoin via new spot Bitcoin ETFs that are expected to arrive in the first quarter of the year. And, finally, they can buy Bitcoin via "Bitcoin proxy stocks" like Coinbase and MicroStrategy.
So, as an investor, the question becomes: How much Bitcoin is too much Bitcoin? If you already have a sizable position in Bitcoin, you might want to diversify elsewhere beyond just companies that are tied to the price of Bitcoin. But if you are looking to amplify your Bitcoin returns and accelerate your path to millionaire status, it might be worth considering these stocks as a way to turbocharge your portfolio returns.
Should you invest $1,000 in Coinbase Global right now?
Before you buy stock in Coinbase Global, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coinbase Global wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Dominic Basulto has positions in Bitcoin. The Motley Fool has positions in and recommends Bitcoin and Coinbase Global. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In one recent marketing promotion, all you had to do was make a single crypto trade on the platform, and you'd be entered into a drawing for two Bitcoins (worth more than $86,000 at today's prices). In August 2022, for example, it partnered with BlackRock, the largest asset manager in the world, to provide crypto trading services to institutional investors. Then, last June, BlackRock tapped Coinbase to be the custodian for its highly anticipated spot Bitcoin exchange-traded fund (ETF) offering.
|
In August 2022, for example, it partnered with BlackRock, the largest asset manager in the world, to provide crypto trading services to institutional investors. Currently, MicroStrategy holds 174,530 Bitcoins on its balance sheet, making the company the largest public holder of Bitcoin in the world. Before you buy stock in Coinbase Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coinbase Global wasn't one of them.
|
How much Bitcoin is too much Bitcoin? And, finally, they can buy Bitcoin via "Bitcoin proxy stocks" like Coinbase and MicroStrategy. Before you buy stock in Coinbase Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coinbase Global wasn't one of them.
|
In August 2022, for example, it partnered with BlackRock, the largest asset manager in the world, to provide crypto trading services to institutional investors. If Bitcoin goes up, then the price of MicroStrategy goes up. Before you buy stock in Coinbase Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Coinbase Global wasn't one of them.
|
8813c5c9-3ef0-43ba-8442-c8c1eb7fa88c
|
712445.0
|
2023-12-12 00:00:00 UTC
|
Want to Invest in Flying Cars? Check Out EHang Stock (Plus 2 Other Picks).
|
DCOMP
|
https://www.nasdaq.com/articles/want-to-invest-in-flying-cars-check-out-ehang-stock-plus-2-other-picks.
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Could the market for aerial urban mobility soar to new heights in 2024? Anything’s possible, and if you’re ready to get on board and invest in flying cars, take a look at EHang (NASDAQ:EH). It’s risky to own EH stock by itself, though, so I’ll give you two other flying-car stock picks to add to the mix.
EHang is a China-based company that builds electric vertical takeoff and landing aircraft, also informally known as flying cars or flying taxis. Before you consider buying EHang stock, consider your risk tolerance. As we’ll discuss in a moment, there’s a short report floating around that might cause investors to think twice about EHang.
EHang’s Improving Financials
The eVTOL is still in its early stages. Therefore, before jumping into a trade with an eVTOL business, it’s important to check the company’s financials. They don’t have to be perfect, but they should at least be moving in the right direction.
Fortunately, EHang passes that test. In 2023’s third quarter, EHang’s revenue increased 248% year over year and 186% quarter over quarter. That’s pretty impressive, wouldn’t you agree?
Furthermore, EHang’s gross margin remained high at 64.6%. On top of all that, the company’s non-GAAP adjusted net earnings loss improved (i.e., shrank) 43.1% YoY and 39.5% QoQ. So, if you can forgive EHang for not being profitable, you might actually conclude that the company’s financials look pretty decent.
EHang CEO Huazhi Hu reminded investors that the company has “forged strategic alliances with key entities such as the Bao’an District Government of Shenzhen and the Hefei Municipal Government.” Hopefully, these partnerships will provide significant, ongoing revenue sources for EHang.
Should a Short Report Dissuade You From Buying EH Stock?
So far, I’ve provided a bullish argument in favor of EHang stock. At the same time, there’s a report from short seller Hindenburg Research which you might choose to read before making an investment.
I can’t confirm or deny any of the claims made in the Hindenburg report. It’s quite lengthy, so I recommend using InvestorPlace contributor Thomas Yeung’s handy guide to help you summarize its contents.
This is the snippet from the Hindenburg report that you’ll definitely want to take note of.
“After examining every preorder and partnership, itemized below, our research indicates that over 92% of EHang’s preorder book is based on deals that were later ‘abandoned’ or came from customers in no financial position to purchase EHang’s aircraft in volume, or at all,” they wrote.
Again, I can’t confirm or deny the accuracy of Hindenburg’s claims. Frankly, I don’t know if EHang’s 1,300-plus-unit order book is real or exaggerated.
EHang strenuously rejected Hindenburg’s fraud allegations. Here’s EHang official statement on the matter: “The Company firmly denies the allegations in the short seller report that the Company misled investors about its order pipeline and sales, and will take appropriate actions to protect its and its shareholders’ interests.”
EHang Stock: Two Alternatives for Portfolio Diversification
As you can see, there’s a lot to consider with EHang. I encourage you to consider all sides of the debate surrounding EHang. Be sure to weigh the risks and potential rewards, and don’t over-leverage yourself on EHang stock.
Finally, investors should think about diversifying their portfolios by adding two similar stocks to EH stock. For broader exposure to the eVTOL market’s growth, check out Joby Aviation (NYSE:JOBY) stock and Archer Aviation (NYSE:ACHR) stock.
I consider both of those stocks, JOBY and ACHR, to be must-own assets. So, feel free to look at those two flying-car stocks along with EHang stock for better diversification and less risk.
On the date of publication, David Moadel did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com. He also serves as the chief analyst and market researcher for Portfolio Wealth Global and hosts the popular financial YouTube channel Looking at the Markets.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Want to Invest in Flying Cars? Check Out EHang Stock (Plus 2 Other Picks). appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
On top of all that, the company’s non-GAAP adjusted net earnings loss improved (i.e., shrank) 43.1% YoY and 39.5% QoQ. David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires.
|
At the same time, there’s a report from short seller Hindenburg Research which you might choose to read before making an investment. Here’s EHang official statement on the matter: “The Company firmly denies the allegations in the short seller report that the Company misled investors about its order pipeline and sales, and will take appropriate actions to protect its and its shareholders’ interests.” EHang Stock: Two Alternatives for Portfolio Diversification As you can see, there’s a lot to consider with EHang. For broader exposure to the eVTOL market’s growth, check out Joby Aviation (NYSE:JOBY) stock and Archer Aviation (NYSE:ACHR) stock.
|
EHang CEO Huazhi Hu reminded investors that the company has “forged strategic alliances with key entities such as the Bao’an District Government of Shenzhen and the Hefei Municipal Government.” Hopefully, these partnerships will provide significant, ongoing revenue sources for EHang. Here’s EHang official statement on the matter: “The Company firmly denies the allegations in the short seller report that the Company misled investors about its order pipeline and sales, and will take appropriate actions to protect its and its shareholders’ interests.” EHang Stock: Two Alternatives for Portfolio Diversification As you can see, there’s a lot to consider with EHang. So, feel free to look at those two flying-car stocks along with EHang stock for better diversification and less risk.
|
They don’t have to be perfect, but they should at least be moving in the right direction. Should a Short Report Dissuade You From Buying EH Stock? appeared first on InvestorPlace.
|
d536aa8a-dc60-4ed3-859c-254d43e28504
|
712446.0
|
2023-12-12 00:00:00 UTC
|
Here's What Verizon's CEO Has to Say About the Stock's Incredibly High 7% Yield
|
DCOMP
|
https://www.nasdaq.com/articles/heres-what-verizons-ceo-has-to-say-about-the-stocks-incredibly-high-7-yield
|
nan
|
nan
|
When dividend stocks offer high yields, investors primarily take notice for a couple of reasons. One, they could find the yield enticing. A generous dividend, with respect to the share price paid, can become a significant source of income for their portfolios. The other reason, antithetically, could be a general concern why the stock price is lagging, thus pushing up its yield -- in other words, is the dividend safe?
Verizon Communications (NYSE: VZ) is one high-yielding stock that investors are certainly asking questions about. While there's no doubt that locking in a high yield for one of the nation's top telecom providers could be a great move, there's also the nagging feeling that perhaps there's some risk here that investors are overlooking, and that maybe the yield is too good to be true.
The company's CEO recently weighed in on the unusually high yield.
Why Verizon's yield is so high
Verizon's dividend yield isn't usually 7%. This isn't normal territory for the stock. Historically, Verizon has been paying around the 4% mark.
In a recent interview with Yahoo! Finance, CEO Hans Vestberg talked about the company's yield and his thoughts as to why it was as high as it is today. He highlighted three reasons for the stock's poor performance and why the payout is so high:
The company didn't perform well in 2022, and there have been many changes in the management team this year.
Investors are valuing the industry at lower multiples.
He believes investors see the stock as comparable to bonds given its continued dividend growth. And with interest rates rising, investors have shifted to bonds.
Vestberg did say, however, that he believes the company is on the right track in light of its recent results.
Will Verizon stock to better next year?
Verizon's stock has been struggling this year, but there are reasons it could do better in 2024. One is that its share price trades at just 8 times its trailing earnings; that's well below the earnings multiple it has averaged in recent years. And with the Fed suggesting that there may be three rate cuts next year, lower interest rates (which could sway investors away from bonds and back into the equity markets) combined with a low valuation for Verizon's stock should make it an attractive option for both value and dividend investors.
VZ PE Ratio data by YCharts.
Sooner or later, investors won't be able to ignore the value the stock possesses, especially as Verizon continues to post strong results and as interest rates come down. In October, the company announced it was increasing its forecast for free cash flow by $1 billion for the year, now projecting $18 billion in free cash.
The company also has a potential growth catalyst on the way because it is reportedly partnering with Netflix and Warner Bros. Discovery to offer bundled streaming options of their ad-based plans at a cheaper rate than what consumers could buy them for separately. And Verizon will share in the revenue from the deal.
Should you buy Verizon's stock?
Verizon is one of the best dividend stocks investors can buy right now. It's a leading company in the telecom space, and with a payout ratio of around 53%, its dividend isn't in any danger. With a low valuation and potentially lower interest rates next year, it may just be a matter of time before investors start buying up this incredibly cheap stock.
Should you invest $1,000 in Verizon Communications right now?
Before you buy stock in Verizon Communications, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Verizon Communications wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Netflix and Warner Bros. Discovery. The Motley Fool recommends Verizon Communications. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The other reason, antithetically, could be a general concern why the stock price is lagging, thus pushing up its yield -- in other words, is the dividend safe? Sooner or later, investors won't be able to ignore the value the stock possesses, especially as Verizon continues to post strong results and as interest rates come down. With a low valuation and potentially lower interest rates next year, it may just be a matter of time before investors start buying up this incredibly cheap stock.
|
When dividend stocks offer high yields, investors primarily take notice for a couple of reasons. With a low valuation and potentially lower interest rates next year, it may just be a matter of time before investors start buying up this incredibly cheap stock. Before you buy stock in Verizon Communications, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Verizon Communications wasn't one of them.
|
Why Verizon's yield is so high Verizon's dividend yield isn't usually 7%. And with the Fed suggesting that there may be three rate cuts next year, lower interest rates (which could sway investors away from bonds and back into the equity markets) combined with a low valuation for Verizon's stock should make it an attractive option for both value and dividend investors. Before you buy stock in Verizon Communications, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Verizon Communications wasn't one of them.
|
Why Verizon's yield is so high Verizon's dividend yield isn't usually 7%. Will Verizon stock to better next year? Before you buy stock in Verizon Communications, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Verizon Communications wasn't one of them.
|
0c22c06f-6828-4803-aac5-6236b4b816ce
|
712447.0
|
2023-12-12 00:00:00 UTC
|
Investors Heavily Search Verizon Communications Inc. (VZ): Here is What You Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/investors-heavily-search-verizon-communications-inc.-vz%3A-here-is-what-you-need-to-know-8
|
nan
|
nan
|
Verizon Communications (VZ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this largest U.S. cellphone carrier have returned +4.7%, compared to the Zacks S&P 500 composite's +5.2% change. During this period, the Zacks Wireless National industry, which Verizon falls in, has gained 6.3%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings Estimates
Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Verizon is expected to post earnings of $1.08 per share, indicating a change of -9.2% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.1% over the last 30 days.
The consensus earnings estimate of $4.70 for the current fiscal year indicates a year-over-year change of -9.3%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $4.63 indicates a change of -1.6% from what Verizon is expected to report a year ago. Over the past month, the estimate has changed -0.1%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Verizon is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth Forecast
Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Verizon, the consensus sales estimate for the current quarter of $34.75 billion indicates a year-over-year change of -1.4%. For the current and next fiscal years, $133.59 billion and $135.92 billion estimates indicate -2.4% and +1.8% changes, respectively.
Last Reported Results and Surprise History
Verizon reported revenues of $33.34 billion in the last reported quarter, representing a year-over-year change of -2.6%. EPS of $1.22 for the same period compares with $1.32 a year ago.
Compared to the Zacks Consensus Estimate of $33.39 billion, the reported revenues represent a surprise of -0.16%. The EPS surprise was +4.27%.
Over the last four quarters, Verizon surpassed consensus EPS estimates three times. The company topped consensus revenue estimates just once over this period.
Valuation
No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Verizon is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Conclusion
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Verizon. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Verizon Communications Inc. (VZ) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Conclusion The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Verizon.
|
Last Reported Results and Surprise History Verizon reported revenues of $33.34 billion in the last reported quarter, representing a year-over-year change of -2.6%. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. Click to get this free report Verizon Communications Inc. (VZ) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Verizon is rated Zacks Rank #3 (Hold). While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
For the next fiscal year, the consensus earnings estimate of $4.63 indicates a change of -1.6% from what Verizon is expected to report a year ago. EPS of $1.22 for the same period compares with $1.32 a year ago. The company topped consensus revenue estimates just once over this period.
|
a69982b7-17af-4272-89b2-4a0f2d558a3a
|
712448.0
|
2023-12-12 00:00:00 UTC
|
Paycom Software, Inc. (PAYC) Is a Trending Stock: Facts to Know Before Betting on It
|
DCOMP
|
https://www.nasdaq.com/articles/paycom-software-inc.-payc-is-a-trending-stock%3A-facts-to-know-before-betting-on-it-2
|
nan
|
nan
|
Paycom Software (PAYC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this maker of human-resources and payroll software have returned +17.3% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Internet - Software industry, to which Paycom belongs, has gained 7.1% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate Revisions
Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Paycom is expected to post earnings of $1.78 per share for the current quarter, representing a year-over-year change of +2.9%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.1%.
The consensus earnings estimate of $7.64 for the current fiscal year indicates a year-over-year change of +24.4%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $8.12 indicates a change of +6.2% from what Paycom is expected to report a year ago. Over the past month, the estimate has changed -0.4%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Paycom.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue Growth
While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Paycom, the consensus sales estimate for the current quarter of $422.54 million indicates a year-over-year change of +14%. For the current and next fiscal years, $1.68 billion and $1.87 billion estimates indicate +22.3% and +11.2% changes, respectively.
Last Reported Results and Surprise History
Paycom reported revenues of $406.3 million in the last reported quarter, representing a year-over-year change of +21.6%. EPS of $1.77 for the same period compares with $1.27 a year ago.
Compared to the Zacks Consensus Estimate of $411.04 million, the reported revenues represent a surprise of -1.15%. The EPS surprise was +9.26%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
Valuation
Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Paycom is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom Line
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Paycom. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Paycom Software, Inc. (PAYC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Bottom Line The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Paycom.
|
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. Last Reported Results and Surprise History Paycom reported revenues of $406.3 million in the last reported quarter, representing a year-over-year change of +21.6%. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
And if earnings estimates go up for a company, the fair value for its stock goes up. Over the last 30 days, the Zacks Consensus Estimate has changed +0.1%. The company topped consensus revenue estimates three times over this period.
|
876d48ac-29d0-4c89-a3eb-6e74688f1cd2
|
712449.0
|
2023-12-12 00:00:00 UTC
|
Citizens Financial Group (CFG) Soars 6.6%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/citizens-financial-group-cfg-soars-6.6%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Citizens Financial Group (CFG) shares ended the last trading session 6.6% higher at $33.63. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 15.5% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the Citizens Financial Group stock moved higher.
This bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -57.6%. Revenues are expected to be $2 billion, down 9.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Citizens Financial Group, the consensus EPS estimate for the quarter has been revised 17.6% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on CFG going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Citizens Financial Group is a member of the Zacks Financial - Savings and Loan industry. One other stock in the same industry, Essa Bancorp (ESSA), finished the last trading session 2.5% higher at $19.10. ESSA has returned 13.5% over the past month.
For Essa Bancorp, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.46. This represents a change of -8% from what the company reported a year ago. Essa Bancorp currently has a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Citizens Financial Group, Inc. (CFG) : Free Stock Analysis Report
ESSA Bancorp, Inc. (ESSA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. For Citizens Financial Group, the consensus EPS estimate for the quarter has been revised 17.6% lower over the last 30 days to the current level. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Citizens Financial Group (CFG) shares ended the last trading session 6.6% higher at $33.63. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Citizens Financial Group is a member of the Zacks Financial - Savings and Loan industry. Click to get this free report Citizens Financial Group, Inc. (CFG) : Free Stock Analysis Report ESSA Bancorp, Inc. (ESSA) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Citizens Financial Group is a member of the Zacks Financial - Savings and Loan industry. Click to get this free report Citizens Financial Group, Inc. (CFG) : Free Stock Analysis Report ESSA Bancorp, Inc. (ESSA) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Citizens Financial Group (CFG) shares ended the last trading session 6.6% higher at $33.63. For Citizens Financial Group, the consensus EPS estimate for the quarter has been revised 17.6% lower over the last 30 days to the current level. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Citizens Financial Group is a member of the Zacks Financial - Savings and Loan industry.
|
78643e24-37e0-4453-8877-fe098d9bc791
|
712450.0
|
2023-12-12 00:00:00 UTC
|
Western Alliance (WAL) Soars 9.4%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/western-alliance-wal-soars-9.4%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Western Alliance (WAL) shares ended the last trading session 9.4% higher at $66.30. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 23.4% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the Western Alliance stock moved higher.
This bank holding company is expected to post quarterly earnings of $1.94 per share in its upcoming report, which represents a year-over-year change of -27.3%. Revenues are expected to be $690.94 million, down 2.7% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Western Alliance, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on WAL going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Western Alliance is a member of the Zacks Banks - West industry. One other stock in the same industry, RBB (RBB), finished the last trading session 4.2% higher at $18.73. RBB has returned 15.2% over the past month.
For RBB, the consensus EPS estimate for the upcoming report has changed +26.1% over the past month to $0.44. This represents a change of -52.2% from what the company reported a year ago. RBB currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Western Alliance Bancorporation (WAL) : Free Stock Analysis Report
RBB Bancorp (RBB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. This bank holding company is expected to post quarterly earnings of $1.94 per share in its upcoming report, which represents a year-over-year change of -27.3%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Western Alliance (WAL) shares ended the last trading session 9.4% higher at $66.30. This bank holding company is expected to post quarterly earnings of $1.94 per share in its upcoming report, which represents a year-over-year change of -27.3%. Click to get this free report Western Alliance Bancorporation (WAL) : Free Stock Analysis Report RBB Bancorp (RBB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Western Alliance is a member of the Zacks Banks - West industry. Click to get this free report Western Alliance Bancorporation (WAL) : Free Stock Analysis Report RBB Bancorp (RBB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Western Alliance (WAL) shares ended the last trading session 9.4% higher at $66.30. This bank holding company is expected to post quarterly earnings of $1.94 per share in its upcoming report, which represents a year-over-year change of -27.3%. For RBB, the consensus EPS estimate for the upcoming report has changed +26.1% over the past month to $0.44.
|
870cf2a5-444d-4c94-973c-d7b141638e30
|
712451.0
|
2023-12-12 00:00:00 UTC
|
Sirius XM Holdings Inc Shares Close the Week 20.8% Higher - Weekly Wrap
|
DCOMP
|
https://www.nasdaq.com/articles/sirius-xm-holdings-inc-shares-close-the-week-20.8-higher-weekly-wrap
|
nan
|
nan
|
Sirius XM Holdings Inc (SIRI) shares closed this week 20.8% higher than it did at the end of last week. The stock is currently up 1.3% year-to-date, down 3.3% over the past 12 months, and up 3.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Shares traded as high as $5.75 and as low as $4.57 this week.
Trading volume this week was 18.7% higher than the 10-day average and 62.1% higher than the 30-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
The company share price beats the performance of its peers in the Communication Services industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by -205.4%
The company's stock price performance over the past 12 months beats the peer average by -49.7%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 399.7% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Communication Services industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -205.4% The company's stock price performance over the past 12 months beats the peer average by -49.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 399.7% higher than the average peer. This story was produced by the Kwhen Automated News Generator.
|
Sirius XM Holdings Inc (SIRI) shares closed this week 20.8% higher than it did at the end of last week. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Communication Services industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -205.4% The company's stock price performance over the past 12 months beats the peer average by -49.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 399.7% higher than the average peer.
|
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Communication Services industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -205.4% The company's stock price performance over the past 12 months beats the peer average by -49.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 399.7% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Trading volume this week was 18.7% higher than the 10-day average and 62.1% higher than the 30-day average. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Communication Services industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -205.4% The company's stock price performance over the past 12 months beats the peer average by -49.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 399.7% higher than the average peer.
|
a9f8cc60-37d2-4dc8-9243-f7b0566936f6
|
712452.0
|
2023-12-12 00:00:00 UTC
|
Why Fisker Stock Zoomed Almost 5% Higher on Thursday
|
DCOMP
|
https://www.nasdaq.com/articles/why-fisker-stock-zoomed-almost-5-higher-on-thursday
|
nan
|
nan
|
Upstart electric vehicle (EV) manufacturer Fisker (NYSE: FSR) was electric on the stock exchange Thursday. Thanks to a partnership with one of this country's top banks, the company is able to provide an inexpensive financing option for customers. The potential popularity of this initiative excited investors, and they traded Fisker stock up by nearly 5% on the day in response.
1.99% financing promised -- but for a limited time
Through its Fisker Finance unit, the company is rolling out a low-cost auto loan program for qualified customers. This would allow such folks to own one of the company's high-end Ocean SUVs for an annual percentage rate (APR) as low as 1.99% for a 60-month loan.
The program is being offered through a partnership with banking giant JPMorgan Chase.
The rates are basically a teaser to get sales juiced quickly and to drum up interest and publicity. Fisker is describing them as "special rates," adding that they will be available until Jan. 10, 2024.
As is common in the auto industry these days, potential Ocean owners can apply for such financing through the Fisker Finance portal. According to the EV specialist, the system can render a financing decision within minutes. There is, of course, no guarantee an applicant will receive the favorable rates or be offered a loan at all.
Fisker says its finance unit offers loans of up to 24.99% APR.
It might be the deciding factor for fence-sitters
In these days of (relatively) elevated interest rates throughout our economy, a figure like 1.99% is certainly tempting. It may well move the needle for people who are on the fence about ponying up for a pricey Ocean; at the very least, it will produce favorable publicity for Fisker. Investors were right to cheer the scrappy company's latest move.
Should you invest $1,000 in Fisker right now?
Before you buy stock in Fisker, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Fisker wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The potential popularity of this initiative excited investors, and they traded Fisker stock up by nearly 5% on the day in response. This would allow such folks to own one of the company's high-end Ocean SUVs for an annual percentage rate (APR) as low as 1.99% for a 60-month loan. It may well move the needle for people who are on the fence about ponying up for a pricey Ocean; at the very least, it will produce favorable publicity for Fisker.
|
Fisker says its finance unit offers loans of up to 24.99% APR. Before you buy stock in Fisker, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Fisker wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company.
|
1.99% financing promised -- but for a limited time Through its Fisker Finance unit, the company is rolling out a low-cost auto loan program for qualified customers. Before you buy stock in Fisker, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Fisker wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company.
|
Fisker says its finance unit offers loans of up to 24.99% APR. Before you buy stock in Fisker, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Fisker wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company.
|
32310116-119b-4c41-8700-a791467048ea
|
712453.0
|
2023-12-12 00:00:00 UTC
|
Despite Fast-paced Momentum, Gates Industrial (GTES) Is Still a Bargain Stock
|
DCOMP
|
https://www.nasdaq.com/articles/despite-fast-paced-momentum-gates-industrial-gtes-is-still-a-bargain-stock
|
nan
|
nan
|
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.
Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potential fails to justify their swelled-up valuation. In that phase, investors find themselves invested in shares that have limited to no upside or even a downside. So, betting on a stock just by looking at the traditional momentum parameters could be risky at times.
A safer approach could be investing in bargain stocks with recent price momentum. While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock's price or earnings, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced.
Gates Industrial (GTES) is one of the several great candidates that made it through the screen. While there are numerous reasons why this stock is a great choice, here are the most vital ones:
A dash of recent price momentum reflects growing interest of investors in a stock. With a four-week price change of 4.3%, the stock of this manufacturer of power transmission and fluid power systems is certainly well-positioned in this regard.
While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. GTES meets this criterion too, as the stock gained 0.9% over the past 12 weeks.
Moreover, the momentum for GTES is fast paced, as the stock currently has a beta of 1.51. This indicates that the stock moves 51% higher than the market in either direction.
Given this price performance, it is no surprise that GTES has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped GTES earn a Zacks Rank #1 (Strong Buy). Our research shows that the momentum-effect is quite strong among Zacks Rank #1 and #2 stocks. That's because as covering analysts raise their earnings estimates for a stock, more and more investors take an interest in it, helping its price race to keep up. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Most importantly, despite possessing fast-paced momentum features, GTES is trading at a reasonable valuation. In terms of Price-to-Sales ratio, which is considered as one of the best valuation metrics, the stock looks quite cheap now. GTES is currently trading at 0.86 times its sales. In other words, investors need to pay only 86 cents for each dollar of sales.
So, GTES appears to have plenty of room to run, and that too at a fast pace.
In addition to GTES, there are several other stocks that currently pass through our 'Fast-Paced Momentum at a Bargain' screen. You may consider investing in them and start looking for the newest stocks that fit these criteria.
This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.
However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies.
Click here to sign up for a free trial to the Research Wizard today.
4 Oil Stocks with Massive Upsides
Global demand for oil is through the roof... and oil producers are struggling to keep up. So even though oil prices are well off their recent highs, you can expect big profits from the companies that supply the world with "black gold."
Zacks Investment Research has just released an urgent special report to help you bank on this trend.
In Oil Market on Fire, you'll discover 4 unexpected oil and gas stocks positioned for big gains in the coming weeks and months. You don't want to miss these recommendations.
Download your free report now to see them.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Gates Industrial Corporation PLC (GTES) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Most importantly, despite possessing fast-paced momentum features, GTES is trading at a reasonable valuation. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.
|
While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock's price or earnings, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced. In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped GTES earn a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Most importantly, despite possessing fast-paced momentum features, GTES is trading at a reasonable valuation.
|
While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock's price or earnings, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced. While there are numerous reasons why this stock is a great choice, here are the most vital ones: A dash of recent price momentum reflects growing interest of investors in a stock. Given this price performance, it is no surprise that GTES has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
|
Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock's price or earnings, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced. Given this price performance, it is no surprise that GTES has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
|
78a11104-e2db-4400-acb6-db3deb60e09d
|
712454.0
|
2023-12-12 00:00:00 UTC
|
US Chamber, Comcast, tech group split over net neutrality
|
DCOMP
|
https://www.nasdaq.com/articles/us-chamber-comcast-tech-group-split-over-net-neutrality
|
nan
|
nan
|
By David Shepardson
WASHINGTON, Dec 14 (Reuters) - The U.S. Chamber of Commerce and Comcast Corp CMCSA.O said on Thursday they oppose the Federal Communications Commission's proposal to reinstate landmark net neutrality rules, while major tech firms backed the plan.
The FCC in November voted to advance a proposal to assume new regulatory oversight over broadband internet rescinded under former President Donald Trump.
The Chamber called the plan "unlawful and unwise," and argued it "will have significant negative impacts on investment, innovation, and unserved and underserved consumers." Comcast said in a filing with the commission "there is no broadband market failure to justify the sweeping government takeover proposed here."
The Computer & Communications Industry Association, whose members include Amazon.com AMZN.O , Apple AAPL.O, Alphabet GOOGL.O and Meta Platforms META.O, backed reinstatement saying "rules prohibiting blocking, throttling, paid prioritization, and unreasonable conduct must be reinstated to preserve open access to the internet."
The vote to give the FCC wide authority over the internet comes after Democrats took majority control of the five-member FCC in October for the first time since President Joe Biden took office. Biden signed a July 2021 executive order encouraging the FCC to reinstate net neutrality rules.
FCC Chair Jessica Rosenworcel said "there is no expert agency ensuring that the internet is fast, open, and fair."
Despite the 2017 repeal, a dozen states now have net neutrality laws or regulations in place. Industry groups abandoned legal challenges in 2022.
The New York Public Service Commission said it supported FCC plan to reinstate net neutrality but said New York and other states "should be recognized for their the ability to regulate issues of state or local concern" and opposed the FCC proposal to preeempt some state authority.
(Reporting by David Shepardson; editing by Jonathan Oatis and David Gregorio)
((David.Shepardson@thomsonreuters.com; 2028988324;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By David Shepardson WASHINGTON, Dec 14 (Reuters) - The U.S. Chamber of Commerce and Comcast Corp CMCSA.O said on Thursday they oppose the Federal Communications Commission's proposal to reinstate landmark net neutrality rules, while major tech firms backed the plan. The FCC in November voted to advance a proposal to assume new regulatory oversight over broadband internet rescinded under former President Donald Trump. The Chamber called the plan "unlawful and unwise," and argued it "will have significant negative impacts on investment, innovation, and unserved and underserved consumers."
|
By David Shepardson WASHINGTON, Dec 14 (Reuters) - The U.S. Chamber of Commerce and Comcast Corp CMCSA.O said on Thursday they oppose the Federal Communications Commission's proposal to reinstate landmark net neutrality rules, while major tech firms backed the plan. Biden signed a July 2021 executive order encouraging the FCC to reinstate net neutrality rules. The New York Public Service Commission said it supported FCC plan to reinstate net neutrality but said New York and other states "should be recognized for their the ability to regulate issues of state or local concern" and opposed the FCC proposal to preeempt some state authority.
|
By David Shepardson WASHINGTON, Dec 14 (Reuters) - The U.S. Chamber of Commerce and Comcast Corp CMCSA.O said on Thursday they oppose the Federal Communications Commission's proposal to reinstate landmark net neutrality rules, while major tech firms backed the plan. The Computer & Communications Industry Association, whose members include Amazon.com AMZN.O , Apple AAPL.O, Alphabet GOOGL.O and Meta Platforms META.O, backed reinstatement saying "rules prohibiting blocking, throttling, paid prioritization, and unreasonable conduct must be reinstated to preserve open access to the internet." The New York Public Service Commission said it supported FCC plan to reinstate net neutrality but said New York and other states "should be recognized for their the ability to regulate issues of state or local concern" and opposed the FCC proposal to preeempt some state authority.
|
By David Shepardson WASHINGTON, Dec 14 (Reuters) - The U.S. Chamber of Commerce and Comcast Corp CMCSA.O said on Thursday they oppose the Federal Communications Commission's proposal to reinstate landmark net neutrality rules, while major tech firms backed the plan. The FCC in November voted to advance a proposal to assume new regulatory oversight over broadband internet rescinded under former President Donald Trump. The New York Public Service Commission said it supported FCC plan to reinstate net neutrality but said New York and other states "should be recognized for their the ability to regulate issues of state or local concern" and opposed the FCC proposal to preeempt some state authority.
|
b5fcafd4-a565-426c-844e-ccbb6141bfb1
|
712455.0
|
2023-12-12 00:00:00 UTC
|
Qualcomm (QCOM) Exceeds Market Returns: Some Facts to Consider
|
DCOMP
|
https://www.nasdaq.com/articles/qualcomm-qcom-exceeds-market-returns%3A-some-facts-to-consider
|
nan
|
nan
|
In the latest market close, Qualcomm (QCOM) reached $141.54, with a +1.97% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.27%. Meanwhile, the Dow experienced a rise of 0.43%, and the technology-dominated Nasdaq saw an increase of 0.19%.
Shares of the chipmaker witnessed a gain of 7.66% over the previous month, beating the performance of the Computer and Technology sector with its gain of 5.93% and the S&P 500's gain of 6.94%.
The investment community will be paying close attention to the earnings performance of Qualcomm in its upcoming release. The company's upcoming EPS is projected at $2.34, signifying a 1.27% drop compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $9.49 billion, up 0.37% from the year-ago period.
QCOM's full-year Zacks Consensus Estimates are calling for earnings of $9.10 per share and revenue of $37.38 billion. These results would represent year-over-year changes of +7.95% and +4.38%, respectively.
Any recent changes to analyst estimates for Qualcomm should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.36% higher. Qualcomm is currently sporting a Zacks Rank of #3 (Hold).
In the context of valuation, Qualcomm is at present trading with a Forward P/E ratio of 15.26. This represents a premium compared to its industry's average Forward P/E of 14.02.
It's also important to note that QCOM currently trades at a PEG ratio of 1.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Wireless Equipment stocks are, on average, holding a PEG ratio of 1.26 based on yesterday's closing prices.
The Wireless Equipment industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 83, finds itself in the top 33% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Wireless Equipment stocks are, on average, holding a PEG ratio of 1.26 based on yesterday's closing prices. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Wireless Equipment stocks are, on average, holding a PEG ratio of 1.26 based on yesterday's closing prices. Click to get this free report QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. This industry, currently bearing a Zacks Industry Rank of 83, finds itself in the top 33% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups.
|
This represents a premium compared to its industry's average Forward P/E of 14.02. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Want the latest recommendations from Zacks Investment Research?
|
40d62414-4fc5-41a7-ba71-f65c95667dfb
|
712456.0
|
2023-12-12 00:00:00 UTC
|
Apple (AAPL) Advances But Underperforms Market: Key Facts
|
DCOMP
|
https://www.nasdaq.com/articles/apple-aapl-advances-but-underperforms-market%3A-key-facts
|
nan
|
nan
|
Apple (AAPL) closed the most recent trading day at $198.11, moving +0.08% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.27% for the day. Meanwhile, the Dow gained 0.43%, and the Nasdaq, a tech-heavy index, added 0.19%.
Heading into today, shares of the maker of iPhones, iPads and other products had gained 5.29% over the past month, lagging the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time.
The upcoming earnings release of Apple will be of great interest to investors. The company is forecasted to report an EPS of $2.08, showcasing a 10.64% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $117.31 billion, up 0.13% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.56 per share and a revenue of $393.42 billion, signifying shifts of +7.01% and +2.65%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Apple. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.12% higher. Apple presently features a Zacks Rank of #3 (Hold).
In terms of valuation, Apple is currently trading at a Forward P/E ratio of 30.16. This denotes a premium relative to the industry's average Forward P/E of 12.24.
We can additionally observe that AAPL currently boasts a PEG ratio of 2.73. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Computer - Mini computers stocks are, on average, holding a PEG ratio of 2.73 based on yesterday's closing prices.
The Computer - Mini computers industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 92, putting it in the top 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow AAPL in the coming trading sessions, be sure to utilize Zacks.com.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Apple Inc. (AAPL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.56 per share and a revenue of $393.42 billion, signifying shifts of +7.01% and +2.65%, respectively, from the last year. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Apple (AAPL) closed the most recent trading day at $198.11, moving +0.08% from the previous trading session. Over the past month, the Zacks Consensus EPS estimate has moved 0.12% higher. Computer - Mini computers stocks are, on average, holding a PEG ratio of 2.73 based on yesterday's closing prices.
|
Computer - Mini computers stocks are, on average, holding a PEG ratio of 2.73 based on yesterday's closing prices. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Click to get this free report Apple Inc. (AAPL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Apple (AAPL) closed the most recent trading day at $198.11, moving +0.08% from the previous trading session. Heading into today, shares of the maker of iPhones, iPads and other products had gained 5.29% over the past month, lagging the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time. Computer - Mini computers stocks are, on average, holding a PEG ratio of 2.73 based on yesterday's closing prices.
|
078b7c09-a3f0-43cd-af09-18566a975086
|
712457.0
|
2023-12-12 00:00:00 UTC
|
Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade
|
DCOMP
|
https://www.nasdaq.com/articles/bristol-myers-squibb-bmy-stock-slides-as-market-rises%3A-facts-to-know-before-you-trade
|
nan
|
nan
|
In the latest market close, Bristol Myers Squibb (BMY) reached $51.47, with a -0.75% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.27%. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
The the stock of biopharmaceutical company has risen by 0.56% in the past month, lagging the Medical sector's gain of 7.01% and the S&P 500's gain of 6.94%.
Market participants will be closely following the financial results of Bristol Myers Squibb in its upcoming release. The company is forecasted to report an EPS of $1.76, showcasing a 3.3% downward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $11.15 billion, indicating a 2.24% decline compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $7.53 per share and a revenue of $44.68 billion, demonstrating changes of -2.21% and -3.21%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Bristol Myers Squibb. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 0.06% fall in the Zacks Consensus EPS estimate. Bristol Myers Squibb presently features a Zacks Rank of #3 (Hold).
From a valuation perspective, Bristol Myers Squibb is currently exchanging hands at a Forward P/E ratio of 6.89. Its industry sports an average Forward P/E of 17.45, so one might conclude that Bristol Myers Squibb is trading at a discount comparatively.
Also, we should mention that BMY has a PEG ratio of 2.2. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Medical - Biomedical and Genetics industry held an average PEG ratio of 1.89.
The Medical - Biomedical and Genetics industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 61, placing it within the top 25% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the meantime, our current consensus estimate forecasts the revenue to be $11.15 billion, indicating a 2.24% decline compared to the corresponding quarter of the prior year. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
In the latest market close, Bristol Myers Squibb (BMY) reached $51.47, with a -0.75% movement compared to the previous day. As of the close of trade yesterday, the Medical - Biomedical and Genetics industry held an average PEG ratio of 1.89. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In the latest market close, Bristol Myers Squibb (BMY) reached $51.47, with a -0.75% movement compared to the previous day. Investors should also take note of any recent adjustments to analyst estimates for Bristol Myers Squibb. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
|
a2719e3f-2d3d-40ca-867d-d174e66d785e
|
712458.0
|
2023-12-12 00:00:00 UTC
|
Amazon (AMZN) Stock Sinks As Market Gains: What You Should Know
|
DCOMP
|
https://www.nasdaq.com/articles/amazon-amzn-stock-sinks-as-market-gains%3A-what-you-should-know-9
|
nan
|
nan
|
In the latest market close, Amazon (AMZN) reached $147.42, with a -0.95% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.27%. Elsewhere, the Dow saw an upswing of 0.43%, while the tech-heavy Nasdaq appreciated by 0.19%.
Shares of the online retailer have appreciated by 3.94% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 6.95% and the S&P 500's gain of 6.94%.
Analysts and investors alike will be keeping a close eye on the performance of Amazon in its upcoming earnings disclosure. The company is predicted to post an EPS of $0.78, indicating a 271.43% growth compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $165.93 billion, up 11.21% from the prior-year quarter.
AMZN's full-year Zacks Consensus Estimates are calling for earnings of $2.67 per share and revenue of $570.75 billion. These results would represent year-over-year changes of +276.06% and +11.04%, respectively.
Investors should also pay attention to any latest changes in analyst estimates for Amazon. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 0.22% rise in the Zacks Consensus EPS estimate. At present, Amazon boasts a Zacks Rank of #2 (Buy).
In the context of valuation, Amazon is at present trading with a Forward P/E ratio of 55.71. This valuation marks a premium compared to its industry's average Forward P/E of 21.81.
It's also important to note that AMZN currently trades at a PEG ratio of 1.95. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. By the end of yesterday's trading, the Internet - Commerce industry had an average PEG ratio of 0.61.
The Internet - Commerce industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 33, finds itself in the top 14% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Analysts and investors alike will be keeping a close eye on the performance of Amazon in its upcoming earnings disclosure. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
AMZN's full-year Zacks Consensus Estimates are calling for earnings of $2.67 per share and revenue of $570.75 billion. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. By the end of yesterday's trading, the Internet - Commerce industry had an average PEG ratio of 0.61.
|
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. This industry, currently bearing a Zacks Industry Rank of 33, finds itself in the top 14% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups.
|
Shares of the online retailer have appreciated by 3.94% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 6.95% and the S&P 500's gain of 6.94%. By the end of yesterday's trading, the Internet - Commerce industry had an average PEG ratio of 0.61. Want the latest recommendations from Zacks Investment Research?
|
a7ec9bc4-a28a-40e0-b4c8-88bc3cc130e9
|
712459.0
|
2023-12-12 00:00:00 UTC
|
Honeywell International Inc. (HON) Rises But Trails Market: What Investors Should Know
|
DCOMP
|
https://www.nasdaq.com/articles/honeywell-international-inc.-hon-rises-but-trails-market%3A-what-investors-should-know
|
nan
|
nan
|
In the latest market close, Honeywell International Inc. (HON) reached $203.50, with a +0.21% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.27% for the day. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
Shares of the company have appreciated by 7.14% over the course of the past month, underperforming the Conglomerates sector's gain of 10.13% and outperforming the S&P 500's gain of 6.94%.
The investment community will be paying close attention to the earnings performance of Honeywell International Inc. in its upcoming release. On that day, Honeywell International Inc. is projected to report earnings of $2.59 per share, which would represent year-over-year growth of 2.78%. Our most recent consensus estimate is calling for quarterly revenue of $9.7 billion, up 5.63% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.16 per share and a revenue of $36.92 billion, indicating changes of +4.57% and +4.11%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Honeywell International Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Honeywell International Inc. is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Honeywell International Inc. is presently being traded at a Forward P/E ratio of 22.17. This valuation marks a premium compared to its industry's average Forward P/E of 17.47.
One should further note that HON currently holds a PEG ratio of 2.62. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HON's industry had an average PEG ratio of 2.33 as of yesterday's close.
The Diversified Operations industry is part of the Conglomerates sector. This industry, currently bearing a Zacks Industry Rank of 77, finds itself in the top 31% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Honeywell International Inc. (HON) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the latest market close, Honeywell International Inc. (HON) reached $203.50, with a +0.21% movement compared to the previous day. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Click to get this free report Honeywell International Inc. (HON) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. This industry, currently bearing a Zacks Industry Rank of 77, finds itself in the top 31% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups.
|
Investors might also notice recent changes to analyst estimates for Honeywell International Inc. Honeywell International Inc. is currently sporting a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research?
|
5caa9962-ce7f-45b7-b2b9-1ce162def959
|
712460.0
|
2023-12-12 00:00:00 UTC
|
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
|
DCOMP
|
https://www.nasdaq.com/articles/gilead-sciences-gild-stock-sinks-as-market-gains%3A-heres-why
|
nan
|
nan
|
Gilead Sciences (GILD) closed at $81.78 in the latest trading session, marking a -1.58% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.27% for the day. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
Coming into today, shares of the HIV and hepatitis C drugmaker had gained 10.73% in the past month. In that same time, the Medical sector gained 7.01%, while the S&P 500 gained 6.94%.
Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure. On that day, Gilead Sciences is projected to report earnings of $1.78 per share, which would represent year-over-year growth of 6.59%. In the meantime, our current consensus estimate forecasts the revenue to be $7.07 billion, indicating a 4.26% decline compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.74 per share and a revenue of $27.08 billion, signifying shifts of -7.16% and -0.75%, respectively, from the last year.
Any recent changes to analyst estimates for Gilead Sciences should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.35% lower within the past month. As of now, Gilead Sciences holds a Zacks Rank of #3 (Hold).
With respect to valuation, Gilead Sciences is currently being traded at a Forward P/E ratio of 12.33. For comparison, its industry has an average Forward P/E of 17.45, which means Gilead Sciences is trading at a discount to the group.
We can also see that GILD currently has a PEG ratio of 1.09. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Biomedical and Genetics was holding an average PEG ratio of 1.89 at yesterday's closing price.
The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 61, putting it in the top 25% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the meantime, our current consensus estimate forecasts the revenue to be $7.07 billion, indicating a 4.26% decline compared to the corresponding quarter of the prior year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.74 per share and a revenue of $27.08 billion, signifying shifts of -7.16% and -0.75%, respectively, from the last year. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The Medical - Biomedical and Genetics was holding an average PEG ratio of 1.89 at yesterday's closing price. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Click to get this free report Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
As of now, Gilead Sciences holds a Zacks Rank of #3 (Hold). The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Click to get this free report Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Gilead Sciences (GILD) closed at $81.78 in the latest trading session, marking a -1.58% move from the prior day. In that same time, the Medical sector gained 7.01%, while the S&P 500 gained 6.94%. As of now, Gilead Sciences holds a Zacks Rank of #3 (Hold).
|
3c113b05-008b-4d35-8801-7b349bf2562d
|
712461.0
|
2023-12-12 00:00:00 UTC
|
3 Penny Stocks With Strong Technical Charts
|
DCOMP
|
https://www.nasdaq.com/articles/3-penny-stocks-with-strong-technical-charts
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Some investors prefer to look only at fundamentals for making an investment decision. Yet, others solely rely on technicals for trading. A combination of technical and fundamental analysis can be deadly.
We are going to explore penny stocks with average fundamentals and a strong technical chart. In my view, these stocks are likely to skyrocket in the first half of 2024, with the rally anywhere between 30% to 50%.
Notably, even fundamentally strong stories go through a phase of price and time correction. It makes sense to exit these ideas and invest in stocks that look strong fundamentally and technically. Therefore, many use a combination for trading as well as investing.
Without further ado, let’s delve into three penny stocks with strong technical charts.
Iamgold Corporation (IAG)
Source: Misunseo / Shutterstock.com
Since August, Canadian-based Iamgold’s (NYSE:IAG) stock price has been largely in the range of $2 to $2.5. In the last trading day, IAG stock surged by 12% with good volumes. In fact, a breakout is impending, as supported by two fundamental factors.
First, the federal reserve kept interest rates unchanged. In fact, multiple rate cuts in 2024 make for a strong case. This is bullish for gold, and Iamgold is likely to benefit in the form of higher realized gold price.
Further, Iamgold is positioned for production upside next year as Cote asset is 90% completed. Therefore, production growth and higher realized gold price will characterize 2024. Likely, this will translate into cash flow bump-up.
Technically, for the year-to-date (YTD) chart, IAG stock has remained sideways amidst volatility. This further strengthens the case for a breakout or breakdown from current levels. Fundamental factors point to a big breakout rally.
Bitfarms (BITF)
Source: Useacoin / Shutterstock.com
Between mid-January and the last week of November, Bitfarms (NASDAQ:BITF) stock was trading sideways with a broad range of $1 to $1.2. In the last one month, BITF stock has skyrocketed by 157% on high volumes. Without doubt, this is a confirmation of a big breakout rally. However, the big question is whether the rally is likely to sustain.
BITF stock has more juice in the rally for the next two quarters. If we look at fundamentals, the upside comes from deeply oversold levels. Therefore, the stock remains inexpensive, and investors will buy into small corrections.
Going deeper into the fundamentals, two factors support the rally. First, Bitcoin (BTC-USD) is surging, and with halving due in 2024, I remain bullish on the cryptocurrency. Further, Bitfarms has announced plans to almost triple Bitcoin mining capacity by the second half of 2024. This will translate into robust revenue and cash flow upside. Another 50% rally from current levels of $2.95 does not look like a big hurdle.
Blink Charging (BLNK)
Source: David Tonelson/Shutterstock.com
Blink Charging (NASDAQ:BLNK) stock charts look scary.
A plunge of 76% in the last 12 months has destroyed investor wealth. However, trading volumes have changed since November 10, associated with the stock trending higher from that day. Indeed, the stock may be poised for a big reversal rally.
Notably, BLNK still has a short interest of 30%. It appears as a perfect short-squeeze rally candidate. Further, fundamental factors support the case for a strong rally.
The November 10th date above is significant because that is when Blink Charging reported Q3 earnings for 2023. It shows two big positive takeaways. First, Blink Charging continues to report stellar revenue growth. Further, the company has guided for positive adjusted EBITDA by the end of 2024. As cash burn declines, BLNK stock is poised for upside with industry tailwinds supporting long term growth.
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, Faisal Humayun did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Faisal Humayun is a senior research analyst with 12 years of industry experience in the field of credit research, equity research and financial modeling. Faisal has authored over 1,500 stock specific articles with focus on the technology, energy and commodities sector.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Penny Stocks With Strong Technical Charts appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
As cash burn declines, BLNK stock is poised for upside with industry tailwinds supporting long term growth. Read More: Penny Stocks — How to Profit Without Getting Scammed On the date of publication, Faisal Humayun did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Penny Stocks With Strong Technical Charts appeared first on InvestorPlace.
|
Therefore, production growth and higher realized gold price will characterize 2024. Bitfarms (BITF) Source: Useacoin / Shutterstock.com Between mid-January and the last week of November, Bitfarms (NASDAQ:BITF) stock was trading sideways with a broad range of $1 to $1.2. Blink Charging (BLNK) Source: David Tonelson/Shutterstock.com Blink Charging (NASDAQ:BLNK) stock charts look scary.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some investors prefer to look only at fundamentals for making an investment decision. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Penny Stocks With Strong Technical Charts appeared first on InvestorPlace.
|
Further, fundamental factors support the case for a strong rally. It shows two big positive takeaways. As cash burn declines, BLNK stock is poised for upside with industry tailwinds supporting long term growth.
|
c3fbab42-e5d4-4ad3-a8e3-a11e5028fb0e
|
712462.0
|
2023-12-12 00:00:00 UTC
|
Compared to Estimates, Costco (COST) Q1 Earnings: A Look at Key Metrics
|
DCOMP
|
https://www.nasdaq.com/articles/compared-to-estimates-costco-cost-q1-earnings%3A-a-look-at-key-metrics
|
nan
|
nan
|
Costco (COST) reported $57.8 billion in revenue for the quarter ended November 2023, representing a year-over-year increase of 6.2%. EPS of $3.48 for the same period compares to $3.10 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $57.67 billion, representing a surprise of +0.22%. The company delivered an EPS surprise of +0.87%, with the consensus EPS estimate being $3.45.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Costco performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Number of warehouses - Total worldwide: 871 versus the eight-analyst average estimate of 871.
Comparable sales - Total Company: 3.8% versus the seven-analyst average estimate of 4.2%.
Comparable sales - U.S. 2% versus 3.9% estimated by five analysts on average.
Number of warehouses - United States and Puerto Rico: 600 compared to the 600 average estimate based on four analysts.
Comparable warehouse sales-excluding the impact of changes in foreign-currency and gasoline -YoY change: 3.9% versus 4% estimated by four analysts on average.
Comparable sales - Other International: 11.2% versus 5.7% estimated by three analysts on average.
Number of warehouses - Taiwan: 14 compared to the 14 average estimate based on two analysts.
Number of warehouses - United Kingdom: 29 versus the two-analyst average estimate of 29.
Number of warehouses - Spain: 4 versus the two-analyst average estimate of 4.
Number of warehouses - China: 5 versus the two-analyst average estimate of 5.
Revenue- Membership fees: $1.08 billion compared to the $1.09 billion average estimate based on 10 analysts. The reported number represents a change of +8.2% year over year.
Revenue- Net sales: $56.72 billion versus the 10-analyst average estimate of $56.54 billion. The reported number represents a year-over-year change of +6.1%.
View all Key Company Metrics for Costco here>>>
Shares of Costco have returned +7.6% over the past month versus the Zacks S&P 500 composite's +6.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Here is how Costco performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Number of warehouses - Total worldwide: 871 versus the eight-analyst average estimate of 871. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The reported revenue compares to the Zacks Consensus Estimate of $57.67 billion, representing a surprise of +0.22%. Here is how Costco performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Number of warehouses - Total worldwide: 871 versus the eight-analyst average estimate of 871. Comparable sales - Total Company: 3.8% versus the seven-analyst average estimate of 4.2%.
|
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Costco performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Number of warehouses - Total worldwide: 871 versus the eight-analyst average estimate of 871. Number of warehouses - Taiwan: 14 compared to the 14 average estimate based on two analysts.
|
Costco (COST) reported $57.8 billion in revenue for the quarter ended November 2023, representing a year-over-year increase of 6.2%. Here is how Costco performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Number of warehouses - Total worldwide: 871 versus the eight-analyst average estimate of 871. Comparable sales - U.S. 2% versus 3.9% estimated by five analysts on average.
|
3a0e7bf9-1ef2-46d7-bc1a-6ad5b2296032
|
712463.0
|
2023-12-12 00:00:00 UTC
|
Costco to Pay Special Dividend of $15 Per Share: What You Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/costco-to-pay-special-dividend-of-%2415-per-share%3A-what-you-need-to-know
|
nan
|
nan
|
We knew it was coming. We just didn't know when.
Costco (NASDAQ: COST) Chief Financial Officer Richard Galanti's rhetoric in recent earnings calls, when asked about whether the company would pay out another special dividend, has been that it's "probably a question of when, not if." The day has finally come.
Costco announced on Thursday it would pay a special cash dividend of $15 per share on Jan. 12, 2024 to shareholders of record as of the close of business on Dec. 28. This, of course, is on top of the quarterly dividend the company has already committed to.
The news of Costco's special dividend builds on an upbeat quarterly financial update released on Thursday. The report, which featured double-digit year-over-year earnings-per-share growth, highlighted the membership-based wholesale warehouse's resilience, even in a challenging macroeconomic environment.
Costco's dividend history
This will be Costco's fifth-ever special dividend. Previous special dividends were paid in 2012, 2015, 2017, and 2020 in the amounts of $7, $5, $7, and $10, respectively. This makes the company's 2024 special dividend of $15 its largest, by far.
To fund this dividend, Costco will pay an aggregate amount of $6.7 billion to shareholders.
Unlike many of its peers, Costco operates its business with a significant net cash position. This means its interest expense is extremely low, which helps the company keep its cost structure low to pass those savings onto members. At the end of its just-reported fiscal first quarter, Costco had about $7 billion of debt and nearly $18 billion of cash, cash equivalents, and short-term investments. So there's plenty of cash to spare.
Costco also notably pays a meaningful, growing quarterly dividend of $1.02. The company's most recent hike came in at a double-digit rate of 12%.
Support for a high stock price
A robust special dividend comes at a good time for shareholders. The stock has soared nearly 40% year to date, giving the stock a somewhat pricey valuation. The stock's price-to-earnings ratio is now in the forties. Fortunately, a special dividend and double-digit growth in earnings per share help support this high valuation.
Speaking of Costco's earnings, the company's fiscal first-quarter revenue and earnings per share both came in higher than analysts' estimates. Total revenue of $57.8 billion was up from $54.4 billion in the year-ago quarter, beating analysts' average forecast for revenue of $57.7 billion. Earnings per share of $3.58 (up 17% year over year) was also higher than a consensus estimate of $3.42.
Sales in the quarter were helped by growing demand for the company's groceries and essentials. But strong growth in membership fees also helped. Membership fee revenue rose more than 8%, outpacing net sales growth by 2 percentage points.
Altogether, Costco's results offer a strong reminder of why the company's shares are worth a high premium. This is especially true ahead of a likely membership fee increase in the near future.
Just as management has hinted at a special dividend, it's also hinted that a membership fee increase is up for consideration. Indeed, it wouldn't be surprising to see Costco raise the prices of its memberships in 2024.
Should you invest $1,000 in Costco Wholesale right now?
Before you buy stock in Costco Wholesale, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Costco Wholesale wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Daniel Sparks has positions in Costco Wholesale. His clients own shares of Costco. The Motley Fool has positions in and recommends Costco Wholesale. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Costco (NASDAQ: COST) Chief Financial Officer Richard Galanti's rhetoric in recent earnings calls, when asked about whether the company would pay out another special dividend, has been that it's "probably a question of when, not if." Costco announced on Thursday it would pay a special cash dividend of $15 per share on Jan. 12, 2024 to shareholders of record as of the close of business on Dec. 28. The report, which featured double-digit year-over-year earnings-per-share growth, highlighted the membership-based wholesale warehouse's resilience, even in a challenging macroeconomic environment.
|
Fortunately, a special dividend and double-digit growth in earnings per share help support this high valuation. Speaking of Costco's earnings, the company's fiscal first-quarter revenue and earnings per share both came in higher than analysts' estimates. Before you buy stock in Costco Wholesale, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Costco Wholesale wasn't one of them.
|
Costco (NASDAQ: COST) Chief Financial Officer Richard Galanti's rhetoric in recent earnings calls, when asked about whether the company would pay out another special dividend, has been that it's "probably a question of when, not if." Costco's dividend history This will be Costco's fifth-ever special dividend. Before you buy stock in Costco Wholesale, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Costco Wholesale wasn't one of them.
|
Costco's dividend history This will be Costco's fifth-ever special dividend. Fortunately, a special dividend and double-digit growth in earnings per share help support this high valuation. Before you buy stock in Costco Wholesale, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Costco Wholesale wasn't one of them.
|
4a7fba65-5cc8-4451-b0ab-7e41736b0916
|
712464.0
|
2023-12-12 00:00:00 UTC
|
Ferrari (RACE) Stock Sinks As Market Gains: Here's Why
|
DCOMP
|
https://www.nasdaq.com/articles/ferrari-race-stock-sinks-as-market-gains%3A-heres-why
|
nan
|
nan
|
The latest trading session saw Ferrari (RACE) ending at $363.85, denoting a -1.64% adjustment from its last day's close. This change lagged the S&P 500's daily gain of 0.27%. At the same time, the Dow added 0.43%, and the tech-heavy Nasdaq gained 0.19%.
The luxury sports car maker's shares have seen an increase of 5.18% over the last month, not keeping up with the Auto-Tires-Trucks sector's gain of 6.12% and the S&P 500's gain of 6.94%.
Market participants will be closely following the financial results of Ferrari in its upcoming release. On that day, Ferrari is projected to report earnings of $1.55 per share, which would represent year-over-year growth of 25%. Simultaneously, our latest consensus estimate expects the revenue to be $1.61 billion, showing a 14.92% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $7.07 per share and a revenue of $6.35 billion, indicating changes of +31.9% and +18.37%, respectively, from the former year.
Any recent changes to analyst estimates for Ferrari should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 2.78% lower. At present, Ferrari boasts a Zacks Rank of #3 (Hold).
From a valuation perspective, Ferrari is currently exchanging hands at a Forward P/E ratio of 52.36. Its industry sports an average Forward P/E of 13.33, so one might conclude that Ferrari is trading at a premium comparatively.
Investors should also note that RACE has a PEG ratio of 3.26 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Automotive - Original Equipment industry currently had an average PEG ratio of 0.64 as of yesterday's close.
The Automotive - Original Equipment industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 166, which puts it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ferrari N.V. (RACE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Simultaneously, our latest consensus estimate expects the revenue to be $1.61 billion, showing a 14.92% escalation compared to the year-ago quarter. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Simultaneously, our latest consensus estimate expects the revenue to be $1.61 billion, showing a 14.92% escalation compared to the year-ago quarter. The Automotive - Original Equipment industry currently had an average PEG ratio of 0.64 as of yesterday's close. Click to get this free report Ferrari N.V. (RACE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This industry currently has a Zacks Industry Rank of 166, which puts it in the bottom 35% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Click to get this free report Ferrari N.V. (RACE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The latest trading session saw Ferrari (RACE) ending at $363.85, denoting a -1.64% adjustment from its last day's close. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Want the latest recommendations from Zacks Investment Research?
|
97e3f147-b7b8-4666-9b5a-ae77f36316d7
|
712465.0
|
2023-12-12 00:00:00 UTC
|
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
|
DCOMP
|
https://www.nasdaq.com/articles/thermo-fisher-scientific-tmo-laps-the-stock-market%3A-heres-why
|
nan
|
nan
|
In the latest market close, Thermo Fisher Scientific (TMO) reached $521.52, with a +0.57% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 0.27% for the day. Meanwhile, the Dow gained 0.43%, and the Nasdaq, a tech-heavy index, added 0.19%.
The maker of scientific instrument and laboratory supplies's shares have seen an increase of 10.2% over the last month, surpassing the Medical sector's gain of 7.01% and the S&P 500's gain of 6.94%.
The investment community will be paying close attention to the earnings performance of Thermo Fisher Scientific in its upcoming release. The company is expected to report EPS of $5.64, up 4.44% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $10.74 billion, down 6.24% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $21.52 per share and revenue of $42.71 billion. These totals would mark changes of -7.4% and -4.92%, respectively, from last year.
Any recent changes to analyst estimates for Thermo Fisher Scientific should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Thermo Fisher Scientific is currently a Zacks Rank #4 (Sell).
Investors should also note Thermo Fisher Scientific's current valuation metrics, including its Forward P/E ratio of 24.1. This represents a premium compared to its industry's average Forward P/E of 24.
We can also see that TMO currently has a PEG ratio of 3.15. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Medical - Instruments industry stood at 2.59 at the close of the market yesterday.
The Medical - Instruments industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 71, placing it within the top 29% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the latest market close, Thermo Fisher Scientific (TMO) reached $521.52, with a +0.57% movement compared to the previous day. The investment community will be paying close attention to the earnings performance of Thermo Fisher Scientific in its upcoming release. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
In the latest market close, Thermo Fisher Scientific (TMO) reached $521.52, with a +0.57% movement compared to the previous day. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $21.52 per share and revenue of $42.71 billion. Click to get this free report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
At present, this industry carries a Zacks Industry Rank of 71, placing it within the top 29% of over 250 industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Click to get this free report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $21.52 per share and revenue of $42.71 billion. Any recent changes to analyst estimates for Thermo Fisher Scientific should also be noted by investors. Want the latest recommendations from Zacks Investment Research?
|
88907f0f-9774-47a6-9182-ea01b3aa5a79
|
712466.0
|
2023-12-12 00:00:00 UTC
|
Shell (SHEL) Laps the Stock Market: Here's Why
|
DCOMP
|
https://www.nasdaq.com/articles/shell-shel-laps-the-stock-market%3A-heres-why-0
|
nan
|
nan
|
In the latest market close, Shell (SHEL) reached $65.49, with a +1.98% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 0.27% for the day. Meanwhile, the Dow gained 0.43%, and the Nasdaq, a tech-heavy index, added 0.19%.
The oil and gas company's shares have seen a decrease of 2.62% over the last month, not keeping up with the Oils-Energy sector's loss of 1.25% and the S&P 500's gain of 6.94%.
The investment community will be paying close attention to the earnings performance of Shell in its upcoming release. The company is expected to report EPS of $2.19, down 20.65% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $90.92 billion, down 10.15% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.36 per share and revenue of $357.22 billion. These totals would mark changes of -22.3% and -7.5%, respectively, from last year.
Any recent changes to analyst estimates for Shell should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.66% higher. Shell is currently a Zacks Rank #3 (Hold).
Investors should also note Shell's current valuation metrics, including its Forward P/E ratio of 7.68. This represents a premium compared to its industry's average Forward P/E of 6.54.
We can also see that SHEL currently has a PEG ratio of 0.82. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Oil and Gas - Integrated - International industry stood at 0.82 at the close of the market yesterday.
The Oil and Gas - Integrated - International industry is part of the Oils-Energy sector. At present, this industry carries a Zacks Industry Rank of 63, placing it within the top 25% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Shell PLC Unsponsored ADR (SHEL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The average PEG ratio for the Oil and Gas - Integrated - International industry stood at 0.82 at the close of the market yesterday. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
In the latest market close, Shell (SHEL) reached $65.49, with a +1.98% movement compared to the previous day. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.36 per share and revenue of $357.22 billion. The average PEG ratio for the Oil and Gas - Integrated - International industry stood at 0.82 at the close of the market yesterday.
|
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.36 per share and revenue of $357.22 billion. At present, this industry carries a Zacks Industry Rank of 63, placing it within the top 25% of over 250 industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups.
|
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.36 per share and revenue of $357.22 billion. The average PEG ratio for the Oil and Gas - Integrated - International industry stood at 0.82 at the close of the market yesterday. Want the latest recommendations from Zacks Investment Research?
|
baee4dfc-be72-475f-a106-fb2b91743647
|
712467.0
|
2023-12-12 00:00:00 UTC
|
Linde (LIN) Ascends But Remains Behind Market: Some Facts to Note
|
DCOMP
|
https://www.nasdaq.com/articles/linde-lin-ascends-but-remains-behind-market%3A-some-facts-to-note
|
nan
|
nan
|
Linde (LIN) closed the most recent trading day at $409.72, moving +0.24% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.27%. At the same time, the Dow added 0.43%, and the tech-heavy Nasdaq gained 0.19%.
Prior to today's trading, shares of the gas supplier had gained 1.49% over the past month. This has lagged the Basic Materials sector's gain of 8.1% and the S&P 500's gain of 6.94% in that time.
Market participants will be closely following the financial results of Linde in its upcoming release. It is anticipated that the company will report an EPS of $3.50, marking a 10.76% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $8.06 billion, showing a 2.02% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $14.11 per share and revenue of $32.55 billion, which would represent changes of +14.81% and -2.45%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Linde. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Currently, Linde is carrying a Zacks Rank of #3 (Hold).
In the context of valuation, Linde is at present trading with a Forward P/E ratio of 28.97. This expresses a premium compared to the average Forward P/E of 17.44 of its industry.
Also, we should mention that LIN has a PEG ratio of 2.77. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Chemical - Specialty industry held an average PEG ratio of 2.77.
The Chemical - Specialty industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 182, this industry ranks in the bottom 28% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Linde PLC (LIN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Simultaneously, our latest consensus estimate expects the revenue to be $8.06 billion, showing a 2.02% escalation compared to the year-ago quarter. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Over the past month, the Zacks Consensus EPS estimate has remained steady. As of the close of trade yesterday, the Chemical - Specialty industry held an average PEG ratio of 2.77. Click to get this free report Linde PLC (LIN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With its current Zacks Industry Rank of 182, this industry ranks in the bottom 28% of all industries, numbering over 250. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Click to get this free report Linde PLC (LIN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Linde (LIN) closed the most recent trading day at $409.72, moving +0.24% from the previous trading session. As of the close of trade yesterday, the Chemical - Specialty industry held an average PEG ratio of 2.77. With its current Zacks Industry Rank of 182, this industry ranks in the bottom 28% of all industries, numbering over 250.
|
666fd4af-1af0-49d9-bf5f-a69c4e971ed9
|
712468.0
|
2023-12-12 00:00:00 UTC
|
T-Mobile (TMUS) Stock Declines While Market Improves: Some Information for Investors
|
DCOMP
|
https://www.nasdaq.com/articles/t-mobile-tmus-stock-declines-while-market-improves%3A-some-information-for-investors
|
nan
|
nan
|
T-Mobile (TMUS) closed the most recent trading day at $156.87, moving -1.68% from the previous trading session. This change lagged the S&P 500's daily gain of 0.27%. On the other hand, the Dow registered a gain of 0.43%, and the technology-centric Nasdaq increased by 0.19%.
Heading into today, shares of the wireless carrier had gained 8.39% over the past month, outpacing the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time.
Analysts and investors alike will be keeping a close eye on the performance of T-Mobile in its upcoming earnings disclosure. The company is expected to report EPS of $1.93, up 63.56% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $19.91 billion, reflecting a 1.79% fall from the equivalent quarter last year.
TMUS's full-year Zacks Consensus Estimates are calling for earnings of $7.13 per share and revenue of $77.86 billion. These results would represent year-over-year changes of +246.12% and -2.15%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for T-Mobile. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. T-Mobile is currently sporting a Zacks Rank of #3 (Hold).
Investors should also note T-Mobile's current valuation metrics, including its Forward P/E ratio of 22.37. Its industry sports an average Forward P/E of 8.44, so one might conclude that T-Mobile is trading at a premium comparatively.
The Wireless National industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
T-Mobile US, Inc. (TMUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Analysts and investors alike will be keeping a close eye on the performance of T-Mobile in its upcoming earnings disclosure. At the same time, our most recent consensus estimate is projecting a revenue of $19.91 billion, reflecting a 1.79% fall from the equivalent quarter last year. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
T-Mobile (TMUS) closed the most recent trading day at $156.87, moving -1.68% from the previous trading session. Heading into today, shares of the wireless carrier had gained 8.39% over the past month, outpacing the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time. Over the past month, the Zacks Consensus EPS estimate has remained steady.
|
Heading into today, shares of the wireless carrier had gained 8.39% over the past month, outpacing the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 37% of over 250 industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups.
|
T-Mobile (TMUS) closed the most recent trading day at $156.87, moving -1.68% from the previous trading session. Heading into today, shares of the wireless carrier had gained 8.39% over the past month, outpacing the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 6.94% in that time. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 37% of over 250 industries.
|
ff8c332a-a5a6-4a84-96a4-6db5c7660565
|
712469.0
|
2023-12-12 00:00:00 UTC
|
GSK (GSK) Beats Stock Market Upswing: What Investors Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/gsk-gsk-beats-stock-market-upswing%3A-what-investors-need-to-know
|
nan
|
nan
|
GSK (GSK) closed the latest trading day at $36.98, indicating a +0.65% change from the previous session's end. This change outpaced the S&P 500's 0.27% gain on the day. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
The drug developer's shares have seen an increase of 6.59% over the last month, not keeping up with the Medical sector's gain of 7.01% and the S&P 500's gain of 6.94%.
Market participants will be closely following the financial results of GSK in its upcoming release. The company is expected to report EPS of $0.79, up 23.44% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $9.69 billion, indicating a 11.89% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of $3.90 per share and a revenue of $37.49 billion, demonstrating changes of +12.72% and -5.6%, respectively, from the preceding year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for GSK. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.68% higher within the past month. At present, GSK boasts a Zacks Rank of #3 (Hold).
With respect to valuation, GSK is currently being traded at a Forward P/E ratio of 9.42. This denotes a discount relative to the industry's average Forward P/E of 17.45.
It's also important to note that GSK currently trades at a PEG ratio of 1.76. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Medical - Biomedical and Genetics industry held an average PEG ratio of 1.89.
The Medical - Biomedical and Genetics industry is part of the Medical sector. With its current Zacks Industry Rank of 61, this industry ranks in the top 25% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Meanwhile, the latest consensus estimate predicts the revenue to be $9.69 billion, indicating a 11.89% increase compared to the same quarter of the previous year. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
GSK (GSK) closed the latest trading day at $36.98, indicating a +0.65% change from the previous session's end. For the full year, the Zacks Consensus Estimates project earnings of $3.90 per share and a revenue of $37.49 billion, demonstrating changes of +12.72% and -5.6%, respectively, from the preceding year. As of the close of trade yesterday, the Medical - Biomedical and Genetics industry held an average PEG ratio of 1.89.
|
With its current Zacks Industry Rank of 61, this industry ranks in the top 25% of all industries, numbering over 250. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
GSK (GSK) closed the latest trading day at $36.98, indicating a +0.65% change from the previous session's end. With its current Zacks Industry Rank of 61, this industry ranks in the top 25% of all industries, numbering over 250. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
|
1d913e10-89f8-4bd3-ba97-e680f7545361
|
712470.0
|
2023-12-12 00:00:00 UTC
|
United States Steel (X) Beats Stock Market Upswing: What Investors Need to Know
|
DCOMP
|
https://www.nasdaq.com/articles/united-states-steel-x-beats-stock-market-upswing%3A-what-investors-need-to-know
|
nan
|
nan
|
United States Steel (X) closed the latest trading day at $38.86, indicating a +0.7% change from the previous session's end. This change outpaced the S&P 500's 0.27% gain on the day. Elsewhere, the Dow gained 0.43%, while the tech-heavy Nasdaq added 0.19%.
The steel maker's shares have seen an increase of 12.31% over the last month, surpassing the Basic Materials sector's gain of 8.1% and the S&P 500's gain of 6.94%.
Market participants will be closely following the financial results of United States Steel in its upcoming release. The company is expected to report EPS of $0.19, down 78.16% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.87 billion, indicating a 10.69% decrease compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of $4.33 per share and a revenue of $17.83 billion, demonstrating changes of -56.48% and -15.37%, respectively, from the preceding year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for United States Steel. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.98% higher within the past month. At present, United States Steel boasts a Zacks Rank of #2 (Buy).
With respect to valuation, United States Steel is currently being traded at a Forward P/E ratio of 8.92. This denotes a premium relative to the industry's average Forward P/E of 8.82.
The Steel - Producers industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 85, which puts it in the top 34% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
United States Steel Corporation (X) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
United States Steel (X) closed the latest trading day at $38.86, indicating a +0.7% change from the previous session's end. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
United States Steel (X) closed the latest trading day at $38.86, indicating a +0.7% change from the previous session's end. At present, United States Steel boasts a Zacks Rank of #2 (Buy). Click to get this free report United States Steel Corporation (X) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This industry currently has a Zacks Industry Rank of 85, which puts it in the top 34% of all 250+ industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Click to get this free report United States Steel Corporation (X) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
United States Steel (X) closed the latest trading day at $38.86, indicating a +0.7% change from the previous session's end. At present, United States Steel boasts a Zacks Rank of #2 (Buy). This industry currently has a Zacks Industry Rank of 85, which puts it in the top 34% of all 250+ industries.
|
f646a059-abaa-4476-ba8a-bf8b5ddef9bf
|
712471.0
|
2023-12-12 00:00:00 UTC
|
Owens Corning Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/owens-corning-shares-near-52-week-high-market-mover-0
|
nan
|
nan
|
Owens Corning (OC) shares closed today at 0.8% below its 52 week high of $153.65, giving the company a market cap of $13B. The stock is currently up 82.6% year-to-date, up 66.0% over the past 12 months, and up 282.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 87.5% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 234.8%
The company's stock price performance over the past 12 months beats the peer average by 236.7%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.8% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Owens Corning (OC) shares closed today at 0.8% below its 52 week high of $153.65, giving the company a market cap of $13B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 234.8% The company's stock price performance over the past 12 months beats the peer average by 236.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.8% lower than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 234.8% The company's stock price performance over the past 12 months beats the peer average by 236.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.8% lower than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 234.8% The company's stock price performance over the past 12 months beats the peer average by 236.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 234.8% The company's stock price performance over the past 12 months beats the peer average by 236.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.8% lower than the average peer.
|
1f6c3b74-41b5-43f5-9032-9da753de06f9
|
712472.0
|
2023-12-12 00:00:00 UTC
|
Fomento Economico Mexicano S.A.B. de C.V. - ADR Shares Near 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/fomento-economico-mexicano-s.a.b.-de-c.v.-adr-shares-near-52-week-high-market-mover-4
|
nan
|
nan
|
Fomento Economico Mexicano S.A.B. de C.V. - ADR (FMX) shares closed today at 1.5% below its 52 week high of $131.32, giving the company a market cap of $28B. The stock is currently up 70.5% year-to-date, up 70.9% over the past 12 months, and up 72.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 30.2% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates a downward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 153.7%
The company's stock price performance over the past 12 months beats the peer average by 133.0%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
de C.V. - ADR (FMX) shares closed today at 1.5% below its 52 week high of $131.32, giving the company a market cap of $28B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 153.7% The company's stock price performance over the past 12 months beats the peer average by 133.0%
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 153.7% The company's stock price performance over the past 12 months beats the peer average by 133.0%
|
Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 153.7% The company's stock price performance over the past 12 months beats the peer average by 133.0% This story was produced by the Kwhen Automated News Generator.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 153.7% The company's stock price performance over the past 12 months beats the peer average by 133.0%
|
dba8087b-fbd7-48b5-befb-a4c9eb23021f
|
712473.0
|
2023-12-12 00:00:00 UTC
|
Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/budding-potential%3A-3-cannabis-stocks-poised-for-growth-in-2024
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. As the smoke clears from regulatory shifts and market fluctuations, the spotlight shines on three trailblazing cannabis stocks poised for substantial strides in 2024.
In the emerging direction, three companies stand tall. Each with its unique tale of triumphs, challenges, and strategic maneuvers in this ever-evolving domain. From innovative financial metrics and resilient market strategies to international expansions and product diversification, these companies exemplify the resilience and adaptability required to thrive in the cannabis industry.
This article navigates through the strategic threads that weave through these corporations. It peels back the layers of financial data, strategic initiatives, and market positioning. Read the article for more insight into the potent world of cannabis stocks and their growth trajectories in the intriguing year ahead.
Innovative Industrial Properties (IIPR)
Source: gvictoria / Shutterstock.com
Adjusted funds from operations (AFFO), a key financial metric for real estate investment trusts (REITs) like Innovative Industrial Properties (NYSE:IIPR). The AFFO was reported at $65 million in Q3 2023, a 7.5% increase from the previous year. This metric represents the cash generated from operations after accounting for capital expenditures required to maintain and upgrade properties. The consistent growth in AFFO indicates the company’s ability to generate cash flow and sustain profitability from its real estate assets.
Additionally, the increase in AFFO is attributed to various factors. These include increased tenant reimbursements, revenue from properties acquired in prior periods, contractual rent escalations, and revenue earned on additional CapEx investments at existing properties. Hence, this showcases Innovative Industrial Properties’ adeptness at maximizing returns on its property investments.
Moving to capital allocation, Innovative Industrial Properties’ capital efficiency is evident from its prudent investment approach. The company has invested and committed approximately $274 per square foot across its operating portfolio, significantly below the estimated replacement cost. This indicates a disciplined approach to capital allocation and highlights the company’s ability to acquire and develop properties at costs lower than the prevailing market rates.
In the same direction, Innovative Industrial Properties’ dividend payouts have shown steady growth. In this context, the dividends declared per share reached $7.20 in the past 12 months, representing a 6% increase over the prior 12-month period. Notably, the consistent dividend growth reflects the company’s focus on rewarding shareholders by sharing its profits through dividends.
Finally, the Q3 dividend payout ratio stood at 79% of AFFO, modestly below the midpoint of the targeted ratio range of 75% to 85% of AFFO. This balanced payout ratio signaled prudent financial management. As a result, it allows Innovative Industrial Properties to distribute dividends to shareholders while retaining sufficient earnings to create long-term value.
OrganiGram (OGI)
Source: Jetacom Autofocus / Shutterstock.com
OrganiGram (NASDAQ:OGI) demonstrates both successes and challenges in its revenue growth strategies, especially in the Canadian recreational business. For instance, in Q3 2023, the company witnessed a 7% sequential increase in net revenue. It is predominantly driven by the success of hash sales and a late resurgence in flower sales. Year-to-date, recreational net revenue also experienced a notable CAD 8 million (10%) increase year-over-year. This growth primarily stemmed from the rise in pre-rolls, gummies, and hash product sales.
However, several external factors affected the company’s Q3 financial results. Notably, the lower-than-expected growth in the flower category delayed international shipments and the impact of removing the Edison JOLTS product from the market due to a Health Canada stop-sale order. These challenges influenced the company’s net sales and gross margin for the quarter.
Despite the challenges, OrganiGram’s ability to sustain revenue growth, especially in key segments like pre-rolls and gummies, showcases market resilience. This resilience favors the company for adapting to industry challenges while maintaining a competitive edge.
Notably, there is a crucial issue of tetrahydrocannabinol inflation within the cannabis industry. To counter THC issues and product differentiation, the company has made a CAD 4 million investment in Green Tank Technologies for vaporization technology. Also, invest in Phylos Bioscience for seed genetics, specifically targeting tetrahydrocannabivarin (THCV) concentrations.
Strategically, OrganiGram’s market share performance emphasized growth in key product segments like gummies, hash, and milled flowers. Despite challenges related to THC inflation impacting flower sales, OrganiGram maintained a leading position in segments like milled flower, infused pre-rolls, and gummies.
Lastly, OrganiGram focuses on product differentiation, exemplified by the progress of innovative products like SHRED X Rip Strips. This underscores the company’s ability to address consumer needs and adapt to evolving market trends.
Cronos (CRON)
Source: Shutterstock
Cronos (NASDAQ:CRON) demonstrates commendable top-line growth. Q3 2023 marks a 22% year-over-year increase and a substantial 30% sequential growth to $24.8 million. This growth was driven by various factors, notably a remarkable 40% year-over-year growth in the Canadian market. The company attributed this growth to its success in product segments like pre-rolls, flowers, and edibles. Hence, this illustrates the effectiveness of its market strategies.
Fundamentally, the Canadian market has been a pivotal area of success for Cronos. The company’s achievements include becoming the number-one brand in edibles and vapes. Consequently, the overall ranking is third in the cannabis brand category in Canada, highlighting its prowess in a competitive market.
Re-entering the German market, the company targets a substantial population of around 83 million. This move signifies a strategic move to tap into a lucrative international market. Also, partnering with Cansativa, a prominent distributor in Germany with access to around 2K high-volume cannabis-focused pharmacies. As a result, it provides Cronos with a robust distribution network to reach a broader consumer base.
Additionally, initiating shipments to Australia through Vitura indicates Cronos’ focus on international expansion. Therefore, this move aligns with the growing medical cannabis market in Australia, offering potential growth opportunities outside of Canada and the US.
Finally, the Spinach brand’s market success, securing top positions across various product categories in Canada, signifies Cronos’ ability to resonate with consumers and gain significant market share. Introducing the Lord Jones brand in the Canadian adult-use market, focusing on premium products, is a strategic move targeting consumers willing to pay for higher-quality cannabis experiences. Thus, this expansion into premium offerings indicates Cronos’ focus on diversifying its product portfolio to cater to prolonged value growth.
As of this writing, Yiannis Zourmpanos held a long position in IIPR. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Notably, the lower-than-expected growth in the flower category delayed international shipments and the impact of removing the Edison JOLTS product from the market due to a Health Canada stop-sale order. Introducing the Lord Jones brand in the Canadian adult-use market, focusing on premium products, is a strategic move targeting consumers willing to pay for higher-quality cannabis experiences. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024 appeared first on InvestorPlace.
|
From innovative financial metrics and resilient market strategies to international expansions and product diversification, these companies exemplify the resilience and adaptability required to thrive in the cannabis industry. OrganiGram (OGI) Source: Jetacom Autofocus / Shutterstock.com OrganiGram (NASDAQ:OGI) demonstrates both successes and challenges in its revenue growth strategies, especially in the Canadian recreational business. Despite challenges related to THC inflation impacting flower sales, OrganiGram maintained a leading position in segments like milled flower, infused pre-rolls, and gummies.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. From innovative financial metrics and resilient market strategies to international expansions and product diversification, these companies exemplify the resilience and adaptability required to thrive in the cannabis industry. Innovative Industrial Properties (IIPR) Source: gvictoria / Shutterstock.com Adjusted funds from operations (AFFO), a key financial metric for real estate investment trusts (REITs) like Innovative Industrial Properties (NYSE:IIPR).
|
From innovative financial metrics and resilient market strategies to international expansions and product diversification, these companies exemplify the resilience and adaptability required to thrive in the cannabis industry. In the same direction, Innovative Industrial Properties’ dividend payouts have shown steady growth. The company attributed this growth to its success in product segments like pre-rolls, flowers, and edibles.
|
4b2a7dd1-a10e-41bd-b393-eb7a367c3f95
|
712474.0
|
2023-12-12 00:00:00 UTC
|
New York Community Bancorp (NYCB) Soars 6.9%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/new-york-community-bancorp-nycb-soars-6.9%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
New York Community Bancorp (NYCB) shares ended the last trading session 6.9% higher at $11.32. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 13.4% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the New York Community Bancorp stock moved higher.
This bank holding company is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +24%. Revenues are expected to be $937.63 million, up 62.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For New York Community Bancorp, the consensus EPS estimate for the quarter has been revised 3.1% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on NYCB going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
New York Community Bancorp belongs to the Zacks Financial - Savings and Loan industry. Another stock from the same industry, BankFinancial (BFIN), closed the last trading session 6.3% higher at $10.09. Over the past month, BFIN has returned 6.8%.
BankFinancial's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.20. Compared to the company's year-ago EPS, this represents a change of -25.9%. BankFinancial currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
New York Community Bancorp, Inc. (NYCB) : Free Stock Analysis Report
BankFinancial Corporation (BFIN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. This bank holding company is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +24%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
New York Community Bancorp (NYCB) shares ended the last trading session 6.9% higher at $11.32. This bank holding company is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +24%. Click to get this free report New York Community Bancorp, Inc. (NYCB) : Free Stock Analysis Report BankFinancial Corporation (BFIN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> New York Community Bancorp belongs to the Zacks Financial - Savings and Loan industry. Click to get this free report New York Community Bancorp, Inc. (NYCB) : Free Stock Analysis Report BankFinancial Corporation (BFIN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
New York Community Bancorp (NYCB) shares ended the last trading session 6.9% higher at $11.32. For New York Community Bancorp, the consensus EPS estimate for the quarter has been revised 3.1% lower over the last 30 days to the current level. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> New York Community Bancorp belongs to the Zacks Financial - Savings and Loan industry.
|
5250d80f-8ccf-490a-8633-64a988a589f6
|
712475.0
|
2023-12-12 00:00:00 UTC
|
Tri-Continental Corp. Shares Climb 0.4% Past Previous 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/tri-continental-corp.-shares-climb-0.4-past-previous-52-week-high-market-mover
|
nan
|
nan
|
Tri-Continental Corp. (TY) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 13.6% year-to-date, up 8.9% over the past 12 months, and up 58.6% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 4.0% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates a downward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Tri-Continental Corp. (TY) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $1B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8. The stock closed below its Bollinger band, indicating it may be oversold.
|
Tri-Continental Corp. (TY) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $1B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
|
Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator.
|
Tri-Continental Corp. (TY) shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 13.6% year-to-date, up 8.9% over the past 12 months, and up 58.6% over the past five years. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
|
47faeedc-646e-4d5e-a4ad-19efae36ac04
|
712476.0
|
2023-12-12 00:00:00 UTC
|
Public Storage Shares Close in on 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/public-storage-shares-close-in-on-52-week-high-market-mover
|
nan
|
nan
|
Public Storage (PSA) shares closed today at 0.7% below its 52 week high of $292.13, giving the company a market cap of $51B. The stock is currently up 9.2% year-to-date, up 9.2% over the past 12 months, and up 9.2% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 68.5% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date lags the peer average by -27.1%
The company's stock price performance over the past 12 months beats the peer average by 15.3%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Public Storage (PSA) shares closed today at 0.7% below its 52 week high of $292.13, giving the company a market cap of $51B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -27.1% The company's stock price performance over the past 12 months beats the peer average by 15.3%
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -27.1% The company's stock price performance over the past 12 months beats the peer average by 15.3%
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -27.1% The company's stock price performance over the past 12 months beats the peer average by 15.3% This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -27.1% The company's stock price performance over the past 12 months beats the peer average by 15.3%
|
0137fd86-1c1f-4373-8a3c-173f09aa1cb8
|
712477.0
|
2023-12-12 00:00:00 UTC
|
Choice Hotels International, Inc. Shares Close in on 52-Week Low - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/choice-hotels-international-inc.-shares-close-in-on-52-week-low-market-mover-0
|
nan
|
nan
|
Choice Hotels International, Inc. (CHH) shares closed today at 1.9% above its 52 week low of $108.47, giving the company a market cap of $5B. The stock is currently up 0.8% year-to-date, down 3.4% over the past 12 months, and up 62.1% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 70.7% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
The Relative Strength Index (RSI) on the stock was between 30 and 70.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Communication Services industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date lags the peer average by -97.6%
The company's stock price performance over the past 12 months lags the peer average by -113.7%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Choice Hotels International, Inc. (CHH) shares closed today at 1.9% above its 52 week low of $108.47, giving the company a market cap of $5B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.
|
Choice Hotels International, Inc. (CHH) shares closed today at 1.9% above its 52 week low of $108.47, giving the company a market cap of $5B. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -97.6% The company's stock price performance over the past 12 months lags the peer average by -113.7%
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -97.6% The company's stock price performance over the past 12 months lags the peer average by -113.7% This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -97.6% The company's stock price performance over the past 12 months lags the peer average by -113.7%
|
dd1025df-878d-4363-aa48-eab8fe244268
|
712478.0
|
2023-12-12 00:00:00 UTC
|
Acuity Brands, Inc. Shares Close in on 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/acuity-brands-inc.-shares-close-in-on-52-week-high-market-mover
|
nan
|
nan
|
Acuity Brands, Inc. (AYI) shares closed today at 1.8% below its 52 week high of $206.95, giving the company a market cap of $6B. The stock is currently up 23.8% year-to-date, up 15.1% over the past 12 months, and up 75.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%.
Trading Activity
Trading volume this week was 131.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by -564.0%
The company's stock price performance over the past 12 months beats the peer average by -263.3%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1061.7% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Acuity Brands, Inc. (AYI) shares closed today at 1.8% below its 52 week high of $206.95, giving the company a market cap of $6B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -564.0% The company's stock price performance over the past 12 months beats the peer average by -263.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1061.7% higher than the average peer.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 131.8% higher than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -564.0% The company's stock price performance over the past 12 months beats the peer average by -263.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1061.7% higher than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -564.0% The company's stock price performance over the past 12 months beats the peer average by -263.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1061.7% higher than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.0%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -564.0% The company's stock price performance over the past 12 months beats the peer average by -263.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1061.7% higher than the average peer.
|
5541dcaf-2575-43ad-85e4-5df6a89663ea
|
712479.0
|
2023-12-12 00:00:00 UTC
|
Huntington Bancshares (HBAN) Moves 6.9% Higher: Will This Strength Last?
|
DCOMP
|
https://www.nasdaq.com/articles/huntington-bancshares-hban-moves-6.9-higher%3A-will-this-strength-last
|
nan
|
nan
|
Huntington Bancshares (HBAN) shares soared 6.9% in the last trading session to close at $13.18. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.1% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the Huntington Bancshares stock moved higher.
This regional bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -32.6%. Revenues are expected to be $1.82 billion, down 7.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Huntington Bancshares, the consensus EPS estimate for the quarter has been revised marginally higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on HBAN going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Huntington Bancshares is part of the Zacks Banks - Midwest industry. First Merchants (FRME), another stock in the same industry, closed the last trading session 2.4% higher at $37.45. FRME has returned 14.7% in the past month.
First Merchants' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.87. Compared to the company's year-ago EPS, this represents a change of -26.9%. First Merchants currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Huntington Bancshares Incorporated (HBAN) : Free Stock Analysis Report
First Merchants Corporation (FRME) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. This regional bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -32.6%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This regional bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -32.6%. For Huntington Bancshares, the consensus EPS estimate for the quarter has been revised marginally higher over the last 30 days to the current level. Click to get this free report Huntington Bancshares Incorporated (HBAN) : Free Stock Analysis Report First Merchants Corporation (FRME) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Huntington Bancshares is part of the Zacks Banks - Midwest industry. Click to get this free report Huntington Bancshares Incorporated (HBAN) : Free Stock Analysis Report First Merchants Corporation (FRME) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This regional bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -32.6%. For Huntington Bancshares, the consensus EPS estimate for the quarter has been revised marginally higher over the last 30 days to the current level. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Huntington Bancshares is part of the Zacks Banks - Midwest industry.
|
6bd87cc7-55d0-4704-8b6b-5f9c18b17d9c
|
712480.0
|
2023-12-12 00:00:00 UTC
|
SB Financial Group, Inc. (SBFG) Soars 5.6%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/sb-financial-group-inc.-sbfg-soars-5.6%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
SB Financial Group, Inc. (SBFG) shares soared 5.6% in the last trading session to close at $15. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 7.5% gain over the past four weeks.
The Federal Reserve signaled the end of the current rate hike cycle and kept the interest rates unchanged at a 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024 end. These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. Also, going forward, such monetary easing is likely to propel consumer spending. Hence, the SB Financial Group stock moved higher.
This company is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of -28.6%. Revenues are expected to be $13.4 million, down 8.3% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For SB Financial Group, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SBFG going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
SB Financial Group, Inc. is a member of the Zacks Banks - Northeast industry. One other stock in the same industry, TrustCo Bank (TRST), finished the last trading session 2% higher at $31.24. TRST has returned 7.9% over the past month.
TrustCo's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.66. Compared to the company's year-ago EPS, this represents a change of -40%. TrustCo currently boasts a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report
TrustCo Bank Corp NY (TRST) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs will somewhat come down next year, thus supporting spread income and margin. This company is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of -28.6%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> SB Financial Group, Inc. is a member of the Zacks Banks - Northeast industry. TrustCo's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.66. Click to get this free report SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report TrustCo Bank Corp NY (TRST) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> SB Financial Group, Inc. is a member of the Zacks Banks - Northeast industry. Click to get this free report SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report TrustCo Bank Corp NY (TRST) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
SB Financial Group, Inc. (SBFG) shares soared 5.6% in the last trading session to close at $15. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> SB Financial Group, Inc. is a member of the Zacks Banks - Northeast industry. One other stock in the same industry, TrustCo Bank (TRST), finished the last trading session 2% higher at $31.24.
|
22275d2b-636b-4228-b999-68e1ae8cdfde
|
712481.0
|
2023-12-12 00:00:00 UTC
|
Top 10 High-Yield Stocks for 2024 and How to Choose Them
|
DCOMP
|
https://www.nasdaq.com/articles/top-10-high-yield-stocks-for-2024-and-how-to-choose-them
|
nan
|
nan
|
In 2023, high-yield stocks exhibited a notable underperformance relative to the broader market. This contrast is vividly apparent when examining the performance of some of the most popular high-yield ETFs in comparison to the S&P 500.
The JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), Amplify High Income ETF (NYSEARCA:YYY), and Global X SuperDividend ETF (NYSEARCA:SDIV) returned 1%, -1%, and -8%, respectively, year-to-date. Even if you add their impressive dividend yields of 9.1%, 12.7%, and 12.6%, all three ETFs lagged behind the S&P 500 on a total-return basis, as the popular index posted a robust 23% gain over the same period, excluding dividends.
Why Did High-Yield Stocks Underperform in 2023?
The recent underperformance of high-yield stocks can be attributed to the rapid interest rate hikes implemented by the Federal Reserve over the past year. High-yield stocks often underperform in a rising interest rate environment, as their appeal diminishes relative to alternative fixed-income investments.
More specifically, as interest rates increase, investors may opt for safer fixed-income securities that offer competitive returns with lower risk. The narrowing yield spread between high-yield stocks and bonds makes the incremental risk associated with stocks less attractive.
Another reason explaining their underperformance is that rising rates impact their discounted cash flow valuations, leading to lower present values for future cash flows. However, this phenomenon applies broadly to all equities, so I'll emphasize the first explanation for now.
Why Are High-Yield Stocks Looking Attractive Moving Into 2024?
Moving into 2024, high-yield stocks are looking quite attractive as the anticipated reversal of the impact from previous rate hikes comes into play. After a fierce rate-hiking cycle that endured nearly two years, the Fed is expected to start cutting rates in 2024. This is a common expectation among most major banks on Wall Street.
In such a scenario, high-yield stocks will immediately become more attractive when anticipating declining interest rates. As fixed-income yields drop, the relatively higher yields from dividend-paying stocks become appealing. It's the opposite effect of rising rates, as noted earlier.
How to Pick High-Yield Stocks for 2024
Expecting a more favorable performance next year than 2023, high-yield stocks are in the spotlight. The challenge now lies in identifying the "best" high-yield stocks for 2024. Of course, this is a highly subjective question. If you ask 100 different investors for their "Top 10 Picks," you will get 100 different lists.
Despite its subjective nature, I've curated a set of criteria designed to filter through high-yield stocks, resulting in a carefully selected list of 10 exceptionally promising options.
Dividend Yield: Go for Stocks That Yield at Least 6.0%
I've set a baseline requirement for a stock's dividend yield at 6%, considering it a solid mark for it to be classified as "high yield." I believe this rate is just right for catching investors' attention, especially when interest rates are on the decline.
Currently, the Federal Reserve's target range for the federal funds rate is at a 22-year high of 5.25%-5.5%. If rates drop (by anywhere from 1% to 2.75%), as predicted by major Wall Street banks, any stock with a yield of 6% or more should stand out to investors looking for better returns in a landscape of shrinking bond yields.
Dividend Growth Streak: At Least Five Years
In an effort to filter out companies with temporarily inflated yields that may not accurately represent their ongoing performance, I've established a minimum dividend growth streak of five years. For instance, consider a company currently paying out substantial dividends due to reaching the peak cycle in its industry.
Although it presently boasts a high dividend yield, this might be short-lived as the industry normalizes. By implementing a minimum five-year dividend growth streak, we not only eliminate the likelihood of including such transient cases but also ensure that the highlighted companies prioritize rewarding shareholders, given the sustained growth in their dividends.
Leverage: A Net Debt/EBITDA Ratio No Higher Than 3.5x
In the final stage of my research, I implemented a stringent filter to ensure that the chosen high-yield stocks exhibit a net debt/EBITDA ratio not exceeding 3.5x. This presents a noteworthy challenge, as the definition of a "reasonable" net debt/EBITDA level varies from one company to another, influenced by their distinct business models. Some companies heavily leverage debt, while others do not.
Consider this filter a deliberate effort on my part to systematically screen out companies with substantial debt burdens. This approach aims to enhance the probability of these stocks maintaining their dividend growth streak, which has already endured for five years or more. I believe that the 3.5x is good enough to eliminate high-yield, high-leverage stocks that could potentially face a dividend cut, especially if they choose to incur additional debt.
Blending All The Requirements
If we blend the above criteria and apply them to every single stock in the U.S. stock market, we come out with a great list of 10 top high-yield stocks worthy of consideration for the upcoming year, 2024. Here is the full list, along with the respective metrics for each filter we applied.
Company Name Div Yield Dividend Streak (Years) Net Debt / EBITDA (Latest Quarter)
Verizon Communications Inc. (NYSE:VZ) 7.06% 19 3.2
Altria Group Inc. (NYSE:MO) 9.47% 15 1.8
Enterprise Products Partners L.P. (NYSE:EPD) 7.64% 7 3.3
Pioneer Natural Resources (NYSE:PXD) 6.32% 6 0.5
Devon Energy Corporation (NYSE:DVN) 6.46% 6 0.8
Cheniere Energy Partners L.P. (NYSE:CQP) 7.67% 7 3.4
Walgreens Boots Alliance Inc. (NYSE:WBA) 8.35% 48 2.6
CNA Financial Corporation (NYSE:CNA) 6.91% 7 1.9
Hess Midstream LP (NYSE:HESM) 8.08% 5 2.9
Innovative Industrial Properties (NYSE:IIPR) 8.13% 5 0.8
Disclosure
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The recent underperformance of high-yield stocks can be attributed to the rapid interest rate hikes implemented by the Federal Reserve over the past year. More specifically, as interest rates increase, investors may opt for safer fixed-income securities that offer competitive returns with lower risk. Despite its subjective nature, I've curated a set of criteria designed to filter through high-yield stocks, resulting in a carefully selected list of 10 exceptionally promising options.
|
The JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), Amplify High Income ETF (NYSEARCA:YYY), and Global X SuperDividend ETF (NYSEARCA:SDIV) returned 1%, -1%, and -8%, respectively, year-to-date. As fixed-income yields drop, the relatively higher yields from dividend-paying stocks become appealing. Company Name Div Yield Dividend Streak (Years) Net Debt / EBITDA (Latest Quarter) Verizon Communications Inc. (NYSE:VZ) 7.06% 19 3.2 Altria Group Inc. (NYSE:MO) 9.47% 15 1.8 Enterprise Products Partners L.P. (NYSE:EPD) 7.64% 7 3.3 Pioneer Natural Resources (NYSE:PXD) 6.32% 6 0.5 Devon Energy Corporation (NYSE:DVN) 6.46% 6 0.8 Cheniere Energy Partners L.P. (NYSE:CQP) 7.67% 7 3.4 Walgreens Boots Alliance Inc. (NYSE:WBA) 8.35% 48 2.6 CNA Financial Corporation (NYSE:CNA) 6.91% 7 1.9 Hess Midstream LP (NYSE:HESM) 8.08% 5 2.9 Innovative Industrial Properties (NYSE:IIPR) 8.13% 5 0.8 Disclosure The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Dividend Yield: Go for Stocks That Yield at Least 6.0% I've set a baseline requirement for a stock's dividend yield at 6%, considering it a solid mark for it to be classified as "high yield." Blending All The Requirements If we blend the above criteria and apply them to every single stock in the U.S. stock market, we come out with a great list of 10 top high-yield stocks worthy of consideration for the upcoming year, 2024. Company Name Div Yield Dividend Streak (Years) Net Debt / EBITDA (Latest Quarter) Verizon Communications Inc. (NYSE:VZ) 7.06% 19 3.2 Altria Group Inc. (NYSE:MO) 9.47% 15 1.8 Enterprise Products Partners L.P. (NYSE:EPD) 7.64% 7 3.3 Pioneer Natural Resources (NYSE:PXD) 6.32% 6 0.5 Devon Energy Corporation (NYSE:DVN) 6.46% 6 0.8 Cheniere Energy Partners L.P. (NYSE:CQP) 7.67% 7 3.4 Walgreens Boots Alliance Inc. (NYSE:WBA) 8.35% 48 2.6 CNA Financial Corporation (NYSE:CNA) 6.91% 7 1.9 Hess Midstream LP (NYSE:HESM) 8.08% 5 2.9 Innovative Industrial Properties (NYSE:IIPR) 8.13% 5 0.8 Disclosure The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Why Did High-Yield Stocks Underperform in 2023? High-yield stocks often underperform in a rising interest rate environment, as their appeal diminishes relative to alternative fixed-income investments. How to Pick High-Yield Stocks for 2024 Expecting a more favorable performance next year than 2023, high-yield stocks are in the spotlight.
|
e6d53268-c130-40ea-b033-192c30265cf6
|
712482.0
|
2023-12-12 00:00:00 UTC
|
Carvana Co. (CVNA) is Attracting Investor Attention: Here is What You Should Know
|
DCOMP
|
https://www.nasdaq.com/articles/carvana-co.-cvna-is-attracting-investor-attention%3A-here-is-what-you-should-know-2
|
nan
|
nan
|
Carvana (CVNA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this company have returned +56.4% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Internet - Commerce industry, to which Carvana belongs, has gained 3% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings Estimates
Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Carvana is expected to post a loss of $0.93 per share for the current quarter, representing a year-over-year change of +4.1%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.1%.
For the current fiscal year, the consensus earnings estimate of $0.71 points to a change of +108.2% from the prior year. Over the last 30 days, this estimate has changed +5.1%.
For the next fiscal year, the consensus earnings estimate of -$3.47 indicates a change of -588% from what Carvana is expected to report a year ago. Over the past month, the estimate has changed -1.1%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Carvana is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth Forecast
While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Carvana, the consensus sales estimate for the current quarter of $2.57 billion indicates a year-over-year change of -9.3%. For the current and next fiscal years, $10.98 billion and $11.59 billion estimates indicate -19.3% and +5.6% changes, respectively.
Last Reported Results and Surprise History
Carvana reported revenues of $2.77 billion in the last reported quarter, representing a year-over-year change of -18.1%. EPS of $0.23 for the same period compares with -$2.67 a year ago.
Compared to the Zacks Consensus Estimate of $2.74 billion, the reported revenues represent a surprise of +1.12%. The EPS surprise was +127.06%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
Valuation
Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Carvana is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom Line
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Carvana. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Carvana Co. (CVNA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Bottom Line The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Carvana.
|
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth Forecast While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. Last Reported Results and Surprise History Carvana reported revenues of $2.77 billion in the last reported quarter, representing a year-over-year change of -18.1%. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Carvana is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth Forecast While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
When earnings estimates for a company go up, the fair value for its stock goes up as well. EPS of $0.23 for the same period compares with -$2.67 a year ago. The company topped consensus revenue estimates three times over this period.
|
2504fc82-bdd0-45be-b900-edfb7e739cdb
|
712483.0
|
2023-12-12 00:00:00 UTC
|
Is Trending Stock RTX Corporation (RTX) a Buy Now?
|
DCOMP
|
https://www.nasdaq.com/articles/is-trending-stock-rtx-corporation-rtx-a-buy-now
|
nan
|
nan
|
RTX (RTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this an aerospace and defense company have returned +2% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Aerospace - Defense industry, to which RTX belongs, has gained 7.1% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate Revisions
Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
RTX is expected to post earnings of $1.25 per share for the current quarter, representing a year-over-year change of -1.6%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The consensus earnings estimate of $5 for the current fiscal year indicates a year-over-year change of +4.6%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $5.40 indicates a change of +8% from what RTX is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for RTX.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue Growth
While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For RTX, the consensus sales estimate for the current quarter of $19.75 billion indicates a year-over-year change of +9.2%. For the current and next fiscal years, $74.1 billion and $78.48 billion estimates indicate +10.5% and +5.9% changes, respectively.
Last Reported Results and Surprise History
RTX reported revenues of $18.95 billion in the last reported quarter, representing a year-over-year change of +11.8%. EPS of $1.25 for the same period compares with $1.21 a year ago.
Compared to the Zacks Consensus Estimate of $18.71 billion, the reported revenues represent a surprise of +1.3%. The EPS surprise was +5.04%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
Valuation
Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
RTX is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom Line
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about RTX. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
RTX Corporation (RTX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Bottom Line The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about RTX.
|
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. Last Reported Results and Surprise History RTX reported revenues of $18.95 billion in the last reported quarter, representing a year-over-year change of +11.8%. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
|
And if earnings estimates go up for a company, the fair value for its stock goes up. The company topped consensus revenue estimates three times over this period. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
|
dac25ee5-3cef-42b3-bec9-3c18ab83fdd2
|
712484.0
|
2023-12-12 00:00:00 UTC
|
Is Most-Watched Stock CrowdStrike (CRWD) Worth Betting on Now?
|
DCOMP
|
https://www.nasdaq.com/articles/is-most-watched-stock-crowdstrike-crwd-worth-betting-on-now-1
|
nan
|
nan
|
CrowdStrike Holdings (CRWD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this cloud-based security company have returned +23.7% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Internet - Software industry, to which CrowdStrike belongs, has gained 7.1% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate Revisions
Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
CrowdStrike is expected to post earnings of $0.82 per share for the current quarter, representing a year-over-year change of +74.5%. Over the last 30 days, the Zacks Consensus Estimate has changed +69.7%.
The consensus earnings estimate of $2.93 for the current fiscal year indicates a year-over-year change of +90.3%. This estimate has changed +45.3% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $3.63 indicates a change of +23.9% from what CrowdStrike is expected to report a year ago. Over the past month, the estimate has changed +5.2%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for CrowdStrike.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue Growth
While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of CrowdStrike, the consensus sales estimate of $838.64 million for the current quarter points to a year-over-year change of +31.6%. The $3.05 billion and $3.91 billion estimates for the current and next fiscal years indicate changes of +36.1% and +28.3%, respectively.
Last Reported Results and Surprise History
CrowdStrike reported revenues of $786.01 million in the last reported quarter, representing a year-over-year change of +35.3%. EPS of $0.82 for the same period compares with $0.40 a year ago.
Compared to the Zacks Consensus Estimate of $777.2 million, the reported revenues represent a surprise of +1.13%. The EPS surprise was +10.81%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
Valuation
Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
CrowdStrike is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom Line
The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about CrowdStrike. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CrowdStrike (CRWD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Bottom Line The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about CrowdStrike.
|
A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. Last Reported Results and Surprise History CrowdStrike reported revenues of $786.01 million in the last reported quarter, representing a year-over-year change of +35.3%.
|
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for CrowdStrike. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Projected Revenue Growth While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
|
And if earnings estimates go up for a company, the fair value for its stock goes up. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for CrowdStrike. EPS of $0.82 for the same period compares with $0.40 a year ago.
|
f991fdc7-987f-450c-b337-c6528eb598f5
|
712485.0
|
2023-12-12 00:00:00 UTC
|
First Interstate BancSystem (FIBK) Surges 6.3%: Is This an Indication of Further Gains?
|
DCOMP
|
https://www.nasdaq.com/articles/first-interstate-bancsystem-fibk-surges-6.3%3A-is-this-an-indication-of-further-gains
|
nan
|
nan
|
First Interstate BancSystem (FIBK) shares rallied 6.3% in the last trading session to close at $32.14. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 17.5% gain over the past four weeks.
Shares of First Interstate BancSystem rallied for the second consecutive day. The Federal Reserve has signaled end of the current rate cycle and kept the interest rates unchanged at 22-year high of 5.25-5.5% at the end of two-day FOMC meeting. The central bank also indicated three interest rate cuts by 2024-end.
These favorable developments turned investor sentiments bullish on bank stocks as high funding costs being faced by the industry players will somewhat come down next year. This will support net interest income and margin growth. Hence, the FIBK stock moved higher.
This holding company for First Interstate Bank is expected to post quarterly earnings of $0.63 per share in its upcoming report, which represents a year-over-year change of -26.7%. Revenues are expected to be $254.5 million, down 15.2% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For First Interstate BancSystem, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FIBK going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
First Interstate BancSystem belongs to the Zacks Banks - Midwest industry. Another stock from the same industry, QCR Holdings (QCRH), closed the last trading session 1.3% higher at $59.19. Over the past month, QCRH has returned 11.2%.
QCR Holdings' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.36. Compared to the company's year-ago EPS, this represents a change of -25.7%. QCR Holdings currently boasts a Zacks Rank of #3 (Hold).
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
First Interstate BancSystem, Inc. (FIBK) : Free Stock Analysis Report
QCR Holdings, Inc. (QCRH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These favorable developments turned investor sentiments bullish on bank stocks as high funding costs being faced by the industry players will somewhat come down next year. This holding company for First Interstate Bank is expected to post quarterly earnings of $0.63 per share in its upcoming report, which represents a year-over-year change of -26.7%. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
This holding company for First Interstate Bank is expected to post quarterly earnings of $0.63 per share in its upcoming report, which represents a year-over-year change of -26.7%. QCR Holdings' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.36. Click to get this free report First Interstate BancSystem, Inc. (FIBK) : Free Stock Analysis Report QCR Holdings, Inc. (QCRH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Interstate BancSystem belongs to the Zacks Banks - Midwest industry. Click to get this free report First Interstate BancSystem, Inc. (FIBK) : Free Stock Analysis Report QCR Holdings, Inc. (QCRH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Interstate BancSystem belongs to the Zacks Banks - Midwest industry. Another stock from the same industry, QCR Holdings (QCRH), closed the last trading session 1.3% higher at $59.19. Compared to the company's year-ago EPS, this represents a change of -25.7%.
|
2ed7ea84-a89a-4145-b0f8-aba90fd37939
|
712486.0
|
2023-12-12 00:00:00 UTC
|
Blue Bird (BLBD) Recently Broke Out Above the 50-Day Moving Average
|
DCOMP
|
https://www.nasdaq.com/articles/blue-bird-blbd-recently-broke-out-above-the-50-day-moving-average
|
nan
|
nan
|
After reaching an important support level, Blue Bird (BLBD) could be a good stock pick from a technical perspective. BLBD surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.
The 50-day simple moving average is one of three major moving averages used by traders and analysts to determine support or resistance levels for a wide range of securities. But the 50-day is considered to be more important because it's the first marker of an up or down trend.
BLBD has rallied 37% over the past four weeks, and the company is a Zacks Rank #3 (Hold) at the moment. This combination suggests BLBD could be on the verge of another move higher.
The bullish case solidifies once investors consider BLBD's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too.
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on BLBD for more gains in the near future.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Blue Bird Corporation (BLBD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
After reaching an important support level, Blue Bird (BLBD) could be a good stock pick from a technical perspective. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on BLBD for more gains in the near future. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
After reaching an important support level, Blue Bird (BLBD) could be a good stock pick from a technical perspective. BLBD surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend. Click to get this free report Blue Bird Corporation (BLBD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
After reaching an important support level, Blue Bird (BLBD) could be a good stock pick from a technical perspective. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report Blue Bird Corporation (BLBD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
After reaching an important support level, Blue Bird (BLBD) could be a good stock pick from a technical perspective. This combination suggests BLBD could be on the verge of another move higher. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
9d3fdf0e-aabd-47cd-9f0a-fd6530d17f07
|
712487.0
|
2023-12-12 00:00:00 UTC
|
Technology Sector Update for 12/15/2023: INTC, TIGO, GOOG, GOOGL, XLK, XSD
|
DCOMP
|
https://www.nasdaq.com/articles/technology-sector-update-for-12-15-2023%3A-intc-tigo-goog-googl-xlk-xsd
|
nan
|
nan
|
Technology stocks were gaining premarket Friday, with the Technology Select Sector SPDR Fund (XLK) up 0.3% and the SPDR S&P Semiconductor ETF (XSD) marginally higher.
Intel (INTC) Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters reported Thursday. Intel was up more than 2% in recent Friday premarket activity.
Millicom International Cellular (TIGO) was nearly 4% higher after saying late Thursday it initiated a share buyback program aimed at funding employee share plans.
Alphabet's (GOOG, GOOGL) Google unit said it will start testing a new Tracking Protection feature for its Chrome browser on Jan. 4 that is designed to block third-party cookies that other websites use to track users' web activities. Alphabet was up 0.4% in recent Friday premarket activity.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Technology stocks were gaining premarket Friday, with the Technology Select Sector SPDR Fund (XLK) up 0.3% and the SPDR S&P Semiconductor ETF (XSD) marginally higher. Intel (INTC) Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters reported Thursday. Alphabet's (GOOG, GOOGL) Google unit said it will start testing a new Tracking Protection feature for its Chrome browser on Jan. 4 that is designed to block third-party cookies that other websites use to track users' web activities.
|
Intel was up more than 2% in recent Friday premarket activity. Alphabet's (GOOG, GOOGL) Google unit said it will start testing a new Tracking Protection feature for its Chrome browser on Jan. 4 that is designed to block third-party cookies that other websites use to track users' web activities. Alphabet was up 0.4% in recent Friday premarket activity.
|
Technology stocks were gaining premarket Friday, with the Technology Select Sector SPDR Fund (XLK) up 0.3% and the SPDR S&P Semiconductor ETF (XSD) marginally higher. Alphabet's (GOOG, GOOGL) Google unit said it will start testing a new Tracking Protection feature for its Chrome browser on Jan. 4 that is designed to block third-party cookies that other websites use to track users' web activities. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Technology stocks were gaining premarket Friday, with the Technology Select Sector SPDR Fund (XLK) up 0.3% and the SPDR S&P Semiconductor ETF (XSD) marginally higher. Intel (INTC) Chief Executive Officer Pat Gelsinger said the company has no plans to spin out its contract chip manufacturing unit as a separate entity, Reuters reported Thursday. Alphabet was up 0.4% in recent Friday premarket activity.
|
2f6cc9f5-d875-4f8a-a474-acad0793c842
|
712488.0
|
2023-12-12 00:00:00 UTC
|
Energy Sector Update for 12/15/2023: NCSM, TTE, SHEL, XLE, USO, UNG
|
DCOMP
|
https://www.nasdaq.com/articles/energy-sector-update-for-12-15-2023%3A-ncsm-tte-shel-xle-uso-ung
|
nan
|
nan
|
Energy stocks were edging higher premarket Friday, with the Energy Select Sector SPDR Fund (XLE) slightly advancing recently.
The United States Oil Fund (USO) was 0.1% higher and the United States Natural Gas Fund (UNG) was inactive.
Front-month US West Texas Intermediate crude oil was up 0.5% at $71.93 per barrel at the New York Mercantile Exchange. Global benchmark Brent gained 0.4% to $76.95 per barrel, and natural-gas futures were 2.2% higher at $2.44 per 1 million BTU.
NCS Multistage Holdings (NCSM) was more than over 33% in value after saying its subsidiary has reached a settlement in a litigation with Boyd & McWilliams Energy Group, who filed a lawsuit in 2019 for property damage claims.
TotalEnergies (TTE) and its partners are initiating the building of hybrid renewable complex in South Africa, consisting of a 216 megawatt solar plant and a 500 MWh battery storage system. TotalEnergies was slightly higher pre-bell.
Shell (SHEL) was marginally declining after saying it agreed to divest its 37.5% stake in the PCK Raffinerie in Germany to UK-based Prax Group.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
NCS Multistage Holdings (NCSM) was more than over 33% in value after saying its subsidiary has reached a settlement in a litigation with Boyd & McWilliams Energy Group, who filed a lawsuit in 2019 for property damage claims. TotalEnergies (TTE) and its partners are initiating the building of hybrid renewable complex in South Africa, consisting of a 216 megawatt solar plant and a 500 MWh battery storage system. Shell (SHEL) was marginally declining after saying it agreed to divest its 37.5% stake in the PCK Raffinerie in Germany to UK-based Prax Group.
|
The United States Oil Fund (USO) was 0.1% higher and the United States Natural Gas Fund (UNG) was inactive. NCS Multistage Holdings (NCSM) was more than over 33% in value after saying its subsidiary has reached a settlement in a litigation with Boyd & McWilliams Energy Group, who filed a lawsuit in 2019 for property damage claims. TotalEnergies was slightly higher pre-bell.
|
Energy stocks were edging higher premarket Friday, with the Energy Select Sector SPDR Fund (XLE) slightly advancing recently. The United States Oil Fund (USO) was 0.1% higher and the United States Natural Gas Fund (UNG) was inactive. NCS Multistage Holdings (NCSM) was more than over 33% in value after saying its subsidiary has reached a settlement in a litigation with Boyd & McWilliams Energy Group, who filed a lawsuit in 2019 for property damage claims.
|
Energy stocks were edging higher premarket Friday, with the Energy Select Sector SPDR Fund (XLE) slightly advancing recently. The United States Oil Fund (USO) was 0.1% higher and the United States Natural Gas Fund (UNG) was inactive. Front-month US West Texas Intermediate crude oil was up 0.5% at $71.93 per barrel at the New York Mercantile Exchange.
|
3643bc40-ec6e-4fe4-9f8c-bdc4c21ce639
|
712489.0
|
2023-12-12 00:00:00 UTC
|
Financial Sector Update for 12/15/2023: HRTG, CRBG, AIG, BX, C, XLF, FAS, FAZ
|
DCOMP
|
https://www.nasdaq.com/articles/financial-sector-update-for-12-15-2023%3A-hrtg-crbg-aig-bx-c-xlf-fas-faz
|
nan
|
nan
|
Financial stocks were declining premarket Friday with the Financial Select Sector SPDR Fund (XLF) slipping by 0.3% recently.
The Direxion Daily Financial Bull 3X Shares (FAS) was down 0.7% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 0.7%.
Heritage Insurance Holdings' (HRTG) shares were over 8% lower after announcing that it is launching an underwritten public offering of its common shares.
Corebridge Financial (CRBG) said it signed a share repurchase agreement with American International Group (AIG) and an affiliate of Blackstone (BX) to buy back $150 million Corebridge common shares. Corebridge Financial shares were declining 0.1% in recent premarket activity.
Citigroup (C) will separate its Mexico consumer banking division from its US-based parent company in the second half of 2024 and sell it off in a public offering the following year, the company's general director told local reporters. Citigroup shares were up 0.1% pre-bell.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Corebridge Financial (CRBG) said it signed a share repurchase agreement with American International Group (AIG) and an affiliate of Blackstone (BX) to buy back $150 million Corebridge common shares. Corebridge Financial shares were declining 0.1% in recent premarket activity. Citigroup (C) will separate its Mexico consumer banking division from its US-based parent company in the second half of 2024 and sell it off in a public offering the following year, the company's general director told local reporters.
|
The Direxion Daily Financial Bull 3X Shares (FAS) was down 0.7% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 0.7%. Corebridge Financial (CRBG) said it signed a share repurchase agreement with American International Group (AIG) and an affiliate of Blackstone (BX) to buy back $150 million Corebridge common shares. Corebridge Financial shares were declining 0.1% in recent premarket activity.
|
The Direxion Daily Financial Bull 3X Shares (FAS) was down 0.7% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 0.7%. Heritage Insurance Holdings' (HRTG) shares were over 8% lower after announcing that it is launching an underwritten public offering of its common shares. Corebridge Financial (CRBG) said it signed a share repurchase agreement with American International Group (AIG) and an affiliate of Blackstone (BX) to buy back $150 million Corebridge common shares.
|
The Direxion Daily Financial Bull 3X Shares (FAS) was down 0.7% and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 0.7%. Heritage Insurance Holdings' (HRTG) shares were over 8% lower after announcing that it is launching an underwritten public offering of its common shares. Corebridge Financial shares were declining 0.1% in recent premarket activity.
|
753c06ec-f19e-4341-a83d-43e1b294a984
|
712490.0
|
2023-12-12 00:00:00 UTC
|
AIG's Corebridge Financial to Buy Back $150M of Common Stock
|
DCOMP
|
https://www.nasdaq.com/articles/aigs-corebridge-financial-to-buy-back-%24150m-of-common-stock
|
nan
|
nan
|
American International Group, Inc. AIG subsidiary, Corebridge Financial, Inc. CRBG, has recently disclosed a share repurchase agreement with AIG and an affiliate of Blackstone Inc. BX. Under this agreement, CRBG is set to repurchase $150 million worth of its common stock from AIG and BX.
AIG is slated to have around $135 million worth of Corebridge common shares repurchased, while Blackstone will see $15 million worth of stock bought back. The completion of the repurchase program is set to be on Dec 18, 2023, with the purchase price for the stocks locked at $21.75 per share.
This strategic move is anticipated to reduce AIG's stake in Corebridge, unlocking capital in the process. Despite the transaction, AIG will retain its majority shareholder status in CRBG. As of the end of the third quarter, the subsidiary boasted $360 billion in assets under management and administration.
In September 2022, AIG closed the IPO of Corebridge, the holding company for its Life and Retirement business, to focus more on de-levering and investing in core business growth. Additionally, earlier this month, it completed a secondary offering of CRBG shares, resulting in net proceeds of $712 million after deductions.
AIG is poised to further streamline its portfolio, emphasizing concentration on the General Insurance unit to minimize portfolio volatility and enhance cash liquidity. In line with this strategy, in May 2023, the company entered into a definitive agreement to divest Validus Re, AlphaCat and the Talbot Treaty reinsurance unit to RenaissanceRe Holdings.
Price Performance
AIG shares have gained 6.9% in the past year compared with the 4.7% rise in the industry.
Image Source: Zacks Investment Research
Zacks Rank & A Key Pick
AIG currently has a Zacks Rank #3 (Hold). A better-ranked stock in the broader Finance space is Assurant, Inc. AIZ, which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Assurant’s current-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 42.4%. Also, the consensus mark for AIZ’s 2023 revenues suggests 5.4% year-over-year growth.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Blackstone Inc. (BX) : Free Stock Analysis Report
American International Group, Inc. (AIG) : Free Stock Analysis Report
Assurant, Inc. (AIZ) : Free Stock Analysis Report
Corebridge Financial, Inc. (CRBG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Additionally, earlier this month, it completed a secondary offering of CRBG shares, resulting in net proceeds of $712 million after deductions. In line with this strategy, in May 2023, the company entered into a definitive agreement to divest Validus Re, AlphaCat and the Talbot Treaty reinsurance unit to RenaissanceRe Holdings. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
American International Group, Inc. AIG subsidiary, Corebridge Financial, Inc. CRBG, has recently disclosed a share repurchase agreement with AIG and an affiliate of Blackstone Inc. BX. AIG is slated to have around $135 million worth of Corebridge common shares repurchased, while Blackstone will see $15 million worth of stock bought back. Click to get this free report Blackstone Inc. (BX) : Free Stock Analysis Report American International Group, Inc. (AIG) : Free Stock Analysis Report Assurant, Inc. (AIZ) : Free Stock Analysis Report Corebridge Financial, Inc. (CRBG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
American International Group, Inc. AIG subsidiary, Corebridge Financial, Inc. CRBG, has recently disclosed a share repurchase agreement with AIG and an affiliate of Blackstone Inc. BX. Image Source: Zacks Investment Research Zacks Rank & A Key Pick AIG currently has a Zacks Rank #3 (Hold). Click to get this free report Blackstone Inc. (BX) : Free Stock Analysis Report American International Group, Inc. (AIG) : Free Stock Analysis Report Assurant, Inc. (AIZ) : Free Stock Analysis Report Corebridge Financial, Inc. (CRBG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Image Source: Zacks Investment Research Zacks Rank & A Key Pick AIG currently has a Zacks Rank #3 (Hold). The Zacks Consensus Estimate for Assurant’s current-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 42.4%.
|
9d626dad-b768-4b74-b6f1-7096654402fe
|
712491.0
|
2023-12-12 00:00:00 UTC
|
Where Will CRISPR Therapeutics Be in 5 Years?
|
DCOMP
|
https://www.nasdaq.com/articles/where-will-crispr-therapeutics-be-in-5-years-1
|
nan
|
nan
|
CRISPR Therapeutics (NASDAQ: CRSP) received great news last week. Its gene-editing therapy, which it has been developing with Vertex Pharmaceuticals, obtained approval from the Food and Drug Administration for sickle cell disease. It's a turning point for the business, which now has its first approved product.
But what's next for the business, and where does CRISPR Therapeutics go from here? Below I'll look at where the company may be in five years, and whether it's a good time to invest in the stock.
Will it be a market leader?
The CRISPR gene-editing market is expected to be worth $14.8 billion by 2030, according to projections from Straits Research. The industry is growing at an incredibly fast compound annual rate of 29.8%. And amid its early growth, CRISPR is starting to establish itself as a big name in gene editing. It's not a huge market, but CRISPR has the potential to become an early market leader within it.
Bluebird Bio also obtained FDA approval for its gene-editing therapy Lyfgenia, but it will have a black box warning on the label related to blood cancer. CRISPR's treatment, Casgevy, comes with no such warning. It's a good example of the company already setting itself apart from rivals as a safer option; Bluebird Bio, despite obtaining approval, crashed following the news as investors feared the warning would cripple the product's sales potential.
CRISPR and Vertex are also awaiting approval for their therapy as a treatment for transfusion-dependent beta thalassemia. The PDUFA date for that is set for March 30, 2024.
Further down the road, the company may have other gene-editing therapy treatments that come to market, including CTX112 and CTX131, which are allogeneic CAR T programs that are in early stage trials. CRISPR is also working on the first gene therapy treatment for diabetes with ViaCyte.
It's early on, but in five years CRISPR Therapeutics could have more approved therapies and could be well on its way to establishing itself as a leader in the market for gene-editing therapies.
Will the business be profitable?
Another big question for investors is whether or not CRISPR will be a profitable company in five years. Its recent approval will go a long way towards determining that. At its peak, analysts from Goldman Sachs project that Casgevy could generate up to $3.9 billion in revenue.
However, it's important to remember that CRISPR will share any earnings on the treatment with its development partner Vertex Pharmaceuticals, collecting 40% of the profits. In CRISPR's most recent quarterly results, which ended on Sept. 30, the company incurred a net loss of $112.2 million, which is down from $174.5 million in the prior-year period.
I don't believe that CRISPR will be profitable in five years, but it will be close to breaking even. While its expenses don't appear astronomical, it will need to spend money on commercialization efforts and its costs will increase. Plus, while the potential is high for Casgevy, it will take a while for it to reach its peak.
The good news is that even if it doesn't become profitable in five years, investors can rest assured that at least the business is moving in the right direction.
Could CRISPR become an acquisition target?
One scenario that could become a very real possibility is that another, larger healthcare company buys out CRISPR Therapeutics in an effort to diversify its operations. Now that CRISPR has an approved gene-editing therapy, it may attract greater interest from big names in the healthcare industry.
What's also attractive about CRISPR is that it has minimal debt on its books and lots of cash. Its total liabilities as of the end of September total just $359 million. Meanwhile, the company has more than $1.7 billion in cash and marketable securities. With loads of cash and not much in liabilities to worry about, that could make the stock a highly attractive acquisition target.
Predicting an acquisition is difficult, but I think there's a good chance that within the next five years CRISPR could get acquired. At a market capitalization of less than $5 billion, it's a fairly reasonably priced business given what it offers to an acquiror.
Should you invest in CRISPR's stock today?
CRISPR Therapeutics is looking like one of the better healthcare stocks to buy right now. With a high-priced treatment in its portfolio (Casgevy costs $2.2 million) and the potential for it to generate billions in revenue -- as well as tons of cash on its books and relatively modest liabilities -- the stock looks to be a no-brainer buy at this point. The recent approval has minimized the overall risk for investors.
As long as you're willing to be patient and are holding the stock for the long haul, CRISPR looks to be a top stock to buy right now.
Should you invest $1,000 in CRISPR Therapeutics right now?
Before you buy stock in CRISPR Therapeutics, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and CRISPR Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CRISPR Therapeutics, Goldman Sachs Group, and Vertex Pharmaceuticals. The Motley Fool recommends Bluebird Bio. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Bluebird Bio also obtained FDA approval for its gene-editing therapy Lyfgenia, but it will have a black box warning on the label related to blood cancer. It's a good example of the company already setting itself apart from rivals as a safer option; Bluebird Bio, despite obtaining approval, crashed following the news as investors feared the warning would cripple the product's sales potential. With a high-priced treatment in its portfolio (Casgevy costs $2.2 million) and the potential for it to generate billions in revenue -- as well as tons of cash on its books and relatively modest liabilities -- the stock looks to be a no-brainer buy at this point.
|
At its peak, analysts from Goldman Sachs project that Casgevy could generate up to $3.9 billion in revenue. Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and CRISPR Therapeutics wasn't one of them. The Motley Fool has positions in and recommends CRISPR Therapeutics, Goldman Sachs Group, and Vertex Pharmaceuticals.
|
It's early on, but in five years CRISPR Therapeutics could have more approved therapies and could be well on its way to establishing itself as a leader in the market for gene-editing therapies. As long as you're willing to be patient and are holding the stock for the long haul, CRISPR looks to be a top stock to buy right now. Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and CRISPR Therapeutics wasn't one of them.
|
It's early on, but in five years CRISPR Therapeutics could have more approved therapies and could be well on its way to establishing itself as a leader in the market for gene-editing therapies. With a high-priced treatment in its portfolio (Casgevy costs $2.2 million) and the potential for it to generate billions in revenue -- as well as tons of cash on its books and relatively modest liabilities -- the stock looks to be a no-brainer buy at this point. Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and CRISPR Therapeutics wasn't one of them.
|
6d6e9295-5f2a-4759-873d-9b34ebf41856
|
712492.0
|
2023-12-12 00:00:00 UTC
|
Here's What Key Metrics Tell Us About Darden Restaurants (DRI) Q2 Earnings
|
DCOMP
|
https://www.nasdaq.com/articles/heres-what-key-metrics-tell-us-about-darden-restaurants-dri-q2-earnings
|
nan
|
nan
|
Darden Restaurants (DRI) reported $2.73 billion in revenue for the quarter ended November 2023, representing a year-over-year increase of 9.7%. EPS of $1.84 for the same period compares to $1.52 a year ago.
The reported revenue represents a surprise of -0.41% over the Zacks Consensus Estimate of $2.74 billion. With the consensus EPS estimate being $1.71, the EPS surprise was +7.60%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Darden Restaurants performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Same-restaurant sales - LongHorn Steakhouse - YoY change: 4.9% compared to the 4.5% average estimate based on 10 analysts.
Same-restaurant sales - Olive Garden - YoY change: 4.1% versus 2.4% estimated by 10 analysts on average.
Company-owned restaurants - Olive Garden: 912 versus the nine-analyst average estimate of 910.
Same-restaurant sales - Consolidated - YoY change: 2.8% versus the nine-analyst average estimate of 2.4%.
Company-owned restaurants - LongHorn Steakhouse: 566 compared to the 566 average estimate based on nine analysts.
Company-owned restaurants - Total: 2,010 compared to the 2,016 average estimate based on nine analysts.
Same-restaurant sales - Other Business - YoY change: -1.1% versus 1.8% estimated by seven analysts on average.
Same-restaurant sales - Fine Dining - YoY change: -1.7% versus -0.8% estimated by seven analysts on average.
Sales- Olive Garden: $1.25 billion compared to the $1.21 billion average estimate based on five analysts. The reported number represents a change of +6.4% year over year.
Sales- Other Business: $514.90 million versus the five-analyst average estimate of $532.54 million. The reported number represents a year-over-year change of +1.5%.
Sales- Fine Dining: $318 million versus the five-analyst average estimate of $353.25 million. The reported number represents a year-over-year change of +57.4%.
Sales- LongHorn Steakhouse: $643 million compared to the $638.04 million average estimate based on five analysts. The reported number represents a change of +7.1% year over year.
View all Key Company Metrics for Darden Restaurants here>>>
Shares of Darden Restaurants have returned +4.8% over the past month versus the Zacks S&P 500 composite's +5.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Darden Restaurants, Inc. (DRI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Darden Restaurants (DRI) reported $2.73 billion in revenue for the quarter ended November 2023, representing a year-over-year increase of 9.7%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
Here is how Darden Restaurants performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Same-restaurant sales - LongHorn Steakhouse - YoY change: 4.9% compared to the 4.5% average estimate based on 10 analysts. Same-restaurant sales - Olive Garden - YoY change: 4.1% versus 2.4% estimated by 10 analysts on average. Same-restaurant sales - Fine Dining - YoY change: -1.7% versus -0.8% estimated by seven analysts on average.
|
Here is how Darden Restaurants performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Same-restaurant sales - LongHorn Steakhouse - YoY change: 4.9% compared to the 4.5% average estimate based on 10 analysts. Same-restaurant sales - Olive Garden - YoY change: 4.1% versus 2.4% estimated by 10 analysts on average. Same-restaurant sales - Fine Dining - YoY change: -1.7% versus -0.8% estimated by seven analysts on average.
|
Here is how Darden Restaurants performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Same-restaurant sales - LongHorn Steakhouse - YoY change: 4.9% compared to the 4.5% average estimate based on 10 analysts. Sales- Olive Garden: $1.25 billion compared to the $1.21 billion average estimate based on five analysts. The reported number represents a change of +6.4% year over year.
|
bdc1c3d9-8414-4d3d-bf30-78a86a8a8300
|
712493.0
|
2023-12-12 00:00:00 UTC
|
Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term
|
DCOMP
|
https://www.nasdaq.com/articles/why-broadridge-financial-solutions-br-is-a-top-stock-for-the-long-term-1
|
nan
|
nan
|
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. All of the features can help you identify what stocks to buy, what to sell, and what are today's hottest industries.
It also includes the Focus List, a long-term portfolio of top stocks that have all the elements to beat the market.
Breaking Down the Zacks Focus List
If you could get access to a curated list of stocks to kickstart your investment portfolio, wouldn't you jump at the chance to take a peek?
That's what the Zacks Focus List, a portfolio of 50 stocks, offers investors. Not only does it serve as a starting point for long-term investors, but all stocks included in the list are poised to outperform the market over the next 12 months.
Additionally, each selection is accompanied by a full Zacks Analyst Report, something that makes the Focus List even more valuable. The report explains in detail why each stock was picked and why we believe it's good for the long-term.
The portfolio's past performance only solidifies why investors should consider it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500's return of 9.38%. Cumulatively, the portfolio has returned 2,519.23% while the S&P returned 854.95%. Returns are for the period of February 1, 1996 to March 31, 2021.
Focus List Methodology
When stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.
Earnings estimates, or expectations of growth and profitability, come from brokerage analysts who track publicly traded companies; these analysts work together with company management to analyze every aspect that may affect future earnings, like interest rates, the economy, and sector and industry optimism.
Earnings estimate revisions are very important, since investors also need to take into consideration what a company will earn in the future.
When a stock receives upward earnings estimate revisions, it will likely get even more positive changes in the future. For instance, if an analyst raised their earnings outlook last month, they'll probably do so again this month, and other analysts will follow.
Harnessing the power of earnings estimate revisions is where the Zacks Rank comes in. The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions to make it easier to build a winning portfolio.
There are four main factors behind the Zacks Rank: Agreement, Magnitude, Upside, and Surprise. Each one of these features is then given a raw score that's recalculated every night and compiled into the Rank. Using this data, stocks are classified into five groups, ranging from "Strong Buy" to "Strong Sell."
The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts.
It can be very profitable to buy stocks with rising earnings estimates, as stock prices respond to revisions. By adding Focus List stocks, there's a great chance you'll be getting into companies whose future earnings estimates will be raised, which can lead to price momentum.
Focus List Spotlight: Broadridge Financial Solutions (BR)
Based in Lake Success, NY, Broadridge is a global financial technology company that offers investor communications and technology-driven solutions to banks, broker-dealers, asset managers and corporate issuers. The company is a leading producer and distributor of a variety of documents, widely used in the financial industry including proxies, annual reports, prospectuses and trade confirmations.
On August 29, 2017, BR was added to the Focus List at $76.91 per share. Shares have increased 151.77% to $193.64 since then, and the company is a #2 (Buy) on the Zacks Rank.
Four analysts revised their earnings estimate higher in the last 60 days for fiscal 2024, while the Zacks Consensus Estimate has increased $0.09 to $7.72. BR also boasts an average earnings surprise of 5.4%.
Moreover, analysts are expecting BR's earnings to grow 10.1% for the current fiscal year.
Reveal Winning Stocks
Unlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. You'll quickly identify which stocks to buy, hold and sell, and target today's hottest industries, to help improve the performance of your portfolio. Gain full access now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions to make it easier to build a winning portfolio. By adding Focus List stocks, there's a great chance you'll be getting into companies whose future earnings estimates will be raised, which can lead to price momentum. The company is a leading producer and distributor of a variety of documents, widely used in the financial industry including proxies, annual reports, prospectuses and trade confirmations.
|
The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. Reveal Winning Stocks Unlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Click to get this free report Broadridge Financial Solutions, Inc. (BR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts. Reveal Winning Stocks Unlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium.
|
All of the features can help you identify what stocks to buy, what to sell, and what are today's hottest industries. That's what the Zacks Focus List, a portfolio of 50 stocks, offers investors. Focus List Methodology When stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.
|
673c77f5-ac9b-48bb-b4de-499a3ce960d0
|
712494.0
|
2023-12-12 00:00:00 UTC
|
NIO Inc. (NIO) Recently Broke Out Above the 50-Day Moving Average
|
DCOMP
|
https://www.nasdaq.com/articles/nio-inc.-nio-recently-broke-out-above-the-50-day-moving-average
|
nan
|
nan
|
NIO Inc. (NIO) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NIO broke through the 50-day moving average, which suggests a short-term bullish trend.
The 50-day simple moving average is one of three major moving averages used by traders and analysts to determine support or resistance levels for a wide range of securities. But the 50-day is considered to be more important because it's the first marker of an up or down trend.
Over the past four weeks, NIO has gained 6.2%. The company is currently ranked a Zacks Rank #2 (Buy), another strong indication the stock could move even higher.
The bullish case solidifies once investors consider NIO's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too.
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on NIO for more gains in the near future.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NIO Inc. (NIO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The bullish case solidifies once investors consider NIO's positive earnings estimate revisions. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on NIO for more gains in the near future. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
The bullish case solidifies once investors consider NIO's positive earnings estimate revisions. Click to get this free report NIO Inc. (NIO) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on NIO for more gains in the near future. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report NIO Inc. (NIO) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on NIO for more gains in the near future. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Free: See Our Top Stock and 4 Runners Up >> Want the latest recommendations from Zacks Investment Research?
|
4cd9e888-8001-4191-9ad5-84590c1536fb
|
712495.0
|
2023-12-12 00:00:00 UTC
|
Intuit (INTU) Launches 'Business Differently' Brand Platform
|
DCOMP
|
https://www.nasdaq.com/articles/intuit-intu-launches-business-differently-brand-platform
|
nan
|
nan
|
Intuit INTU recently announced the launch of a global QuickBooks brand platform called "Business Differently." This platform is focused on reaching solopreneur small business owners.
The marketing campaign, created in partnership with QuickBooks' creative agency FCB and other agencies, features a TV spot with football star Saquon Barkley highlighting a solopreneur sports photographer. The campaign extends to social media, influencers and a new solopreneur content hub on the QuickBooks blog.
Activation across various social media platforms depicts how real solopreneurs are doing "business differently" with personal stories and creative storytelling.
As solopreneur businesses grow, they can seamlessly upgrade to the full range of solutions the QuickBooks platform offers, including accounting, payroll, workforce management and more.
This initiative by Intuit aims to emphasize that QuickBooks offers more than just accounting services, providing dynamic money management tools to help small businesses operate on their own terms.
The company also introduced QuickBooks Money, a subscription-free payments and banking solution designed for solopreneurs to get paid and manage their money without monthly fees or minimum balance requirements.
It combines QuickBooks Checking and QuickBooks Payments. QuickBooks Money offers an APY of 5.00%, which is more than 70 times the U.S. average, providing a competitive financial incentive for users.
QuickBooks Money is targeted toward the company’s Small Business and Self-Employed Group segment, which accounted for 56% of total revenues in fiscal 2023 compared with 51% in fiscal 2022.
Intuit Inc. Price and Consensus
Intuit Inc. price-consensus-chart | Intuit Inc. Quote
Intuit Benefits From Robust Product Portfolio
Intuit is benefiting from strong momentum in online ecosystem revenues and solid professional tax revenues. The TurboTax Live offering is also driving growth in the Consumer tax business. Solid momentum in the company’s lending product, QuickBooks Capital, is an upside.
Moreover, the company’s strategy of shifting its business to a cloud-based subscription model will help generate stable revenues. Intuit expects double-digit revenue growth and margin expansion in fiscal 2024.
The newly introduced Generative AI-based feature — Intuit Assist — added to all its major solutions, including Intuit TurboTax, Credit Karma, QuickBooks and Mailchimp, is expected to be a game changer.
Intuit Assist is powered by GenOS, which is built on OpenAI’s large language model. It leverages Intuit's ecosystem and database to offer personalized recommendations to both B2C and B2B customers.
TurboTax utilizes Intuit Assist to customize tax checklists and provide answers, insights and suggestions tailored to customers' needs. It draws upon Intuit's tax expertise, AI-driven Tax Knowledge Engine and proprietary data to provide this facility.
The users of Credit Karma can seek personalized financial recommendations, develop strategies and optimize their monthly spending.
For the second quarter of fiscal 2024, INTU expects revenues to grow between 11% and 12% on a year-over-year basis in the band of $3.362-$3.392 billion. Non-GAAP earnings for the quarter are estimated in the range of $2.25-$2.31 per share.
The Zacks Consensus Estimate for fiscal second-quarter 2024 revenues is pegged at $3.39 billion, indicating 11.37% year over year. The consensus estimate for earnings is pegged at $2.28 per share, down 10.2% over the past 30 days.
Zacks Rank and Stocks to Consider
Intuit currently carries a Zacks Rank #3 (Hold). Shares of the company have rallied 54.5% year to date, outperforming the Zacks Computer and Technology sector’s return of 49.1%.
Some better-ranked stocks from the broader technology sector are MongoDB MDB, Cloudflare NET and Bel Fuse BELFB. While BELFB sports a Zacks Rank #1 (Strong Buy), MDB and NET carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for MongoDB's fourth-quarter 2024 earnings has been revised 10 cents northward to 46 cents per share in the past 30 days. For fiscal 2024, earnings estimates have moved upward by 56 cents to $2.90 per share in the past 30 days.
MDB’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 277.91%. Shares of MDB have gained 108.9% year to date.
The Zacks Consensus Estimate for Clouflare's fourth-quarter 2023 earnings has moved northward by 2 cents to 12 cents in the past 60 days. For fiscal 2023, NET’s earnings estimates have been revised 9 cents upward to 46 cents per share in the past 60 days.
Cloudflare’s earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 63.22%. Shares of NET have gained 77.8% year to date.
The Zacks Consensus Estimate for Bel Fuse’s fourth-quarter fiscal 2023 earnings has been revised upward by 38 cents to $1.44 per share in the past 60 days. For fiscal 2023, earnings estimates have been raised by 72 cents to $6.28 in the past 60 days.
Bel Fuse’s earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 56.92%. Shares of Bel Fuse have surged 89.2% year to date.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuit Inc. (INTU) : Free Stock Analysis Report
Bel Fuse Inc. (BELFB) : Free Stock Analysis Report
MongoDB, Inc. (MDB) : Free Stock Analysis Report
Cloudflare, Inc. (NET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
As solopreneur businesses grow, they can seamlessly upgrade to the full range of solutions the QuickBooks platform offers, including accounting, payroll, workforce management and more. This initiative by Intuit aims to emphasize that QuickBooks offers more than just accounting services, providing dynamic money management tools to help small businesses operate on their own terms. The Zacks Consensus Estimate for Bel Fuse’s fourth-quarter fiscal 2023 earnings has been revised upward by 38 cents to $1.44 per share in the past 60 days.
|
Intuit Inc. Price and Consensus Intuit Inc. price-consensus-chart | Intuit Inc. Quote Intuit Benefits From Robust Product Portfolio Intuit is benefiting from strong momentum in online ecosystem revenues and solid professional tax revenues. While BELFB sports a Zacks Rank #1 (Strong Buy), MDB and NET carry a Zacks Rank #2 (Buy) each at present. Click to get this free report Intuit Inc. (INTU) : Free Stock Analysis Report Bel Fuse Inc. (BELFB) : Free Stock Analysis Report MongoDB, Inc. (MDB) : Free Stock Analysis Report Cloudflare, Inc. (NET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Intuit Inc. Price and Consensus Intuit Inc. price-consensus-chart | Intuit Inc. Quote Intuit Benefits From Robust Product Portfolio Intuit is benefiting from strong momentum in online ecosystem revenues and solid professional tax revenues. The Zacks Consensus Estimate for Bel Fuse’s fourth-quarter fiscal 2023 earnings has been revised upward by 38 cents to $1.44 per share in the past 60 days. Click to get this free report Intuit Inc. (INTU) : Free Stock Analysis Report Bel Fuse Inc. (BELFB) : Free Stock Analysis Report MongoDB, Inc. (MDB) : Free Stock Analysis Report Cloudflare, Inc. (NET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
QuickBooks Money is targeted toward the company’s Small Business and Self-Employed Group segment, which accounted for 56% of total revenues in fiscal 2023 compared with 51% in fiscal 2022. The Zacks Consensus Estimate for fiscal second-quarter 2024 revenues is pegged at $3.39 billion, indicating 11.37% year over year. Some better-ranked stocks from the broader technology sector are MongoDB MDB, Cloudflare NET and Bel Fuse BELFB.
|
e0e80e8a-0b98-49dd-8b17-1cfc76977faf
|
712496.0
|
2023-12-12 00:00:00 UTC
|
Realty Income Corp. (O) Crossed Above the 200-Day Moving Average: What That Means for Investors
|
DCOMP
|
https://www.nasdaq.com/articles/realty-income-corp.-o-crossed-above-the-200-day-moving-average%3A-what-that-means-for
|
nan
|
nan
|
After reaching an important support level, Realty Income Corp. (O) could be a good stock pick from a technical perspective. O surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.
The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.
O has rallied 8.9% over the past four weeks, and the company is a Zacks Rank #2 (Buy) at the moment. This combination suggests O could be on the verge of another move higher.
The bullish case solidifies once investors consider O's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too.
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on O for more gains in the near future.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Realty Income Corporation (O) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on O for more gains in the near future. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
|
After reaching an important support level, Realty Income Corp. (O) could be a good stock pick from a technical perspective. O surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. Click to get this free report Realty Income Corporation (O) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
O surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
4e8071c3-3392-4a44-9d72-a5b8a361b825
|
712497.0
|
2023-12-12 00:00:00 UTC
|
Lantheus Holdings (LNTH) Crossed Above the 200-Day Moving Average: What That Means for Investors
|
DCOMP
|
https://www.nasdaq.com/articles/lantheus-holdings-lnth-crossed-above-the-200-day-moving-average%3A-what-that-means-for
|
nan
|
nan
|
After reaching an important support level, Lantheus Holdings (LNTH) could be a good stock pick from a technical perspective. LNTH surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.
The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.
LNTH has rallied 14.3% over the past four weeks, and the company is a Zacks Rank #3 (Hold) at the moment. This combination suggests LNTH could be on the verge of another move higher.
The bullish case solidifies once investors consider LNTH's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 5 higher, while the consensus estimate has increased too.
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on LNTH for more gains in the near future.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lantheus Holdings, Inc. (LNTH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
After reaching an important support level, Lantheus Holdings (LNTH) could be a good stock pick from a technical perspective. The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on LNTH for more gains in the near future.
|
After reaching an important support level, Lantheus Holdings (LNTH) could be a good stock pick from a technical perspective. LNTH surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. Click to get this free report Lantheus Holdings, Inc. (LNTH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report Lantheus Holdings, Inc. (LNTH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
LNTH surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
735d51f6-6ef2-40e7-a446-86bb0f160d05
|
712498.0
|
2023-12-12 00:00:00 UTC
|
GE HealthCare Technologies (GEHC) Crossed Above the 200-Day Moving Average: What That Means for Investors
|
DCOMP
|
https://www.nasdaq.com/articles/ge-healthcare-technologies-gehc-crossed-above-the-200-day-moving-average%3A-what-that-means
|
nan
|
nan
|
After reaching an important support level, GE HealthCare Technologies (GEHC) could be a good stock pick from a technical perspective. GEHC surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.
The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.
GEHC has rallied 5.6% over the past four weeks, and the company is a Zacks Rank #3 (Hold) at the moment. This combination suggests GEHC could be on the verge of another move higher.
The bullish case solidifies once investors consider GEHC's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 3 higher, while the consensus estimate has increased too.
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on GEHC for more gains in the near future.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
After reaching an important support level, GE HealthCare Technologies (GEHC) could be a good stock pick from a technical perspective. The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on GEHC for more gains in the near future.
|
After reaching an important support level, GE HealthCare Technologies (GEHC) could be a good stock pick from a technical perspective. GEHC surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. Click to get this free report GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. Click to get this free report GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
GEHC surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
a910bb21-a479-4185-96a2-713c26d5c98d
|
712499.0
|
2023-12-12 00:00:00 UTC
|
Brokers Suggest Investing in Advanced Micro (AMD): Read This Before Placing a Bet
|
DCOMP
|
https://www.nasdaq.com/articles/brokers-suggest-investing-in-advanced-micro-amd%3A-read-this-before-placing-a-bet-0
|
nan
|
nan
|
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Advanced Micro Devices (AMD).
Advanced Micro currently has an average brokerage recommendation (ABR) of 1.43, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 29 brokerage firms. An ABR of 1.43 approximates between Strong Buy and Buy.
Of the 29 recommendations that derive the current ABR, 22 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75.9% and 3.5% of all recommendations.
Brokerage Recommendation Trends for AMD
Check price target & stock forecast for Advanced Micro here>>>
The ABR suggests buying Advanced Micro, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.
In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.
Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.
ABR Should Not Be Confused With Zacks Rank
Although both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
Is AMD a Good Investment?
In terms of earnings estimate revisions for Advanced Micro, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $2.65.
Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Advanced Micro. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Advanced Micro.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements. Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Advanced Micro.
|
Advanced Micro currently has an average brokerage recommendation (ABR) of 1.43, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) In terms of earnings estimate revisions for Advanced Micro, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $2.65. Click to get this free report Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Advanced Micro currently has an average brokerage recommendation (ABR) of 1.43, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Advanced Micro.
|
Brokerage Recommendation Trends for AMD Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Advanced Micro.
|
102ac920-a3d1-4bb8-b95c-a079a707f684
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.